UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
SCHEDULE 14A
(Rule 14a-101)
INFORMATION REQUIRED IN PROXY STATEMENT
SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a) of the
Securities
Exchange Act of 1934 (Amendment
No. )
Filed by the Registrant
þ
Filed by a Party other than the
Registrant
o
Check the appropriate box:
|
|
|
o
Preliminary
Proxy Statement
|
|
|
o
Confidential,
for Use of the Commission Only (as permitted by
Rule 14a-6(e)(2))
|
þ
Definitive
Proxy Statement
|
o
Definitive
Additional Materials
|
o
Soliciting
Material Pursuant to
§240.14a-12
|
HANGER ORTHOPEDIC GROUP, INC.
(Name of Registrant as Specified in
Its Charter)
(Name of Person(s) Filing Proxy
Statement if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
|
|
þ
|
No fee required.
|
|
o
|
Fee computed on table below per Exchange Act
Rules 14a-6(i)(1)
and
0-11.
|
|
|
(1)
|
Title of each class of securities to which transaction applies:
|
|
|
(2)
|
Aggregate number of securities to which transaction applies:
|
|
|
(3)
|
Per unit price or other underlying value of transaction computed
pursuant to Exchange Act
Rule 0-11
(Set forth the amount on which the filing fee is calculated and
state how it was determined):
|
|
|
(4)
|
Proposed maximum aggregate value of transaction:
|
|
|
o
|
Fee paid previously with preliminary materials.
|
|
o
|
Check box if any part of the fee is offset as provided by
Exchange Act
Rule 0-11(a)(2)
and identify the filing for which the offsetting fee was paid
previously. Identify the previous filing by registration
statement number, or the form or schedule and the date of its
filing.
|
|
|
(1)
|
Amount previously paid:
|
|
|
(2)
|
Form, schedule or registration statement no.:
|
HANGER
ORTHOPEDIC GROUP, INC.
Two
Bethesda Metro Center
Suite 1200
Bethesda, Maryland 20814
April 10,
2007
Dear Stockholder:
We are pleased to invite you to attend our Annual Meeting of
Stockholders. It will be held on Thursday, May 10, 2007, at
10:00 a.m. local time, at the Hyatt Regency Bethesda, 7400
Wisconsin Avenue, Bethesda, Maryland. The primary business of
the meeting will be to:
|
|
|
|
|
elect nine directors;
|
|
|
|
approve an amendment to our 2002 Stock Incentive Plan to include
annual variable compensation payments; and
|
|
|
|
approve an amendment to our 2003 Non-Employee Directors
Stock Incentive Plan to provide for the deferral of income
related to stock-based compensation for company directors.
|
A Notice of the Annual Meeting and the Proxy Statement follow.
It is important that your shares be represented and voted at the
meeting whether or not you plan to attend. Therefore, we urge
you to vote your proxy electronically by the Internet or
telephone, or sign and date the enclosed proxy card and mail it
promptly in the return-addressed, postage-prepaid envelope
provided for your convenience.
Sincerely,
Ivan R. Sabel
Chairman of the Board
and Chief Executive Officer
WHETHER OR NOT YOU PLAN TO ATTEND THE MEETING, PLEASE VOTE YOUR
SHARES BY TELEPHONE, INTERNET OR MAIL. IT IS THE
BOARDS RECOMMENDATION THAT SHAREHOLDERS VOTE FOR THE
PERSONS IT HAS NOMINATED TO SERVE AS DIRECTORS AND FOR THE
PROPOSED AMENDMENTS TO THE 2002 STOCK INCENTIVE PLAN AND THE
2003 NON-EMPLOYEE DIRECTORS STOCK INCENTIVE PLAN.
HANGER
ORTHOPEDIC GROUP, INC.
Two
Bethesda Metro Center
Suite 1200
Bethesda, Maryland 20814
NOTICE OF
ANNUAL MEETING OF STOCKHOLDERS
Dear Stockholder:
Notice is hereby given that the Annual Meeting of Stockholders
of Hanger Orthopedic Group, Inc., a Delaware corporation
(Hanger or the Company), will be held at
the Hyatt Regency Bethesda, 7400 Wisconsin Avenue, Bethesda,
Maryland on Thursday, May 10, 2007, at 10:00 a.m.
local time, for the following purposes:
1. to elect nine persons to serve as directors of the
Company for the ensuing year;
2. to approve an amendment to our 2002 Stock Incentive Plan
to include annual variable compensation payments;
3. to approve an amendment to our 2003 Non-Employee
Directors Stock Incentive Plan to provide for the deferral
of income related to stock-based compensation for Company
directors; and
4. to transact such other business as may properly come
before the meeting.
Only stockholders of record at the close of business on
March 22, 2007, are entitled to notice of, and to vote at,
the Annual Meeting.
By order of the Board of Directors,
George E. McHenry
Chief Financial Officer and Corporate Secretary
April 10, 2007
YOUR VOTE
IS IMPORTANT
WHETHER OR NOT YOU PLAN TO ATTEND THE ANNUAL MEETING OF
SHAREHOLDERS, WE URGE YOU TO VOTE AND SUBMIT YOUR PROXY BY
TELEPHONE, THE INTERNET OR BY MAIL AS PROMPTLY AS POSSIBLE TO
ENSURE THE PRESENCE OF A QUORUM FOR THE MEETING. FOR ADDITIONAL
INSTRUCTIONS ON VOTING BY TELEPHONE OR THE INTERNET, PLEASE
REFER TO YOUR PROXY CARD. TO VOTE AND SUBMIT YOUR PROXY BY MAIL,
PLEASE COMPLETE, SIGN AND DATE THE ENCLOSED PROXY CARD AND
RETURN IT IN THE ENCLOSED ENVELOPE. IF YOU ATTEND THE MEETING,
YOU MAY, OF COURSE, REVOKE THE PROXY AND VOTE IN PERSON. IF YOU
HOLD YOUR SHARES THROUGH AN ACCOUNT WITH A BROKERAGE FIRM,
BANK OR OTHER NOMINEE, PLEASE FOLLOW THE INSTRUCTIONS YOU
RECEIVE FROM THEM TO VOTE YOUR SHARES.
HANGER
ORTHOPEDIC GROUP, INC.
Two
Bethesda Metro Center
Suite 1200
Bethesda, Maryland 20814
PROXY
STATEMENT
GENERAL
This Proxy Statement is furnished in connection with the
solicitation by the Board of Directors of Hanger Orthopedic
Group, Inc., a Delaware corporation (Hanger or the
Company), of proxies of stockholders to be voted at
the Annual Meeting of Stockholders to be held at the Hyatt
Regency Bethesda, 7400 Wisconsin Avenue, Bethesda, Maryland at
10:00 a.m., local time, on Thursday, May 10, 2007, and
any and all adjournments thereof.
Any stockholder executing a proxy retains the right to revoke it
at any time prior to its being exercised by giving notice to the
Secretary of the Company.
This Proxy Statement and the accompanying proxy are being mailed
or given on or about April 10, 2007, to stockholders of
record of the Company on March 22, 2007.
VOTING
SECURITIES
As of March 22, 2007, a total of 22,161,214 shares of
common stock of the Company, par value $.01 per share
(Common Stock), which is the only class of voting
securities of the Company, were issued and outstanding. At the
Annual Meeting or any adjournment thereof, all holders of record
of the Common Stock as of the close of business on
March 22, 2007, will be entitled to one vote for each share
held upon the matters listed in the Notice of Annual Meeting.
Cumulative voting is not permitted.
Shares of Common Stock represented by proxy at the Annual
Meeting will be voted according to the instructions, if any,
given in the proxy. Unless otherwise instructed, the person or
persons named in the proxy will vote (1) FOR the election
of the nine nominees for director listed herein (or their
substitutes in the event any of the nominees is unavailable for
election); (2) FOR the approval of the proposed amendment
to the Companys 2002 Stock Incentive Plan to include
annual variable compensation payments; (3) FOR the approval
of the proposed amendment to the Companys 2003
Non-Employee Directors Stock Incentive Plan to provide for
the deferral of income related to stock-based compensation for
Company directors; and (4) in their discretion, with
respect to such other business as may properly come before the
meeting.
To vote your proxy by mail, mark your vote on the enclosed proxy
card; then follow the directions on the card. To vote your proxy
using the Internet or by telephone, see the instructions on the
enclosed proxy card. Your shares will be voted according to your
directions. If you do not mark any selections, your shares will
be voted as recommended by the Board of Directors.
Votes cast by proxy or in person at the Annual Meeting will be
tabulated by the inspectors of election appointed by the Company
for the meeting. The number of shares represented at the Annual
Meeting in person or by proxy will determine whether or not a
quorum is present. The inspectors of election will treat
abstentions as shares that are present and entitled to vote for
purposes of determining the presence of a quorum but as unvoted
for purposes of determining the approval of any matter submitted
to the stockholders for a vote. If a broker indicates on the
proxy that it does not have discretionary authority as to
certain shares to vote on a particular matter, those shares will
not be considered as present and entitled to vote by the
inspectors of election with respect to that matter.
The cost of soliciting proxies will be borne by the Company.
Proxies may be solicited by directors, officers or regular
employees of the Company in person or by telephone.
PROPOSAL ONE
ELECTION OF DIRECTORS
Nine directors are to be elected at the Companys Annual
Meeting of Stockholders, each to serve for one year or until his
or her successor is elected and qualified. Proxies will be voted
at the Annual Meeting, unless authority is withheld, FOR the
election of the nine persons named below, all of whom currently
are directors of the Company. The Company does not contemplate
that any of the persons named below will be unable or will
decline to serve; however, if any such nominee is unable or
declines to serve, the persons named in the accompanying proxy
will vote for a substitute, or substitutes, in their discretion.
The following table sets forth information regarding the
nominees.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Became
|
Name
|
|
Position With the Company
|
|
Age
|
|
Director
|
|
Ivan R. Sabel, CPO
|
|
Chairman of the Board, Chief
Executive Officer and Director
|
|
|
62
|
|
|
|
1986
|
|
Thomas F. Kirk
|
|
President, Chief Operating Officer
and Director
|
|
|
61
|
|
|
|
2002
|
|
Edmond E. Charrette, M.D.
|
|
Director
|
|
|
72
|
|
|
|
1996
|
|
Thomas P. Cooper, M.D.
|
|
Director
|
|
|
63
|
|
|
|
1991
|
|
Cynthia L. Feldmann
|
|
Director
|
|
|
54
|
|
|
|
2003
|
|
Eric Green
|
|
Director
|
|
|
45
|
|
|
|
2001
|
|
Isaac Kaufman
|
|
Director
|
|
|
60
|
|
|
|
2005
|
|
H.E. Thranhardt, CPO
|
|
Director
|
|
|
67
|
|
|
|
1996
|
|
Bennett Rosenthal
|
|
Director
|
|
|
43
|
|
|
|
2006
|
|
Ivan R. Sabel,
CPO has been our Chairman of the Board of
Directors and Chief Executive Officer since August 1995 and was
our President from November 1987 to January 2002. Mr. Sabel
also served as the Chief Operating Officer from November 1987
until August 1995. Prior to that time, Mr. Sabel had been
Vice President, Corporate Development from September 1986 to
November 1987. Mr. Sabel was the founder, owner and
President of Capital Orthopedics, Inc. from 1968 until that
company was acquired by us in 1986. Mr. Sabel is a
Certified Prosthetist and Orthotist (CPO), a former
clinical instructor in orthopedics at the Georgetown University
Medical School in Washington, D.C., a member of the
Government Relations Committee of the American Orthotic and
Prosthetic Association (AOPA), a former Chairman of
the National Commission for Health Certifying Agencies, a former
member of the Strategic Planning Committee, a current member of
the U.S. Veterans Administration Affairs Committee of AOPA
and a former President of the American Board for Certification
in Orthotics and Prosthetics. Mr. Sabel holds a B.S. in
Prosthetics and Orthotics from New York University.
Thomas F. Kirk
has been our President and Chief Operating
Officer since January 2002. From September 1998 to January 2002,
Mr. Kirk was a principal with AlixPartners, LLC (formerly
Jay Alix & Associates, Inc.), a management consulting
company retained by Hanger to facilitate its reengineering
process. From May 1997 to August 1998, Mr. Kirk served as
Vice President, Planning, Development and Quality for FPL Group,
a full service energy provider located in Florida. From April
1996 to April 1997, he served as Vice President and Chief
Financial Officer for Quaker Chemical Corporation in
Pennsylvania. From December 1987 to March 1996, he served as
Senior Vice President and Chief Financial Officer for
Rhone-Poulenc, S.A. in Princeton, New Jersey and Paris, France.
From March 1977 to November 1988, he was employed by St. Joe
Minerals Corp., a division of Fluor Corporation. Prior to this
he held positions in sales, commercial development, and
engineering with Koppers Co., Inc. Mr. Kirk holds a Ph.D.
degree in strategic planning/marketing, and an M.B.A. degree in
finance, from the University of Pittsburgh. He also holds a
Bachelor of Science degree in mechanical engineering from
Carnegie Mellon University. He is a registered professional
engineer and a member of the Financial Executives Institute.
Edmond E. Charrette, M.D.
is the co-founder and
former Chairman of Health Resources Corporation (principally
engaged in occupational medicine services). He also is a General
Partner of Ascendant Healthcare International (an investment
group with equity investments in the Latin American healthcare
sector) and serves as a director and the President of Latin
Healthcare Investment Management Co., LLC (a group composed of
Ascendant Healthcare International and The Global Environmental
Fund, which manages and directs the investment activities of the
Latin Healthcare Investment Fund). Previously, he was the
Executive Vice President and Chief Medical Officer of
Advantage-Health Corporation (a multi-hospital rehabilitation
and post-acute care system) from June 1994 to March 1996. From
1988 to May 1994, Dr. Charrette served as the Corporate
Medical Director and Senior Vice President of Medical Affairs of
Advantage Health Corporation.
2
Thomas P. Cooper, M.D
serves as the lead independent
director. He is the Chairman of the Board of VeriCare Management
Inc. and serves as an Adjunct Professor at the Columbia
University School of Business. From 1991 to 2006,
Dr. Cooper was the Chief Executive Officer of VeriCare
Management, Inc., which provides mental health services to
patients in long-term care facilities. From May 1989 to January
1997, Dr. Cooper served as the President and Chief
Executive Officer of Mobilex U.S.A., a provider of mobile
diagnostic services to long-term care facilities.
Dr. Cooper was the founder of Spectrum Emergency Care, a
provider of emergency physicians to hospitals, and Correctional
Medical Systems, a provider of health services to correctional
facilities.
Cynthia L. Feldmann
is the founder and president of Jetty
Lane Associates, a consultancy serving public company boards on
governance and audit committee issues. Previously,
Ms. Feldmann served as Business Development Officer at
Palmer & Dodge LLP, a Boston-based law firm, with a
specialty in serving life sciences companies. Previously, from
1994 2002, she was a Partner at KPMG LLP, holding
various leadership roles in the firms Medical Technology
and Health Care & Life Sciences industry groups.
Ms. Feldmann also was National
Partner-in-Charge
of Coopers & Lybrands Life Sciences practice from
1989-1994,
among other leadership positions she held during her
18 year career there. Ms. Feldmann was a founding
board member of Mass Medic, a Massachusetts trade association
for medical technology companies, where she also served as
treasurer and as a member of the boards Executive
Committee during her tenure from
1997-2001.
She currently serves as member of the board and audit committee
of STERIS Corporation, a company engaged in the
development, manufacture and marketing of sterilization and
decontamination equipment, consumables and services for
healthcare, scientific, research, industrial and governmental
customers throughout the world, and is also a member of the
board and the nominating & governance committee and
chair of the audit committee of Hayes Lemmerz International
Inc., a worldwide producer of aluminum and steel wheels for
passenger cars, trucks and trailers and a supplier of brakes and
powertrain components.
Eric A. Green
is a Partner of McLain Capital, a New York
based alternative investment firm. Previously, Mr. Green
was a Senior Partner of FriedbergMilstein, where he was
responsible for structured investments, including mezzanine and
growth equity transactions. Previously, he was a Partner-Group
Head and Managing Director of J.P. Morgan Partners (and its
predecessor organizations), the private equity affiliate of JP
Morgan Chase from 1998 to 2003, responsible for mezzanine/growth
equity and structured investments. Prior thereto, he was a
Managing Director in the Merchant Banking Group at BNP Paribas
for eight years, where he was responsible for mezzanine, growth
equity and structured investments. Previously, Mr. Green
held corporate planning and other financial positions at GE
Capital and GE Company. Mr. Green has served on numerous
public and private company boards of directors.
Isaac Kaufman,
has served as the Senior Vice President
and Chief Financial Officer of Advanced Medical Management Inc.,
a manager of medical practices and an outpatient surgical
center, since September 1998. Mr. Kaufman also serves as a
director of TransWorld Entertainment Corporation, a leading
specialty retailer of music and video products, and Kindred
Healthcare, Inc., a healthcare services company that through its
subsidiaries, operates hospitals, nursing centers, institutional
pharmacies and a contract rehabilitation services business
across the United States. Mr. Kaufman holds a Bachelor of
Science degree in accounting and finance from the University of
Maryland.
H.E. Thranhardt, CPO
is the former President and Chief
Executive Officer of J.E. Hanger, Inc. of Georgia
(JEH). He served in that capacity from
January 1, 1977 to November 1, 1996, on which date JEH
was acquired by Hanger. Mr. Thranhardt, who commenced his
employment with JEH in 1958, has occupied leadership positions
in numerous professional O&P associations, including
Chairman of the Board of the Orthotics and Prosthetics National
Office in 1994 and 1995, President of AOPA in 1992 and 1993,
President of the American Board for Certification in Orthotics
and Prosthetics in 1979 and 1980 and President of The American
Academy of Orthotics and Prosthetics in 1976 and 1977.
Bennett Rosenthal
is a founding member of Ares
Management, LLC, which, together with its affiliated managers,
manages the Ares Corporate Opportunities Fund, L.P., a private
securities investment fund. Prior to joining Ares Management,
LLC, Mr. Rosenthal was a Managing Director in the Global
Leveraged Finance Group of Merrill Lynch and was responsible for
originating, structuring and negotiating many leveraged loan and
high yield financings. Mr. Rosenthal was also a senior
member of Merrill Lynchs Leveraged Transaction Commitment
Committee. Mr. Rosenthal is a member of several Boards of
Directors including the Boards of Directors of Ares Capital
Corporation (Chairman), Ameriqual Group LLC, Aspen Dental,
Douglas Dynamics, LLC and National Bedding Company LLC.
3
MANAGEMENT
RECOMMENDS THAT YOU VOTE FOR THE ELECTION OF THE
ABOVE NOMINEES AS DIRECTORS OF THE COMPANY.
There are no family relationships between any of the nominees.
Committees
of the Board of Directors
The Board of Directors has an Audit Committee, a Compensation
Committee, a Corporate Governance and Nominating Committee, and
a Quality and Technology Committee. The Audit Committee held
seven meetings during 2006 and presently consists of Cynthia L.
Feldmann (Chair), Eric Green, and Isaac Kaufman. The Audit
Committee provides oversight on matters relating to accounting,
financial reporting, auditing and internal control and is
responsible for selecting, evaluating and meeting with the
Companys independent accountants to review the proposed
scope of the annual audit of the Companys books and
records, reviewing the findings of the independent accountants
upon completion of the annual audit, and reporting to the Board
of Directors with respect thereto. The Compensation Committee
conducted six meetings during 2006. It presently consists of
Eric Green (Chair), Thomas P. Cooper, M.D. and Edmond E.
Charrette, M.D., and is responsible for, among other
responsibilities, determinations relating to the compensation of
officers and key employees and certain of the Companys
employee benefit plans. The Corporate Governance and Nominating
Committee conducted two meetings in 2006. It presently consists
of Thomas P. Cooper, M.D. (Chair), Bennett Rosenthal, and
Edmond E. Charrette, M.D., and is responsible for, among
other responsibilities, advising the Board on matters relating
to the identification of nominees to the Board of Directors. The
Quality and Technology Committee is responsible for, among other
responsibilities, assisting the Board on matters relating to the
quality of the Companys services and the adequacy of the
Companys scientific and technical direction. It met three
times during 2006, and consists of H. E. Thranhardt, CPO
(Chair), Thomas P. Cooper, M.D., Thomas F. Kirk and Ivan R.
Sabel. The Board of Directors met nine times during 2006. Each
incumbent director attended at least 75% of the aggregate number
of meetings of the Board and committee(s) on which he or she
served as director or member during 2006. Copies of charters of
the Audit Committee, Compensation Committee and Corporate
Governance and Nominating Committee are available on our
website, www.hanger.com, and will be made available in print to
any shareholder who requests them.
Except for Ivan R. Sabel and Thomas F. Kirk, all of the nominees
for election as a director, including each of the members of the
Audit Committee, Compensation Committee, and Corporate
Governance and Nominating Committee, are independent directors
within the meaning of applicable New York Stock Exchange listing
standards and rules. For a director to be deemed independent
under NYSE rules, the Board must affirmatively determine that
the director has no material relationship with the Company
(either directly or as a partner, shareholder, or officer of an
organization that has a relationship with the Company). In
addition, the director (and member of his immediate family) must
meet the following technical independence rules within the last
three years:
|
|
|
|
|
The director has not been employed by the Company, and no
immediate family member has been an executive officer of the
Company;
|
|
|
|
The director (or an immediate family member, other than one who
is a non-executive employee of the Company) has not received,
during any
12-month
period, more than $100,000 in direct compensation from the
Company (other than director and committee fees, and pension and
other forms of deferred compensation for prior service);
|
|
|
|
The director (or an immediate family member) has not been
employed as an executive officer of another organization where
any of the Companys present officers serve on that
organizations compensation committee; and
|
|
|
|
The director has not been an executive officer or an employee of
another organization (and does not have an immediate family
member who has been an executive officer of another
organization) that made payments to or received payments from
the Company for property or services in an amount which, in any
single fiscal year, exceeded the greater of $1 million or
2% of such other organizations total revenue, based on the
reported results for its last fiscal year.
|
In addition to those technical independence rules, the following
must apply under NYSE rules in order for the director to be
deemed independent: (a) neither the director nor an
immediate family member is a current partner of
4
the Companys outside auditor; (b) the director is not
currently an employee of the Companys outside auditor;
(c) the director does not have an immediate family member
who is a current employee of the Companys outside auditor
and who participates in the firms audit, assurance, or tax
compliance (but not tax planning) practice; and (d) during
the last three years, neither the director nor an immediate
family member has been a partner or employee of the
Companys outside auditor and who personally worked on the
Companys audit within that time.
Board
Independence
As discussed above, our Board has determined that each of the
non-management nominees for director of the Company qualifies as
an independent director under the New York Stock
Exchange corporate governance rules and that each member of the
Audit Committee also qualifies as independent under
Rule 10A-3
under the Securities Exchange Act of 1934. The Board considered
the fact that Mr. Rosenthal is a founding member of Ares
Management, LLC, which, together with its affiliated managers,
manages the Ares Corporate Opportunities Fund, L.P.
(ACOF). On May 26, 2006, ACOF purchased
50,000 shares of the Companys newly issued
Series A Convertible Preferred Stock (the Convertible
Preferred Stock) for $50 million. The Convertible
Preferred Shares are convertible at the option of the holder
into shares of Common Stock at an initial conversion price of
$7.56 per share or at the option of the Company upon
satisfaction of certain conditions. Reference is also made to
the various beneficial ownership filings with the SEC
respecting, among other things, the investment by ACOF in the
Companys Convertible Preferred Stock as well as recently
purchased shares of the Companys Common Stock.
Mr. Rosenthal was appointed to the Board pursuant to an
agreement entered into in connection with ACOFs purchase
of such Convertible Preferred Stock.
Policy
Regarding Director Nominating Process
The Corporate Governance and Nominating Committee has adopted a
policy pursuant to which a shareholder who has owned at least 2%
of the Companys outstanding shares of Common Stock for at
least one year may recommend a director candidate that the
committee will consider when there is a vacancy on the board
either as a result of a director resignation or an increase in
the size of the board. Such recommendation must be made in
writing addressed to the Chairperson of the Corporate Governance
and Nominating Committee at the Companys principal
executive offices and must be received by the Chairperson at
least 120 days prior to the anniversary date of the release
of the prior years proxy statement. Although the committee
has not formulated any specific minimum qualifications that the
committee believes must be met by a nominee that the committee
recommends to the board, the factors it will take into account
will include strength of character, mature judgment, career
specialization, relevant technical skills or financial acumen,
diversity of viewpoint and industry knowledge, as set forth in
the committees charter. There will not be any difference
between the manner in which the committee evaluates a nominee
recommended by a shareholder and the manner in which the
committee evaluates any other nominee.
Policy
Regarding Communication with Directors
Shareholders and other interested parties desiring to
communicate with a director, the non-management directors as a
group or the full board may address such communication to the
attention of the Secretary of the Company at the Companys
executive offices and such communication will be forwarded to
the intended recipient or recipients.
Policy
Regarding Director Attendance at Annual Meetings
Under the Companys current policy, each director should
attend each annual meeting of shareholders. All of the current
directors attended last years annual meeting of
shareholders, with the exception of Bennett Rosenthal who was
appointed as a new director on November 9, 2006.
5
Meetings
of Non-Management Directors
Non-management members of the Board of Directors conduct at
least two regularly-scheduled meetings per year without members
of management being present. The chairperson of the Corporate
Governance and Nominating Committee serves as the presiding
director of such meetings and as the lead independent member of
the Board.
Corporate
Governance Guidelines and Code of Business Conduct and Ethics
for Directors and Employees
In 2003, the Board of Directors adopted Corporate Governance
Guidelines and a Code of Business Conduct and Ethics for
directors, officers and employees in accordance with
recently-amended
New York Stock Exchange corporate governance listing standards.
Copies of these documents are set forth on the Companys
website, www.hanger.com, and will be made available in print to
any shareholder who requests them.
Other
Matters
The firm of Foley & Lardner LLP serves as the
Companys outside general counsel. The Companys
Chairman and Chief Executive Officer is the
brother-in-law
of a partner in that firm. Total fees paid by the Company to
Foley & Lardner LLP during 2006 amounted to
approximately one-third of one percent of that firms
annual revenues for its last fiscal year.
COMPENSATION
RELATED MATTERS
SUMMARY
COMPENSATION TABLE
The following table sets forth for each of the named executive
officers: (i) the dollar value of base salary and bonus
earned during the year ended December 31, 2006;
(ii) the dollar amount of stock and option awards
recognized for financial reporting purposes with respect to the
year ended December 31, 2006 in accordance with
FAS 123R; (iii) the dollar value of earnings for
services pursuant to awards granted during the year under
non-equity incentive plans; (iv) the change in the
actuarial present value of the accumulated pension benefit
during the year; (v) all other compensation for the year;
and, finally, (vi) the dollar value of total compensation
for the year.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-Equity
|
|
|
Pension
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock
|
|
|
Option
|
|
|
Incentive Plan
|
|
|
Value and NQDC
|
|
|
All Other
|
|
|
|
|
|
|
|
|
|
Salary
|
|
|
Bonus
|
|
|
Awards
|
|
|
Awards
|
|
|
Compensation
|
|
|
Earnings
|
|
|
Compensation
|
|
|
Total
|
|
Name and Principal Position
|
|
Year
|
|
|
($)
|
|
|
($)
|
|
|
(1) ($)
|
|
|
($)
|
|
|
(2) ($)
|
|
|
(3) ($)
|
|
|
($)(4)
|
|
|
($)
|
|
|
Ivan R. Sabel
|
|
|
2006
|
|
|
$
|
545,000
|
|
|
|
|
|
|
$
|
376,391
|
|
|
|
|
|
|
$
|
135,182
|
|
|
$
|
758,154
|
|
|
$
|
44,745
|
|
|
$
|
1,859,472
|
|
Chairman and Chief Executive
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Officer of the Company
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Thomas F. Kirk
|
|
|
2006
|
|
|
$
|
463,500
|
|
|
|
|
|
|
$
|
121,307
|
|
|
|
|
|
|
$
|
107,781
|
|
|
$
|
524,238
|
|
|
$
|
54,468
|
|
|
$
|
1,271,294
|
|
President and Chief Operating
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Officer of the Company
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
George E. McHenry
|
|
|
2006
|
|
|
$
|
283,250
|
|
|
|
|
|
|
$
|
137,748
|
|
|
|
|
|
|
$
|
42,636
|
|
|
$
|
93,555
|
|
|
$
|
9,810
|
|
|
$
|
566,999
|
|
Executive Vice President and
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Chief Financial Officer
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
of the Company
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Richmond L. Taylor
|
|
|
2006
|
|
|
$
|
352,000
|
|
|
|
|
|
|
$
|
110,222
|
|
|
|
|
|
|
$
|
65,483
|
|
|
$
|
233,339
|
|
|
$
|
12,745
|
|
|
$
|
773,789
|
|
Executive Vice President of the
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Company and Chief Operating
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Officer of Hanger
Prosthetics &
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Orthotics, Inc. and HPO, Inc.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ronald N. May
|
|
|
2006
|
|
|
$
|
230,000
|
|
|
|
|
|
|
$
|
70,970
|
|
|
|
|
|
|
$
|
76,538
|
|
|
$
|
163,524
|
|
|
$
|
11,489
|
|
|
$
|
552,521
|
|
President and Chief Operating
Officer of Southern Prosthetic
Supply, Inc.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
|
All shares of restricted stock vest 25% per year,
commencing one year after the date of issuance. The amount
reported in this column represents the 2006 FAS 123R cost
of current-year and outstanding past equity awards. Reference is
made to Notes B and N to our consolidated financial
statements contained in our Annual Report on
Form 10-K
with respect to the calculation of such costs.
|
6
|
|
|
(2)
|
|
With respect to 2006, the above reported annual incentives were
paid on March 9, 2007 and related to 2006 performance.
|
|
(3)
|
|
The above amounts represent the change in actuarial present
value of the accumulated pension benefit for each named
executive officer under the Supplemental Executive Retirement
Plan (SERP). Details of the SERP are described in the Pension
Benefits table and the Compensation Discussion and Analysis
section below.
|
|
(4)
|
|
For Ivan Sabel, this total includes: taxable reimbursements for
qualified medical expenses not covered under the Companys
basic Group Health Insurance Program ($24,472), non-business
related automobile expenses ($7,487), premiums for additional
life insurance ($8,210), and contributions to the Companys
defined contribution plan ($4,576). For Tom Kirk, this total
includes: reimbursements for local housing in Bethesda, MD
($44,400), taxable reimbursements for qualified medical expenses
not covered under the Companys basic Group Health
Insurance Program ($1,152), premiums for additional life
insurance ($4,748), and contributions to the Companys
defined contribution plan ($4,168). For George McHenry, Richmond
Taylor and Ron May, these totals are for: non-business related
automobile expenses, premiums for additional life insurance, and
Company contributions to the defined contribution plan.
|
GRANTS OF
PLAN-BASED AWARDS
The following table sets forth information regarding all
incentive plan awards that were granted to the named executive
officers during 2006, including incentive plan awards
(equity-based and non-equity based) and other plan-based awards.
Disclosure on a separate line item is provided for each grant of
an award made to a named executive officer during the year.
Non-equity incentive plan awards are awards that are not subject
to FAS 123R and are intended to serve as an incentive for
performance to occur over a specified period.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
All Other
|
|
|
Full Grant
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
All
|
|
|
Option
|
|
|
Date
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other Stock
|
|
|
Awards:
|
|
|
Fair
|
|
|
|
|
|
|
Estimated Future Payouts
|
|
|
|
|
|
|
|
|
|
|
|
Awards:
|
|
|
Number of
|
|
|
Value of
|
|
|
|
|
|
|
Under Non-Equity
|
|
|
Estimated Future Payouts Under Equity
|
|
|
Number of
|
|
|
Securities
|
|
|
Stock or
|
|
|
|
|
|
|
Incentive Plan Awards(1)
|
|
|
Incentive Plan Awards
|
|
|
Shares of
|
|
|
Underlying
|
|
|
Option
|
|
|
|
|
|
|
Threshold
|
|
|
Target
|
|
|
Maximum
|
|
|
Threshold
|
|
|
Target
|
|
|
Maximum
|
|
|
Stock or
|
|
|
Options
|
|
|
Awards
|
|
Name
|
|
Grant Date
|
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
(#)
|
|
|
(#)
|
|
|
(#)
|
|
|
Units (#)(2)
|
|
|
(#)
|
|
|
($)
|
|
|
Ivan R. Sabel
|
|
|
06/12/2006
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
140,000
|
|
|
|
|
|
|
$
|
1,117,200
|
|
Ivan R. Sabel
|
|
|
01/01/2006
|
|
|
$
|
0
|
|
|
$
|
436,000
|
|
|
$
|
872,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Thomas F. Kirk
|
|
|
06/12/2006
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
110,000
|
|
|
|
|
|
|
$
|
877,800
|
|
Thomas F. Kirk
|
|
|
01/01/2006
|
|
|
$
|
0
|
|
|
$
|
347,625
|
|
|
$
|
695,250
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
George E. McHenry
|
|
|
06/12/2006
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
35,000
|
|
|
|
|
|
|
$
|
279,300
|
|
George E. McHenry
|
|
|
01/01/2006
|
|
|
$
|
0
|
|
|
$
|
141,625
|
|
|
$
|
283,250
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Richmond L. Taylor
|
|
|
06/12/2006
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
40,000
|
|
|
|
|
|
|
$
|
319,200
|
|
Richmond L. Taylor
|
|
|
01/01/2006
|
|
|
$
|
0
|
|
|
$
|
211,200
|
|
|
$
|
440,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ronald N. May
|
|
|
06/12/2006
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
25,000
|
|
|
|
|
|
|
$
|
199,500
|
|
Ronald N. May
|
|
|
01/01/2006
|
|
|
$
|
0
|
|
|
$
|
115,000
|
|
|
$
|
230,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Explanatory Notes for Columns:
|
|
(1)
|
Terms of compensation under the Non -Equity Incentive Plan are
discussed in detail in the Compensation Discussion and Analysis
section.
|
|
(2)
|
The restricted stock detailed above was awarded on June 12,
2006. The share price at the time of award was $7.98. All shares
of restricted stock vest 25% per year, commencing one year
after the date of issuance.
|
7
OUTSTANDING
EQUITY AWARDS AT FISCAL YEAR-END
The following table sets forth information on outstanding option
and stock awards held by the named executive officers at
December 31, 2006, including the number of shares
underlying both exercisable and unexercisable portions of each
stock option as well as the exercise price and expiration date
of each outstanding option, and the number and market value of
shares of restricted stock that have not vested.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Option Awards
|
|
|
Stock Awards
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity
|
|
|
Incentive
|
|
|
|
|
|
|
|
|
|
Equity
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Incentive
|
|
|
Plan Awards:
|
|
|
|
|
|
|
|
|
|
Incentive
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Plan
|
|
|
Market
|
|
|
|
|
|
|
|
|
|
Plan
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Awards:
|
|
|
or Payout
|
|
|
|
|
|
|
|
|
|
Awards
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number
|
|
|
Value of
|
|
|
|
|
|
|
|
|
|
Number
|
|
|
|
|
|
|
|
|
|
|
|
Market
|
|
|
of Unearned
|
|
|
Unearned
|
|
|
|
Number of
|
|
|
Number of
|
|
|
of Securities
|
|
|
|
|
|
|
|
|
Number
|
|
|
Value of
|
|
|
Shares,
|
|
|
Shares,
|
|
|
|
Securities
|
|
|
Securities
|
|
|
Underlying
|
|
|
|
|
|
|
|
|
of Shares or
|
|
|
Shares or
|
|
|
Units
|
|
|
Units or Other
|
|
|
|
Underlying
|
|
|
Underlying
|
|
|
Unexercised
|
|
|
Option
|
|
|
|
|
|
Units of
|
|
|
Units of
|
|
|
or Other
|
|
|
Rights
|
|
|
|
Unexercised
|
|
|
Unexercised
|
|
|
Unearned
|
|
|
Exercise
|
|
|
Option
|
|
|
Stock That
|
|
|
Stock That
|
|
|
Rights
|
|
|
That Have
|
|
|
|
Options (#)
|
|
|
Options (#)
|
|
|
Options
|
|
|
Price
|
|
|
Expiration
|
|
|
Have Not
|
|
|
Have Not
|
|
|
That Have
|
|
|
Not Vested
|
|
Name
|
|
Exercisable
|
|
|
Unexercisable
|
|
|
(#)
|
|
|
($)
|
|
|
Date
|
|
|
Vested (#)
|
|
|
Vested ($)(4)
|
|
|
Not Vested (#)
|
|
|
($)
|
|
|
Ivan R. Sabel
|
|
|
37,500
|
|
|
|
0
|
|
|
|
0
|
|
|
$
|
13.25
|
|
|
|
9/18/2007
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ivan R. Sabel
|
|
|
37,500
|
|
|
|
0
|
|
|
|
0
|
|
|
$
|
11.31
|
|
|
|
12/16/2007
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ivan R. Sabel
|
|
|
4,481
|
|
|
|
0
|
|
|
|
0
|
|
|
$
|
22.31
|
|
|
|
12/14/2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ivan R. Sabel
|
|
|
95,519
|
|
|
|
0
|
|
|
|
0
|
|
|
$
|
22.31
|
|
|
|
12/14/2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ivan R. Sabel
|
|
|
6,779
|
|
|
|
0
|
|
|
|
0
|
|
|
$
|
14.75
|
|
|
|
4/28/2009
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ivan R. Sabel
|
|
|
143,221
|
|
|
|
0
|
|
|
|
0
|
|
|
$
|
14.75
|
|
|
|
4/28/2009
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ivan R. Sabel
|
|
|
21,621
|
|
|
|
0
|
|
|
|
0
|
|
|
$
|
4.63
|
|
|
|
2/3/2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ivan R. Sabel
|
|
|
78,379
|
|
|
|
0
|
|
|
|
0
|
|
|
$
|
4.63
|
|
|
|
2/3/2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ivan R. Sabel
|
|
|
75,000
|
|
|
|
0
|
|
|
|
0
|
|
|
$
|
1.64
|
|
|
|
5/30/2009
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ivan R. Sabel
|
|
|
7,027
|
|
|
|
0
|
|
|
|
0
|
|
|
$
|
14.23
|
|
|
|
5/29/2012
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ivan R. Sabel
|
|
|
92,973
|
|
|
|
0
|
|
|
|
0
|
|
|
$
|
14.23
|
|
|
|
5/29/2012
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ivan R. Sabel
|
|
|
90,000
|
|
|
|
0
|
|
|
|
0
|
|
|
$
|
13.80
|
|
|
|
7/31/2013
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ivan R. Sabel(1)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
140,000
|
|
|
$
|
1,054,200
|
|
|
|
|
|
|
|
|
|
Ivan R. Sabel(2)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
56,250
|
|
|
$
|
423,563
|
|
|
|
|
|
|
|
|
|
Ivan R. Sabel(3)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7,500
|
|
|
$
|
56,475
|
|
|
|
|
|
|
|
|
|
Thomas F. Kirk
|
|
|
350,000
|
|
|
|
0
|
|
|
|
0
|
|
|
$
|
6.02
|
|
|
|
1/1/2012
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Thomas F. Kirk
|
|
|
100,000
|
|
|
|
0
|
|
|
|
0
|
|
|
$
|
13.50
|
|
|
|
1/1/2013
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Thomas F. Kirk
|
|
|
100,000
|
|
|
|
0
|
|
|
|
0
|
|
|
$
|
15.67
|
|
|
|
1/1/2014
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Thomas F. Kirk
|
|
|
100,000
|
|
|
|
0
|
|
|
|
0
|
|
|
$
|
8.08
|
|
|
|
1/1/2015
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Thomas F. Kirk(1)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
110,000
|
|
|
$
|
828,300
|
|
|
|
|
|
|
|
|
|
George E. McHenry
|
|
|
56,000
|
|
|
|
0
|
|
|
|
0
|
|
|
$
|
5.50
|
|
|
|
10/14/2011
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
George E. McHenry
|
|
|
17,919
|
|
|
|
0
|
|
|
|
0
|
|
|
$
|
16.74
|
|
|
|
10/14/2012
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
George E. McHenry
|
|
|
57,081
|
|
|
|
0
|
|
|
|
0
|
|
|
$
|
16.74
|
|
|
|
10/14/2012
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
George E. McHenry
|
|
|
40,000
|
|
|
|
0
|
|
|
|
0
|
|
|
$
|
13.80
|
|
|
|
7/31/2013
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
George E. McHenry(1)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
35,000
|
|
|
$
|
263,550
|
|
|
|
|
|
|
|
|
|
George E. McHenry(2)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
22,500
|
|
|
$
|
169,425
|
|
|
|
|
|
|
|
|
|
George E. McHenry(3)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,750
|
|
|
$
|
28,238
|
|
|
|
|
|
|
|
|
|
Richmond L. Taylor
|
|
|
28,192
|
|
|
|
0
|
|
|
|
0
|
|
|
$
|
14.19
|
|
|
|
6/30/2007
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Richmond L. Taylor
|
|
|
121,808
|
|
|
|
0
|
|
|
|
0
|
|
|
$
|
14.19
|
|
|
|
6/30/2007
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Richmond L. Taylor
|
|
|
11,666
|
|
|
|
0
|
|
|
|
0
|
|
|
$
|
4.63
|
|
|
|
2/3/2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Richmond L. Taylor
|
|
|
35,001
|
|
|
|
0
|
|
|
|
0
|
|
|
$
|
4.63
|
|
|
|
2/3/2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Richmond L. Taylor
|
|
|
23,333
|
|
|
|
0
|
|
|
|
0
|
|
|
$
|
1.64
|
|
|
|
5/30/2009
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Richmond L. Taylor
|
|
|
23,334
|
|
|
|
0
|
|
|
|
0
|
|
|
$
|
1.64
|
|
|
|
5/30/2009
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Richmond L. Taylor
|
|
|
7,573
|
|
|
|
0
|
|
|
|
0
|
|
|
$
|
14.23
|
|
|
|
5/29/2012
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Richmond L. Taylor
|
|
|
39,093
|
|
|
|
0
|
|
|
|
0
|
|
|
$
|
14.23
|
|
|
|
5/29/2012
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Richmond L. Taylor(1)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
40,000
|
|
|
$
|
301,200
|
|
|
|
|
|
|
|
|
|
Richmond L. Taylor(2)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
15,000
|
|
|
$
|
112,950
|
|
|
|
|
|
|
|
|
|
Richmond L. Taylor(3)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,500
|
|
|
$
|
18,825
|
|
|
|
|
|
|
|
|
|
Ronald N. May
|
|
|
10,000
|
|
|
|
0
|
|
|
|
0
|
|
|
$
|
16.50
|
|
|
|
5/13/2007
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ronald N. May
|
|
|
8,000
|
|
|
|
0
|
|
|
|
0
|
|
|
$
|
16.75
|
|
|
|
9/16/2012
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ronald N. May(1)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
25,000
|
|
|
$
|
188,250
|
|
|
|
|
|
|
|
|
|
Ronald N. May(2)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7,500
|
|
|
$
|
56,475
|
|
|
|
|
|
|
|
|
|
Ronald N. May(3)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,000
|
|
|
$
|
15,060
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
|
Restricted Stock Award vests 25% annually. The first vest date
is June 12, 2007.
|
|
(2)
|
|
Restricted Stock Award vests 25% annually. The first vest date
was March 4, 2006.
|
|
(3)
|
|
Restricted Stock Award vests 25% annually. The first vest date
was August 1, 2004.
|
|
(4)
|
|
The market value of stock reported was computed by multiplying
the closing market price of the stock at the end of the year
($7.53) by the number of shares of stock.
|
8
OPTION
EXERCISES AND STOCK VESTED
The following table sets forth information regarding each
exercise of stock options and vesting of restricted stock during
2006 for each of the named executive officers on an aggregated
basis:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Option Awards
|
|
|
Stock Awards
|
|
|
|
Number of Shares
|
|
|
Value Realized
|
|
|
Number of Shares
|
|
|
Value Realized on
|
|
|
|
Acquired on
|
|
|
on Exercise(1)
|
|
|
Acquired on
|
|
|
Vesting(2)
|
|
Name
|
|
Exercise (#)
|
|
|
($)
|
|
|
Vesting (#)
|
|
|
($)
|
|
|
Ivan R. Sabel
|
|
|
33,500
|
|
|
$
|
38,247
|
|
|
|
26,250
|
|
|
$
|
181,200
|
|
Thomas F. Kirk
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
George E. McHenry
|
|
|
|
|
|
|
|
|
|
|
11,250
|
|
|
$
|
77,925
|
|
Richmond L. Taylor
|
|
|
|
|
|
|
|
|
|
|
7,500
|
|
|
$
|
51,950
|
|
Ronald N. May
|
|
|
|
|
|
|
|
|
|
|
4,500
|
|
|
$
|
31,420
|
|
|
|
|
(1)
|
|
The value realized on exercise of options during 2006 was
calculated by multiplying the number of shares exercised with
each option exercise times the difference in price between the
market price on the date of the transaction minus the exercise
price (market price on the date of grant).
|
|
(2)
|
|
The value of restricted shares was calculated by multiplying the
number of shares vesting by the market price on the date of
vesting.
|
PENSION
BENEFITS
The following table sets forth the actuarial present value of
each named executive officers accumulated benefit under
each defined benefit plan, assuming benefits are paid at normal
retirement age based on current levels of compensation. The
table also shows the number of years of credited service under
each such plan, computed as of the same pension plan measurement
date used in the companys audited financial statements for
the year ended December 31, 2006.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of Years
|
|
|
Present Value of
|
|
|
Payments During
|
|
Name
|
|
Plan Name
|
|
|
Credited Service (#)
|
|
|
Accumulated Benefit ($)
|
|
|
Last Fiscal Year ($)
|
|
|
Ivan R. Sabel
|
|
|
SERP
|
|
|
|
3.00
|
|
|
$
|
2,024,371
|
|
|
|
0
|
|
Thomas F. Kirk
|
|
|
SERP
|
|
|
|
3.00
|
|
|
$
|
1,457,997
|
|
|
|
0
|
|
George E. McHenry
|
|
|
SERP
|
|
|
|
3.00
|
|
|
$
|
267,839
|
|
|
|
0
|
|
Richmond L. Taylor
|
|
|
SERP
|
|
|
|
3.00
|
|
|
$
|
637,901
|
|
|
|
0
|
|
Ronald N. May
|
|
|
SERP
|
|
|
|
3.00
|
|
|
$
|
444,089
|
|
|
|
0
|
|
The Supplemental Executive Retirement Plan (SERP) is a
nonqualified, unfunded plan that provides retirement benefits
for executive officers; it contains provisions to ensure its
compliance with Internal Revenue Code Section 409A.
Benefits accrue pro rata over the number of years (not to exceed
20) from a participants initial coverage by the SERP
until the participant reaches the age of 65. The Plan was
implemented in January 2004; credited service for the benefit
accrual started at that time. As a result, each of the
participants has three years of credited service under the plan.
The SERP benefit is determined by the benefit percentage
assigned by the Compensation Committee to an executive and is
not primarily determined on the basis of average base
compensation and years of service. The current benefit
percentage for each named executive officer is: Ivan
Sabel 90%; Thomas Kirk 85%; George
McHenry 75%; Richmond Taylor 80%; Ronald
May 65%.
Vesting is at the rate of 20% per year of employment with
the Company. All participants are fully vested.
9
The present value of the accumulated benefit was determined
using the following assumptions, which are the same as used for
financial reporting, except where noted:
|
|
|
|
|
Measurement
date:
12/31/2006
(12/31/05
for amounts calculated to determine
year-over-year
increase in actuarial present values)
|
|
|
|
Fiscal year
end:
12/31/2006
|
|
|
|
Discount rate:
5.75% (5.50% for present values
calculated as of
12/31/2005)
|
|
|
|
Mortality table (pre-retirement):
None*
|
|
|
|
Mortality table (post-retirement):
Not
applicable
|
|
|
|
Normal retirement age for SERP:
Age 65
|
|
|
|
Withdrawal rates:
None*
|
|
|
|
Retirement rates:
None prior to normal
retirement age, 100% at normal retirement date*
|
|
|
|
Accumulated benefit is calculated based on retirement
percentage, credited service and pay as of the respective
measurement dates.
|
|
|
|
Present value is the present value of 15 years certain
annuity payable at normal retirement date.
|
* Assumes executive will not terminate, become disabled,
die or retire prior to normal retirement age.
The SERP benefit, once calculated, is paid out annually for a
15 year period, commencing after a participants
retirement at age 65 from the Company, with no social
security reduction or other offset. Upon the death of a
participant, any unpaid vested benefits will be paid to the
designated beneficiary of the participant. If a participant
retires from the Company before reaching the age of 65, then the
benefits of such participant under the SERP will be subject to a
reduction for early commencement.
Upon the occurrence of a change in control of the Company, as
defined in the SERP, all actively employed participants will be
deemed to be 100% vested and the vested, accrued benefit will be
funded via a Rabbi Trust in an amount equal to the present value
of the accrued benefits. Periodic payments may be made to the
trust so the trusts assets continue to equal the present
value of the accrued benefits. The trust is subject to the
Companys creditors claim in the event of the
Companys insolvency.
10
TERMINATION
AND CHANGE OF CONTROL PROVISIONS
The following table sets forth potential payments upon any
termination of employment, including resignation, other types of
separation or retirement of the named executive officer or
change in control of the Company, assuming the triggering event
took place on December 29, 2006 (i.e., the last business
day of the Companys last completed fiscal year) and the
price per share of the Companys common stock was $7.53,
which was the closing market price as of that date. To the
extent that the form and amount of any payment or benefit that
would be provided in connection with any triggering event is
fully disclosed in the foregoing pension benefits table,
footnote reference is made to that disclosure. All of the
outstanding options of the named executive officers are fully
vested. Therefore, they may be exercised at any time and are
thus not triggered by a termination event and are not included
in the termination scenarios. Details of any current options are
shown in the Outstanding Equity Awards at Fiscal Year End table.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Voluntary
|
|
|
|
|
|
Involuntary
|
|
|
|
|
|
|
|
|
|
|
|
|
Termination &
|
|
|
|
|
|
Termination
|
|
|
|
|
|
|
|
|
|
|
|
|
Involuntary
|
|
|
|
|
|
Without Cause
|
|
|
|
|
|
|
|
|
|
|
|
|
Termination
|
|
|
|
|
|
or Change
|
|
|
Change in
|
|
|
|
|
|
|
|
Ivan Sabel
|
|
for Cause
|
|
|
Retirement
|
|
|
in Conditions
|
|
|
Control
|
|
|
Death
|
|
|
Disability
|
|
|
Death Benefit (including life
insurance)(1)
|
|
$
|
0
|
|
|
$
|
0
|
|
|
$
|
0
|
|
|
$
|
0
|
|
|
$
|
3,052,000
|
|
|
$
|
0
|
|
Severance Payments(2)
|
|
$
|
0
|
|
|
$
|
0
|
|
|
$
|
1,962,000
|
|
|
$
|
1,962,000
|
|
|
$
|
0
|
|
|
$
|
1,482,000
|
|
Restricted Stock (Unvested and
Accelerated)(3)
|
|
$
|
0
|
|
|
$
|
1,534,238
|
|
|
$
|
1,534,238
|
|
|
$
|
1,534,238
|
|
|
$
|
1,534,238
|
|
|
$
|
1,534,238
|
|
SERP Benefit(4)
|
|
$
|
0
|
|
|
$
|
0
|
|
|
$
|
1,308,665
|
|
|
$
|
1,308,665
|
|
|
$
|
0
|
|
|
$
|
1,308,665
|
|
Benefits Continuation(5)
|
|
$
|
0
|
|
|
$
|
0
|
|
|
$
|
29,704
|
|
|
$
|
29,704
|
|
|
$
|
0
|
|
|
$
|
0
|
|
Excise Tax &
Gross-Up(6)
|
|
$
|
0
|
|
|
$
|
0
|
|
|
$
|
0
|
|
|
$
|
1,033,342
|
|
|
$
|
0
|
|
|
$
|
0
|
|
|
|
|
(1)
|
|
The death benefit includes a payment equal to two times base
salary and target bonus (funded by key man life insurance) and a
supplemental life insurance benefit equal to 2 times base
salary. Mr. Sabel is also eligible for the companys
standard life insurance benefit.
|
|
(2)
|
|
The severance benefit is equal to two times base salary and
target bonus, as outlined in the CD&A section. In the event
of permanent and total disability, this severance benefit is
offset by disability insurance coverage.
|
|
(3)
|
|
This calculation is based on the accelerated vesting of all
outstanding restricted shares of stock, as shown on the
Outstanding Equity Awards at Fiscal Year-End table.
|
|
(4)
|
|
This amount reflects the present value of the additional benefit
which would accrue based on providing additional credited
service for the duration of any severance period. This is in
addition to the present value of the SERP benefit as of
12/31/06
as
shown in the Pension Benefits table.
|
|
(5)
|
|
This amount represents the cost of providing the continuation of
certain benefits (e.g., health insurance, life and disability
insurance, financial planning) as provided for in
Mr. Sabels employment agreement, discussed in detail
in the CD&A section.
|
|
(6)
|
|
This calculation represents the estimated amount of excise tax
calculated in accordance with IRS Code Section 280G as well
as the corresponding
gross-up
as
provided for in Mr. Sabels employment agreement.
|
11
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Involuntary
|
|
|
|
|
|
|
|
|
|
|
|
|
Voluntary
|
|
|
|
|
|
Termination
|
|
|
|
|
|
|
|
|
|
|
|
|
Termination &
|
|
|
|
|
|
Without
|
|
|
|
|
|
|
|
|
|
|
|
|
Involuntary
|
|
|
|
|
|
Cause or
|
|
|
|
|
|
|
|
|
|
|
|
|
Termination
|
|
|
|
|
|
Change in
|
|
|
Change in
|
|
|
|
|
|
|
|
Tom Kirk
|
|
for Cause
|
|
|
Retirement
|
|
|
Conditions
|
|
|
Control
|
|
|
Death
|
|
|
Disability
|
|
|
Death Benefit (including life
insurance)(1)
|
|
$
|
0
|
|
|
$
|
0
|
|
|
$
|
0
|
|
|
$
|
0
|
|
|
$
|
2,549,250
|
|
|
$
|
0
|
|
Severance Payments(2)
|
|
$
|
0
|
|
|
$
|
0
|
|
|
$
|
1,622,250
|
|
|
$
|
1,622,250
|
|
|
$
|
0
|
|
|
$
|
1,142,250
|
|
Restricted Stock (Unvested and
Accelerated)(3)
|
|
$
|
0
|
|
|
$
|
828,300
|
|
|
$
|
828,300
|
|
|
$
|
828,300
|
|
|
$
|
828,300
|
|
|
$
|
828,300
|
|
SERP Benefit(4)
|
|
$
|
0
|
|
|
$
|
0
|
|
|
$
|
940,395
|
|
|
$
|
940,395
|
|
|
$
|
0
|
|
|
$
|
940,395
|
|
Benefits Continuation(5)
|
|
$
|
0
|
|
|
$
|
0
|
|
|
$
|
24,511
|
|
|
$
|
24,511
|
|
|
$
|
0
|
|
|
$
|
0
|
|
Excise Tax &
Gross-Up(6)
|
|
$
|
0
|
|
|
$
|
0
|
|
|
$
|
0
|
|
|
$
|
773,087
|
|
|
$
|
0
|
|
|
$
|
0
|
|
|
|
|
(1)
|
|
The death benefit includes a payment equal to two times base
salary and target bonus (funded by key man life insurance) and a
supplemental life insurance benefit equal to 2 times base
salary. Mr. Kirk is also eligible for the companys
standard life insurance benefit.
|
|
(2)
|
|
The severance benefit is equal to two times base salary and
target bonus, as outlined in the CD&A section. In the event
of permanent and total disability, this severance benefit is
offset by disability insurance coverage.
|
|
(3)
|
|
This calculation is based on the accelerated vesting of all
outstanding restricted shares of stock, as shown on the
Outstanding Equity Awards at Fiscal Year-End table.
|
|
(4)
|
|
This amount reflects the present value of the additional benefit
which would accrue based on providing additional credited
service for the duration of any severance period. This is in
addition to the present value of the SERP benefit as of
12/31/06
as
shown in the Pension Benefits table.
|
|
(5)
|
|
This amount represents the cost of providing the continuation of
certain benefits (e.g., health insurance, life and disability
insurance, financial planning) as provided for in
Mr. Kirks employment agreement, discussed in detail
in the CD&A section.
|
|
(6)
|
|
This calculation represents the estimated amount of excise tax
calculated in accordance with IRS Code Section 280G as well
as the corresponding
gross-up
as
provided for in Mr. Kirks employment agreement.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Involuntary
|
|
|
|
|
|
|
|
|
|
|
|
|
Voluntary
|
|
|
|
|
|
Termination
|
|
|
|
|
|
|
|
|
|
|
|
|
Termination &
|
|
|
|
|
|
Without
|
|
|
|
|
|
|
|
|
|
|
|
|
Involuntary
|
|
|
|
|
|
Cause or
|
|
|
|
|
|
|
|
|
|
|
|
|
Termination
|
|
|
|
|
|
Change in
|
|
|
Change in
|
|
|
|
|
|
|
|
George McHenry
|
|
for Cause
|
|
|
Retirement
|
|
|
Conditions
|
|
|
Control
|
|
|
Death
|
|
|
Disability
|
|
|
Death Benefit (including life
insurance)(1)
|
|
$
|
0
|
|
|
$
|
0
|
|
|
$
|
0
|
|
|
$
|
0
|
|
|
$
|
1,203,813
|
|
|
$
|
0
|
|
Severance Payments(2)
|
|
$
|
0
|
|
|
$
|
0
|
|
|
$
|
637,313
|
|
|
$
|
637,313
|
|
|
$
|
0
|
|
|
$
|
382,379
|
|
Restricted Stock (Unvested and
Accelerated)(3)
|
|
$
|
0
|
|
|
$
|
0
|
|
|
$
|
461,213
|
|
|
$
|
461,213
|
|
|
$
|
461,213
|
|
|
$
|
461,213
|
|
SERP Benefit(4)
|
|
$
|
0
|
|
|
$
|
0
|
|
|
$
|
125,209
|
|
|
$
|
125,209
|
|
|
$
|
0
|
|
|
$
|
125,209
|
|
Benefits Continuation(5)
|
|
$
|
0
|
|
|
$
|
0
|
|
|
$
|
22,130
|
|
|
$
|
22,130
|
|
|
$
|
0
|
|
|
$
|
0
|
|
Excise Tax &
Gross-Up(6)
|
|
$
|
0
|
|
|
$
|
0
|
|
|
$
|
0
|
|
|
$
|
0
|
|
|
$
|
0
|
|
|
$
|
0
|
|
|
|
|
(1)
|
|
The death benefit includes a payment equal to 1.5 times base
salary and target bonus (funded by key man life insurance) and a
supplemental life insurance benefit equal to 2 times base
salary. Mr. McHenry is also eligible for the companys
standard life insurance benefit.
|
|
(2)
|
|
The severance benefit is equal to 1.5 times base salary and
target bonus, as outlined in the CD&A section. In the event
of permanent and total disability, this severance benefit is
offset by disability insurance coverage.
|
|
(3)
|
|
This calculation is based on the accelerated vesting of all
outstanding restricted shares of stock, as shown on the
Outstanding Equity Awards at Fiscal Year-End table.
|
12
|
|
|
(4)
|
|
This amount reflects the present value of the additional benefit
which would accrue based on providing additional credited
service for the duration of any severance period. This is in
addition to the present value of the SERP benefit as of
12/31/06
as
shown in the Pension Benefits table.
|
|
(5)
|
|
This amount represents the cost of providing the continuation of
certain benefits (e.g., health insurance, life and disability
insurance) as provided for in Mr. McHenrys employment
agreement, discussed in detail in the CD&A section.
|
|
(6)
|
|
Based on an estimated calculation, Mr. McHenrys
separation payments upon termination following a change in
control would not trigger an excise tax payment in accordance
with IRS Code Section 280G.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Involuntary
|
|
|
|
|
|
|
|
|
|
|
|
|
Voluntary
|
|
|
|
|
|
Termination
|
|
|
|
|
|
|
|
|
|
|
|
|
Termination &
|
|
|
|
|
|
Without
|
|
|
|
|
|
|
|
|
|
|
|
|
Involuntary
|
|
|
|
|
|
Cause or
|
|
|
|
|
|
|
|
|
|
|
|
|
Termination
|
|
|
|
|
|
Change in
|
|
|
Change in
|
|
|
|
|
|
|
|
Richmond Taylor
|
|
for Cause
|
|
|
Retirement
|
|
|
Conditions
|
|
|
Control
|
|
|
Death
|
|
|
Disability
|
|
|
Death Benefit (including life
insurance)(1)
|
|
$
|
0
|
|
|
$
|
0
|
|
|
$
|
0
|
|
|
$
|
0
|
|
|
$
|
1,548,800
|
|
|
$
|
0
|
|
Severance Payments(2)
|
|
$
|
0
|
|
|
$
|
0
|
|
|
$
|
844,800
|
|
|
$
|
844,800
|
|
|
$
|
0
|
|
|
$
|
528,000
|
|
Restricted Stock (Unvested and
Accelerated)(3)
|
|
$
|
0
|
|
|
$
|
432,975
|
|
|
$
|
432,975
|
|
|
$
|
432,975
|
|
|
$
|
432,975
|
|
|
$
|
432,975
|
|
SERP Benefit(4)
|
|
$
|
0
|
|
|
$
|
0
|
|
|
$
|
303,109
|
|
|
$
|
303,109
|
|
|
$
|
0
|
|
|
$
|
303,109
|
|
Benefits Continuation(5)
|
|
$
|
0
|
|
|
$
|
0
|
|
|
$
|
17,967
|
|
|
$
|
17,967
|
|
|
$
|
0
|
|
|
$
|
0
|
|
Excise Tax &
Gross-Up(6)
|
|
$
|
0
|
|
|
$
|
0
|
|
|
$
|
0
|
|
|
$
|
0
|
|
|
$
|
0
|
|
|
$
|
0
|
|
|
|
|
(1)
|
|
The death benefit includes a payment equal to 1.5 times base
salary and target bonus (funded by key man life insurance) and a
supplemental life insurance benefit equal to 2 times base
salary. Mr. Taylor is also eligible for the companys
standard life insurance benefit.
|
|
(2)
|
|
The severance benefit is equal to 1.5 times base salary and
target bonus, as outlined in the CD&A section. In the event
of permanent and total disability, this severance benefit is
offset by disability insurance coverage.
|
|
(3)
|
|
This calculation is based on the accelerated vesting of all
outstanding restricted shares of stock, as shown on the
Outstanding Equity Awards at Fiscal Year-End table.
|
|
(4)
|
|
This amount reflects the present value of the additional benefit
which would accrue based on providing additional credited
service for the duration of any severance period. This is in
addition to the present value of the SERP benefit as of
12/31/06
as
shown in the Pension Benefits table.
|
|
(5)
|
|
This amount represents the cost of providing the continuation of
certain benefits (e.g., health insurance, life and disability
insurance) as provided for in Mr. Taylors employment
agreement, discussed in detail in the CD&A section.
|
|
(6)
|
|
Based on an estimated calculation, Mr. Taylors
separation payments upon termination following a change in
control would not trigger an excise tax payment in accordance
with IRS Code Section 280G.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Involuntary
|
|
|
|
|
|
|
|
|
|
|
|
|
Voluntary
|
|
|
|
|
|
Termination
|
|
|
|
|
|
|
|
|
|
|
|
|
Termination &
|
|
|
|
|
|
Without
|
|
|
|
|
|
|
|
|
|
|
|
|
Involuntary
|
|
|
|
|
|
Cause or
|
|
|
|
|
|
|
|
|
|
|
|
|
Termination for
|
|
|
|
|
|
Change in
|
|
|
Change in
|
|
|
|
|
|
|
|
Ronald May
|
|
Cause
|
|
|
Retirement
|
|
|
Conditions
|
|
|
Control
|
|
|
Death
|
|
|
Disability
|
|
|
Death Benefit (including life
insurance)(1)
|
|
$
|
0
|
|
|
$
|
0
|
|
|
$
|
0
|
|
|
$
|
0
|
|
|
$
|
575,000
|
|
|
$
|
0
|
|
Severance Payments(2)
|
|
$
|
0
|
|
|
$
|
0
|
|
|
$
|
345,000
|
|
|
$
|
345,000
|
|
|
$
|
0
|
|
|
$
|
138,000
|
|
Restricted Stock (Unvested and
Accelerated)(3)
|
|
$
|
0
|
|
|
$
|
259,785
|
|
|
$
|
259,785
|
|
|
$
|
259,785
|
|
|
$
|
259,785
|
|
|
$
|
259,785
|
|
SERP Benefit(4)
|
|
$
|
0
|
|
|
$
|
0
|
|
|
$
|
212,592
|
|
|
$
|
212,592
|
|
|
$
|
0
|
|
|
$
|
212,592
|
|
Benefits Continuation(5)
|
|
$
|
0
|
|
|
$
|
0
|
|
|
$
|
0
|
|
|
$
|
0
|
|
|
$
|
0
|
|
|
$
|
0
|
|
Excise Tax &
Gross-Up(6)
|
|
$
|
0
|
|
|
$
|
0
|
|
|
$
|
0
|
|
|
$
|
0
|
|
|
$
|
0
|
|
|
$
|
0
|
|
13
|
|
|
(1)
|
|
The death benefit includes a payment equal to 1.5 times base
salary (funded by key man life insurance) and a supplemental
life insurance benefit equal to 1 times base salary.
Mr. May is also eligible for the companys standard
life insurance benefit.
|
|
(2)
|
|
The severance benefit is equal to 1.5 times base salary, as
outlined in the CD&A section. In the event of permanent and
total disability, this severance benefit is offset by disability
insurance coverage.
|
|
(3)
|
|
This calculation is based on the accelerated vesting of all
outstanding restricted shares of stock, as shown on the
Outstanding Equity Awards at Fiscal Year-End table.
|
|
(4)
|
|
This amount reflects the present value of the additional benefit
which would accrue based on providing additional credited
service for the duration of any severance period. This is in
addition to the present value of the SERP benefit as of
12/31/06
as
shown in the Pension Benefits table.
|
|
(5)
|
|
There is no provision for additional benefits to be provided to
Mr. May.
|
|
(6)
|
|
Based on an estimated calculation, Mr. Mays
separation payments upon termination following a change in
control would not trigger an excise tax payment in accordance
with IRS Code Section 280G.
|
DIRECTOR
COMPENSATION
The following table sets forth information regarding the
compensation received by each of the Companys directors
during the year ended December 31, 2006:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in Pension
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Value and
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nonqualified
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-Equity
|
|
|
Deferred
|
|
|
|
|
|
|
|
|
|
Fees Earned or
|
|
|
Stock
|
|
|
Option
|
|
|
Incentive Plan
|
|
|
Compensation
|
|
|
All Other
|
|
|
|
|
|
|
Paid in Cash
|
|
|
Awards
|
|
|
Awards
|
|
|
Compensation
|
|
|
Earnings
|
|
|
Compensation
|
|
|
Total
|
|
Name
|
|
($)(1)
|
|
|
($)(2)
|
|
|
($)(3)
|
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
Cynthia L. Feldmann*
|
|
$
|
58,000
|
|
|
$
|
27,222
|
|
|
$
|
27,349
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
112,571
|
|
Eric A. Green*
|
|
$
|
63,000
|
|
|
$
|
27,222
|
|
|
$
|
17,995
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
108,217
|
|
Isaac Kaufman*
|
|
$
|
48,500
|
|
|
$
|
30,723
|
|
|
$
|
2,335
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
81,558
|
|
Edmond Charrette*
|
|
$
|
59,000
|
|
|
$
|
15,770
|
|
|
$
|
17,339
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
92,109
|
|
Thomas Cooper*
|
|
$
|
77,155
|
|
|
$
|
30,330
|
|
|
$
|
17,995
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
125,480
|
|
H.E. Thranhardt
|
|
$
|
49,500
|
|
|
$
|
15,151
|
|
|
$
|
17,365
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
82,016
|
|
William Floyd(4)
|
|
$
|
7,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
7,000
|
|
Bennett Rosenthal
|
|
$
|
10,000
|
|
|
$
|
1,314
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
11,314
|
|
|
|
|
(1)
|
|
Amount Shown in Fees Earned column includes all fees earned or
paid in cash for services as a director, including annual
retainer fees, committee
and/or
chairmanship fees, and meeting fees. The amounts shown include
the cash value of any individual directors annual cash
retainer which may have been voluntarily converted into
restricted shares. Directors noted with an asterisk have
voluntarily elected to convert 110% of their $30,000 retainer
fee to restricted shares based on the May 17,
2006 share price of $7.54 per share resulting in an
award of 4,377 restricted shares which vest 1/3 per year
over 3 years. The value of 3,979 of such shares is shown in
this column; the remainder is shown under the Stock Awards
column.
|
|
(2)
|
|
Stock Awards includes the aggregate grant date fair value of the
standard annual grant for directors plus the 398 shares
resulting from the $3,000 premium provided for directors who
elected to take their retainer as equity in lieu of cash. This
was calculated in accordance with FAS 123R.
|
14
Aggregate number of stock awards outstanding as of
December 31, 2006 for each director is as follows:
|
|
|
|
|
|
|
Aggregate Number of Stock
|
|
|
|
Awards Outstanding as of
|
|
Name
|
|
12/31/2006
|
|
|
Cynthia L. Feldmann
|
|
|
12,877
|
|
Eric A. Green
|
|
|
12,877
|
|
Isaac Kaufman
|
|
|
12,877
|
|
Edmond Charrette
|
|
|
12,877
|
|
Thomas Cooper
|
|
|
14,877
|
|
H.E. Thranhardt
|
|
|
8,500
|
|
William Floyd
|
|
|
|
|
Bennett Rosenthal
|
|
|
4,250
|
|
|
|
|
(3)
|
|
Option Awards includes the aggregate grant date fair value
computed in accordance with FAS 123R. The aggregate number
of option awards outstanding as of December 31, 2006 for
each director is as follows:
|
|
|
|
|
|
|
|
Aggregate Number of Option
|
|
|
|
Awards Outstanding as of
|
|
Name
|
|
12/31/2006
|
|
|
Cynthia L. Feldmann
|
|
|
17,351
|
|
Eric A. Green
|
|
|
18,855
|
|
Isaac Kaufman
|
|
|
7,069
|
|
Edmond Charrette
|
|
|
45,373
|
|
Thomas Cooper
|
|
|
48,855
|
|
H.E. Thranhardt
|
|
|
50,908
|
|
William Floyd
|
|
|
|
|
Bennett Rosenthal
|
|
|
|
|
|
|
|
(4)
|
|
William Floyd elected to take his retainer fee as equity which
was forfeited in full upon his departure from the Board.
|
The compensation structure for non-employee directors includes
the following:
|
|
|
|
|
An annual cash retainer of $30,000 paid in four equal
installments. As outlined above, this may be converted to
restricted shares; if selected, this is converted at 110% of the
cash retainer value.
|
|
|
|
An annual grant of 8,500 shares of restricted
stock. These shares have a
3-year
vesting cycle (1/3 per year).
|
|
|
|
A $1,500 honorarium for Board meetings attended in person, a
$1,000 honorarium for Board meetings attended via a conference
call, and a $1,000 honorarium for any Committee meeting, whether
attended in person or via a conference call.
|
|
|
|
A $7,500 cash retainer for the chairpersons of the Audit and
Compensation Committees and a $5,000 cash retainer for the
chairpersons of the Corporate Governance & Nominating
and Quality & Technology Committees, paid at the same
time as the first installment of the annual cash retainer.
|
|
|
|
The Lead Director (Dr. Tom Cooper) also received an
additional $7,500 cash retainer and 2,000 shares of
restricted stock.
|
15
EXECUTIVE
COMPENSATION COMPENSATION DISCUSSION &
ANALYSIS
Objectives
of Our Executive Compensation Program
The compensation program which covers the named executive
officers is designed to drive the Companys success, which
will be achieved primarily through the actions of talented
employees. Our executive compensation program covering named
executive officers has specific primary objectives which include:
|
|
|
|
|
attracting qualified and talented executives who are capable of
providing the appropriate leadership to our Company;
|
|
|
|
retaining executives who have the critical skills our Company
needs to meet its strategic and operational objectives; and,
|
|
|
|
motivating our executives to drive outstanding Company
performance.
|
These objectives reflect our belief that programs which support
the attraction and retention of a highly-qualified executive
management team coupled with appropriate incentive
programs to motivate performance serve the long-term
interests of our investors.
Compensation arrangements for our named executive officers are
designed to reward long-term commitment to the Companys
success. The following principles guide our compensation
decisions:
|
|
|
|
|
Drive Company performance.
The incentive plans
are designed to reward annual and long-term Company performance.
Performance measures developed for our incentive programs have a
direct influence on shareholder value.
|
|
|
|
Facilitate alignment with shareholders.
Our
long-term incentives are delivered in the form of equity to
provide executives with a direct interest in the performance of
our stock.
|
|
|
|
Be fair and equitable.
Our executive
compensation programs are designed to provide compensation that
is fair and equitable for the performance of the executive and
the Company. In addition to conducting analyses of market pay
levels, we consider the pay of the named executive officers
relative to one another and relative to other members of the
management team.
|
|
|
|
Provide leadership stability and
continuity.
Our executive programs are designed
to reward both long-term contributions, as well as attract new
executive talent and reward commitment of our executives to the
Company regardless of their length of service with the Company.
We recognize that stability of the leadership team enhances our
business.
|
|
|
|
Be competitive.
We conduct market pay analyses
to ensure the compensation we pay our executives is competitive
in terms of elements of pay, program design and resulting levels
of pay.
|
|
|
|
Reflect factors of role and individual.
We use
the information from market pay analyses and apply it to the
individual situation of each of our executives to ensure we are
compensating for the roles responsibilities and the
individuals skills and performance.
|
|
|
|
Encourage long-term executive service.
The
Company provides employees tax effective savings opportunities.
The savings and retirement plans, along with a market
competitive offering of other pay elements, encourage employees
to join and remain at the Company.
|
16
Overview
of Our Executive Compensation Programs
Below are the purpose and key characteristics of the elements of
the executive compensation program.
|
|
|
Element
|
|
Purpose and
Characteristics
|
|
Base salary
|
|
Certain pay
element to compensate for an individuals competencies,
skills, and experience as valued in the marketplace and within
the Company and to reward continued performance.
|
|
|
Base salary may
be adjusted annually/periodically based on changes in job
responsibilities, market conditions and individual performance.
|
Annual
incentives
|
|
Performance-based
annual cash opportunity to motivate and reward the achievement
of annual financial results relative to business-specific
targets and individual goals tied to strategic initiatives.
|
|
|
Incentive goals
are set to balance stakeholders interests.
|
|
|
Awards, if
earned, are payable based on actual results.
|
Long-term
incentives
|
|
Performance-based
equity opportunity to motivate and reward financial performance
and stock price appreciation.
|
|
|
Amounts earned
and realized will vary from the grant date fair value based on
actual stock price performance.
|
Retirement
Benefits
|
|
Component of
compensation that accrues each year to encourage employment
stability of our executive leadership.
|
|
|
Benefits are
payable upon or after retirement.
|
Other Benefits
and Perquisites
|
|
Generally
certain pay elements which provide for life and income security
needs; the actual cost is based on participation/usage.
|
Severance
Benefits
|
|
Contingent
component to provide a bridge to future employment in the event
an executives employment is terminated.
|
|
|
Payable only if
an executives employment is terminated in certain
predefined situations.
|
Pay
Setting Process
To determine competitive market pay, we analyze the proxies of a
peer group of companies and published survey data. In setting
pay for the named executive officers, the target for
compensation, by element and in the aggregate, is based on the
competitive market pay median (50th percentile) considering
individual factors and internal relationships. The design of our
annual and long-term incentive plans provide the executives with
the opportunity to exceed the median based on Company
performance. Actual compensation, based on Company and
individual performance, can vary widely. We have engaged Towers
Perrin, an executive compensation and benefits consulting firm,
to provide this market pay data and advice on executive
compensation matters. We review the assessment of competitive
market pay every two to three years. Based on our analysis of
the competitive market pay for our named executive officers, our
named executive officers are appropriately compensated.
17
Peer
Group
We consider the executive compensation practices of the
executives of a peer group of companies. We have developed the
following peer group of nine companies in the health care
industry. While not specific to the orthotics and prosthetics
area of healthcare, these companies have executive talent with
comparable skills who face similar business challenges common to
the industry. These companies are similar in scope to our
Company with a median revenue size of $423 million. We
believe these companies provide a reasonable benchmark of the
market for compensation purposes.
|
|
|
|
|
|
|
2005 Revenue
|
|
Peer Company
|
|
(Millions)
|
|
|
American HomePatient, Inc.
|
|
$
|
333.2
|
|
AmSurg Corp.
|
|
$
|
391.8
|
|
DaVita, Inc.
|
|
$
|
2,973.9
|
|
Gentiva Health Services, Inc.
|
|
$
|
865.2
|
|
Odyssey Healthcare, Inc.
|
|
$
|
381.6
|
|
Pediatric Services of America,
Inc.
|
|
$
|
119.4
|
|
RehabCare Group, Inc.
|
|
$
|
454.3
|
|
Renal Care Group, Inc.
|
|
|
Acquired
|
|
United Surgical Partners
International
|
|
$
|
474.7
|
|
Practices of the peer group of companies are analyzed for each
named executive officer including base salary, annual incentive
compensation and long-term incentive compensation (as well as
the sum of these components, total direct compensation), and
other compensation practices.
In addition to analyzing the named executive officer
compensation of the peer group of companies, we also analyze the
Companys financial performance in relation to these
companies. We assess our executive compensation opportunities
against peer group practices relative to our financial
performance versus the peer group of companies. Based on our
most recent review of peer practices at the end of 2005, the
peer group companies were of reasonable size based on fiscal
year 2004 revenues. However, the Company performed below the
median of the peer group in several key metrics including
Earnings before Interest, Taxes, Depreciation and Amortization
(EBITDA) margin, Earnings per Share (EPS), one-year EPS growth,
return on equity (ROE) and one-year total shareholder return
(TSR). Our assessment of pay found base salary levels were
competitive with peer practices while incentive payments that
were made to our executives were below the peer group of
companies which reflects our relative financial performance
compared to these peer companies.
Published
survey data
We also analyze published survey data from both the health care
industry and general industry. The survey data used is based on
survey responses compiled for companies of similar size to our
Company from a revenue perspective.
We used survey data from Watson Wyatts Industry Report on
Top Management Compensation and Sullivan Cotters Survey of
Manager and Executive Compensation in Hospitals and Health
Services. The survey data, compiled by Towers Perrin, was from
companies that range close in size to the Company while also
considering the median of those companies participating to
ensure appropriateness of the information. The surveys include
companies that are both public and private in both general and
health care industry with $250M $1B in revenue.
Factors
to set or adjust pay
For each named executive officer, we consider the relevance of
data for the peer group and published survey data, considering:
|
|
|
|
|
The transferability of professional and managerial skills;
|
|
|
|
The depth of knowledge and experience in orthotics and
prosthetics and related industries;
|
18
|
|
|
|
|
The relevance of the named executive officers experience to
other potential employers; and
|
|
|
|
The readiness of the named executive officers to assume a
different or more significant role either within our company or
with another organization.
|
The following factors are also considered in setting and
adjusting pay for our named executive officers:
|
|
|
|
|
The companys financial performance;
|
|
|
|
The individuals performance;
|
|
|
|
Peer group pay practices and broader market
developments/trends; and
|
|
|
|
Our business and people needs.
|
In 2005, the analyses of both the peer group and published
survey data were conducted when considering the 2006
compensation adjustments of our named executive officers. In
2006, we updated the executive pay ranges and considered 2007
adjustments to our executive base salaries based on an
anticipated overall market movement of executive pay.
Focus
on
Pay-for-Performance
Consistent with the Companys objectives, performance-based
incentive opportunities, particularly long-term incentives, are
emphasized versus base salary. This is reflected through the mix
of the total direct compensation of our named executive
officers, which is set to approximate market median practices
(considering individual factors and internal relationships). For
2006, the target mix of our Chief Executive Officers (CEO)
compensation was 24% base salary, 18% annual incentive award and
58% long-term incentives. The average target mix of compensation
for our other named executive officers was 36% base salary, 20%
annual incentive award and 44% long-term incentives.
Based on the principle that named executive officer compensation
opportunities should be competitive with market practices, the
mix of compensation is a function of competitive market pay
practices and the profile of the position. This applies to the
mix of our named executive officers total direct
compensation among base salary, annual incentives, and long-term
incentives and the mix of cash and non-cash components.
Determination
of Pay Elements
We target total direct compensation (sum of base salary, annual
incentive compensation and long-term incentive compensation) at
the median of market practices with the opportunity to earn
amounts above target awards with exceptional levels of Company
performance.
In developing the pay programs and levels for named executive
officers, the compensation consultant provides the Compensation
Committee and management with peer group pay practices and other
relevant benchmarks. Further, the Board of Directors
independently reviews the performance of our CEO. All decisions
regarding any adjustment to the compensation of our CEO are made
solely by the Compensation Committee (the
Committee), based on both competitive practices as
well as the assessment of performance.
The CEO reviews the performance of each of the other named
executive officers and shares his perspective with the
Committee. He also develops pay recommendations for the other
officers. The Committee considers these performance reviews and
recommendations in setting the pay for our named executive
officers other than our CEO. Any changes to base salary and
annual incentive target amounts generally become effective in
January. The CEO is assisted in pay administration by the Vice
President of Human Resources.
Previous compensation earned by the named executive officers and
current Company stock holdings are considered when making
compensation decisions. We believe that our named executive
officers should be fairly and competitively compensated, both
for annual and long-term compensation opportunities, based on
the Companys performance and individual performance which
contributes to the Company performance.
The Committee may meet in executive session without the presence
of any member of management
and/or
the
consultant in making its decisions regarding the compensation of
any of the named executive officers.
19
When making any executive compensation decision, the Committee
follows a deliberate, multiple-step process:
1) Information review,
2) Evaluation and deliberation, and
3) Decision-making.
First, all essential information is collected that may be
necessary to make an educated decision. This is provided to the
Committee. Then, there is a discussion of the information and a
deliberation of possible options ensues. After discussion, the
Committee takes time for reflection and, where appropriate,
consultation with other Board members of the Company. Finally,
the Committee reconvenes for additional discussion, if needed,
before a final decision is made. As a result, most compensation
decisions require two or more Committee meetings before any
final decisions are made.
Additional information about the role and processes of the
Committee are outlined in the Compensation Committee Charter,
which is available on the Companys website.
Base
Salary
We target base salary levels for the named executive officers at
the median of market practices. Typically, our named executive
officers base salaries fall within the competitive range
of market practices when compared with the named executive
officers of our peer group as well as compared to survey data.
Individual increases are based upon several considerations,
including individual performance and contributions, internal
equity considerations, as well as competitive market factors and
practices. The current base salaries for our named executive
officers are competitive with market practices.
Base salary compensates a named executive officer for the
individuals competencies, skills, experience and
performance. When considering a candidate for a named executive
officer role, we consider all of these factors. For annual
adjustments to the base salary of a named executive officer, we
primarily consider the competitive market data, the
Companys performance, the individuals performance
and internal relationships. Changes in the scope of a named
executive officers role and responsibilities could result
in an adjustment being considered and approved by the Committee
at any time during the year.
Annual
Incentive Compensation
We offer annual incentive compensation opportunities to motivate
and reward the achievement of annual financial results and
individual goals. Currently our philosophy for annual incentive
compensation is to target the median of competitive practices
and to provide the opportunity to earn in the range of the
75th percentile with exceptional Company and individual
performance. In other words, when the Company reaches target
performance, then total cash compensation, base salary plus
annual incentive, is close to the median of market practices. If
the Company has exceptional performance, then total cash
compensation could approach the 75th percentile of market
practices. We believe that current target annual incentive
opportunities for our named executive officers are competitive
with market practices.
20
The target and maximum annual incentive awards expressed as a
percentage of base salary for our named executive officers are
included in the below table.
|
|
|
|
|
|
|
|
|
Incentive Awards Expressed as a Percentage of Base Salary
|
|
Target
|
|
|
Maximum
|
|
|
Van Sabel
|
|
|
80
|
%
|
|
|
160
|
%
|
Chief Executive Officer
|
|
|
|
|
|
|
|
|
Thomas F. Kirk
|
|
|
75
|
%
|
|
|
150
|
%
|
President and Chief Operating
Officer
|
|
|
|
|
|
|
|
|
George E. McHenry
|
|
|
50
|
%
|
|
|
100
|
%
|
Executive Vice President and
|
|
|
|
|
|
|
|
|
Chief Financial Officer
|
|
|
|
|
|
|
|
|
Richmond L. Taylor
|
|
|
60
|
%
|
|
|
125
|
%
|
President and Chief Operating
Officer,
|
|
|
|
|
|
|
|
|
Hanger Prosthetics &
Orthotics, Inc.
|
|
|
|
|
|
|
|
|
Ron May
|
|
|
50
|
%
|
|
|
100
|
%
|
President and Chief Operating
Officer,
|
|
|
|
|
|
|
|
|
Southern Prosthetic Supply, Inc.
|
|
|
|
|
|
|
|
|
Our annual incentive program is comprised primarily of annual
financial measures with a small portion (20% or less) based on
individual performance goals. In measuring our financial
performance for our 2006 annual incentive program, we used the
following measures:
|
|
|
|
|
Revenue;
|
|
|
|
Earnings Before Interest, Taxes, Depreciation and Amortization
(EBITDA); and
|
|
|
|
Fully Diluted Earnings per Share (EPS).
|
We chose these measures to ensure appropriate focus on creating
value for all of our stakeholders. The corporate level goals for
our 2006 annual incentive program at threshold, target and
maximum as well as the actual results achieved are presented in
the table below. If appropriate, Hanger may also develop
divisional performance measures, such as Revenue and EBITDA, to
measure financial performance under the annual incentive program
for individuals with division level responsibilities as was the
case with Mr. May for 2006.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 Corporate Performance Measures
|
|
Threshold
|
|
|
Target
|
|
|
Maximum
|
|
|
Actual Results
|
|
|
Revenue
|
|
$
|
555 million
|
|
|
$
|
605 million
|
|
|
$
|
655 million
|
|
|
$
|
598.8 million
|
|
EBITDA
|
|
$
|
72 million
|
|
|
$
|
80 million
|
|
|
$
|
85 million
|
|
|
$
|
77.1 million
|
|
EPS
|
|
$
|
0.33
|
|
|
$
|
0.43
|
|
|
$
|
0.50
|
|
|
$
|
0.49
|
(1)
|
|
|
|
(1)
|
|
Pro-forma for the effects of the re-financing announced in May
2006.
|
The performance measure targets are set as a part of our
strategic budgeting and goal setting process that begins in
December and is finalized in February. Targets for threshold,
target and maximum levels for each of the performance measures
used for the annual incentive program are approved by the
Committee in February for our named executive officers.
In addition to these financial goals, our named executive
officers have individual goals that they must achieve for their
individual performance which are focused on the Companys
strategic and operational initiatives. Individual performance is
measured on initiatives such as cost reductions, process
improvement, business development opportunities and people
initiatives. An executives individual objectives may be
qualitative or quantitative. The individual goals are typically
developed to be stretch goals that are challenging for the
executive to achieve.
The financial and individual performance measures are weighted
to reflect the focus of our annual strategic business plan. In
determining the annual incentive payments to make to our named
executive officers, the Committee may use discretion when
assessing the individuals performance compared with the
qualitative objectives established for the individual goals.
21
After year end, we assess the attainment of the performance
measures for the most recently completed year for the annual
incentive program against both financial and individual goals.
The final assessment of the year-end results is made in February
at which time any payments are approved for payment by
March 15th.
Actual annual incentive awards paid to our executives for 2006
were below target annual incentive percentages based on actual
performance. See the Non-Equity Incentive Plan Compensation
column of the Summary Compensation Table for the 2006 annual
incentive payments to each named executive officer paid in 2007.
Long-Term
Incentive Compensation
Long-term incentive compensation opportunities are provided to
our named executive officers to encourage the executives
continued commitment to the Company by motivating and rewarding
financial performance and stock price appreciation. We believe
this is an important component of their pay which directly
aligns the executives with shareholders since amounts granted,
earned and realized are dependent on actual stock price
performance.
When determining individual grants, we consider the results of a
periodic assessment of competitive market data and the
individual performance and contributions the named executive
officer has made to the Companys performance as well as
the contributions that are expected to be made in the future
based on the executives role. Every three to four years,
we conduct a competitive market assessment to establish a
general range for the number of shares to grant to our named
executive officers. We target the median of competitive market
data to set our long-term incentive awards with the potential to
earn above the median if the Company has exceptional
performance. Competitive long-term incentive market data is
developed based on an assessment of market practices of our peer
group and published survey data. This assessment was most
recently made at the end of 2005. The Compensation Committee
approves all grants to named executive officers.
We believe our methodology of reviewing the general range for
the number of shares for long-term incentive grants every three
to four years is appropriate. Our logic is that, by not
automatically readjusting the general range for the number of
shares granted annually, the fluctuating stock price will impact
our executives in the same manner as our shareholders. For
instance, if awards are recalibrated annually, below targeted
performance resulting in lower stock price could result in
additional shares being granted to our named executive officers.
We want to avoid this unintended potential to reward below
target performance as well as preclude the additional dilutive
effect to shareholders. Likewise, we perceive it to be a
detriment to our executives if an increase in stock price due to
above average performance results in fewer shares granted. By
not recalibrating in the first year of the stock price increase,
our executives are recognized for the above-target performance
which increased the stock price and are further encouraged to
sustain the performance level achieved.
In 2003, we commenced a multiple year transition process
(completed in 2006) to grant long-term incentives using
restricted shares in lieu of stock options. Our decision to make
this transition from stock options to full value shares was
based on the less dilutive effect of full value shares to our
shareholders, the new accounting rules requiring the expensing
of stock options and the possibility of providing a disincentive
to executives if the stock price decreases below the grant price.
Beginning with the grant in 2003, we granted our named executive
officers both stock options and time-based restricted shares.
Prior to 2003, we granted our long-term incentive awards
primarily in the form of stock options. We also anticipate
continuing this transition in the future with the grant of both
time-based and performance-based restricted shares.
In addition, we have been moving from an
18-month
grant cycle to a more typical and appropriate annual cycle. On
June 12, 2006, we granted time-based restricted shares to
our named executive officers which were 15 months after the
previous grant. The stock price at the time of this grant was
$7.98. We expect to continue to make grants of restricted shares
in 2007 and annually thereafter.
Only restricted shares were granted to our named executive
officers in 2006. They vest 25% annually over 4 years on
the anniversary of the grant date commencing on the first
anniversary. The awards are taxable income to the named
executive officer when the award vests in the amount equal to
the number of shares vested multiplied by the Companys
stock price on the vesting date. Also, on the vesting date, the
Company generally receives a tax deduction in the same amount.
The grants are valued as of the grant date for accounting
purposes under Statement of
22
Financial Accounting Standards Number 123 (Revised December
2004). The grants made in 2006 to each of our named executive
officers are included in the Grants of Plan-Based Awards Table
and are presented using the accounting values. The Company does
not coordinate the timing of equity grants with the release of
material, non-public information.
Special
Review of Previously Granted Stock Options
In 2006, we conducted a review of stock options previously
granted by the Company. This analysis, which covered a
7-year
period, was reviewed by outside counsel. We concluded that there
was no indication of any backdating of options. The data
reflects that the strike prices of the options were equal to the
stock price on the grant date. To ensure no perception of
manipulating the timing of grants, we also reviewed the strike
price of each grant and concluded that all were within a
reasonable range of the highs and lows for the month of the
grant; in fact, there were no grants made at shares low
price for the month of grant and the strike prices were usually
higher than the midpoint of the price for each month. Grants
made all correspond appropriately with actions taken by the
Board, by the Compensation Committee or under the provisions of
employment agreements.
Other Pay
Elements
Employment
Agreements
All of our named executive officers have entered into employment
agreements with the Company. The agreements provide for
compensation and benefits such as:
|
|
|
|
|
Base salary,
|
|
|
|
Annual and long-term incentive opportunities,
|
|
|
|
Benefits that are provided to all employees of the Company who
meet the eligibility requirements,
|
|
|
|
Various executive benefits such as a company-provided automobile,
|
|
|
|
Severance benefits, and
|
|
|
|
Change in control severance protection which may only be
triggered upon a change in control and a material change in the
terms of employment or responsibilities.
|
We currently provide no other special benefits not outlined in
the agreements. We also allow no tax gross ups for executive
benefits with the exception of excise taxes that may be imposed
on the executive due to a change in control. The employment
agreement of each named executive officer is described below.
Employment
agreement with Mr. Ivan R. Sabel
The employment and non-compete agreement, dated as of
April 29, 1999, as amended to comply with Internal Revenue
Code Section 409A, between Hanger and Ivan R. Sabel,
Chairman and CEO, had an initial five-year term which ended on
April 28, 2004. Presently, the agreement automatically
renews each year for successive one-year periods unless
terminated by either party.
The employment agreement entitles Mr. Sabel to certain
perquisites that have been offered to him to complete his
overall annual compensation package. As shown in the Summary
Compensation Table, the value of these perquisites in 2006 was
$44,745. These benefits include:
|
|
|
|
|
Taxable reimbursement for medical expenses not covered by the
Companys Basic Group Health insurance;
|
|
|
|
Premiums for supplemental long-term disability insurance;
|
|
|
|
Premiums for long-term care insurance for Mr. Sabel and his
spouse;
|
|
|
|
Premiums for supplemental life insurance equal to two times his
salary;
|
|
|
|
A Company-provided automobile; and
|
|
|
|
Financial and tax planning services.
|
23
Mr. Sabel is a participant in our Supplemental Executive
Retirement Plan. Pursuant to the agreement, his benefit under
this plan is equal to 90% of his final average base salary based
on the three highest years of the last five years of his
employment assuming normal retirement age of 65. See
Retirement Benefits below for a description of our
Supplemental Executive Retirement Plan.
Mr. Sabels employment agreement contains a severance
provision which provides that upon the termination of his
employment without cause, Mr. Sabel will receive severance
compensation equal to 24 months of his base salary then in
effect plus two years of his annual target bonus. Benefits
continuation will be provided to Mr. Sabel for eighteen
months following his termination. Mr. Sabels
employment agreement further provides that if his employment is
terminated within two years after a change in control of the
Company and the occurrence of a material diminution of his
responsibilities, a reduction of his compensation or benefits, a
relocation of his principal site of employment more than
25 miles from his then current location, or any material
breach of his employment agreement by the Company, then within
90 days after the occurrence of any such triggering events,
Mr. Sabel may resign and receive a continuation of his
benefits for a period of 18 months and severance
compensation equal to 24 months of base pay then in effect
plus two years of his annual target bonus. If any excise, income
and other taxes resulting from the imposition of parachute
penalties of the Internal Revenue Code or applicable state tax
law are imposed, Mr. Sabel will receive a payment for these
taxes.
In the event of his disability or death, Mr. Sabel or his
estate, will receive a payment equal to two years of base salary
and two years of target bonus payments, less any disability
payments he would be eligible to receive.
All unvested restricted shares granted to Mr. Sabel will
immediately vest on the date of his termination unless such
termination is by the Company for due cause or voluntarily by
Mr. Sabel prior to retirement (at or after the age of 65).
Mr. Sabels employment agreement also contains
non-compete provisions which provide that upon the termination
of his employment, Mr. Sabel will not be able to engage in
any business that is competitive with the Company anywhere in
the continental United States and will be unable to solicit any
of our employees or customers for a period of 24 months
from the date of termination.
Employment
agreement with Mr. Thomas F. Kirk
The employment and non-compete agreement between Hanger and
Thomas F. Kirk, President and Chief Operating Officer, dated
January 2, 2002, as amended to comply with Internal Revenue
Code Section 409A, provided for the continuation of his
employment in those positions for a period of five years, which
ended January 2, 2007. Presently, the agreement is
automatically renewed for successive one-year terms unless
terminated by either party.
The employment agreement entitles Mr. Kirk to certain
perquisites that have been offered to him to complete his
overall annual compensation package. As shown in the Summary
Compensation Table, the value of these perquisites in 2006 was
$54,468. These benefits include:
|
|
|
|
|
Taxable reimbursement for medical expenses not covered by the
Companys Basic Group Health insurance;
|
|
|
|
Premiums for supplemental long-term disability insurance;
|
|
|
|
Premiums for supplemental life insurance equal to two times his
salary;
|
|
|
|
A housing allowance;
|
|
|
|
Eligibility for a Company-provided automobile; and
|
|
|
|
Financial and tax planning services.
|
Mr. Kirk is a participant in our Supplemental Executive
Retirement Plan. Pursuant to the agreement, his benefit under
this plan is equal to 85% of his final average base salary based
on the three highest years of the last five years of his
employment assuming normal retirement age of 65.
The change in control, severance and non-compete provisions of
Mr. Kirks agreement are similar to those contained in
Mr. Sabels agreement.
24
Employment
agreement with Mr. George E. McHenry
The employment and non-compete agreement between Hanger and
George E. McHenry, Executive Vice President and Chief Financial
Officer, dated August 1, 2001, as amended to comply with
Internal Revenue Code Section 409A, provided for the
continuation of his employment in those positions for a period
of five years, through October 15, 2006. Presently, the
agreement is automatically renewed for successive one-year terms
unless terminated by either party.
The employment agreement entitles Mr. McHenry to certain
perquisites that have been offered to him to complete his
overall annual compensation package. As shown in the Summary
Compensation Table, the value of these perquisites in 2006 was
$9,810. These benefits include:
|
|
|
|
|
Premiums for supplemental long-term disability insurance;
|
|
|
|
Premiums for supplemental life insurance equal to two times his
salary; and
|
|
|
|
A Company-provided automobile.
|
Mr. McHenry is a participant in our Supplemental Executive
Retirement Plan. Pursuant to the agreement, his benefit under
this plan is equal to 75% of his final average base salary based
on the three highest years of the last five years of his
employment assuming normal retirement age of 65.
Mr. McHenrys employment agreement contains a
severance provision which provides that upon the termination of
his employment without cause, Mr. McHenry will receive
severance compensation equal to 18 months of his base
salary then in effect plus one and one-half years of his annual
target bonus plus continuation of his benefits for a period of
18 months. Mr. McHenrys employment agreement
further provides that if his employment is terminated within two
years after a change in control of the Company and the
occurrence of a material diminution of his responsibilities, a
reduction of his compensation or benefits, a relocation of his
principal site of employment more than 25 miles from his
then current location, or any material breach of his employment
agreement by the Company, then within 90 days after the
occurrence of any such triggering events, Mr. McHenry may
resign and receive a continuation of his benefits for a period
of 18 months and severance compensation equal to
18 months of his base pay then in effect plus one and
one-half years of his annual target bonus. Mr. McHenry will
receive a payment equal to any excise, income and other taxes
resulting from the imposition of parachute penalties of the
Internal Revenue Code or applicable state tax law.
In the event of his disability or death, Mr. McHenry or his
estate will receive a payment equal to 18 months of base
salary and 18 months of bonus payments, less any disability
payments he would be eligible to receive.
All restricted shares granted to Mr. McHenry will
immediately vest on the date of his termination, if such
termination is by reason of his death or disability, termination
without cause or following a change of control.
Mr. McHenrys agreement also contains non-compete and
non-solicitation provisions that provide that upon the
termination of his employment, he will be unable to engage in
any business that is competitive with the Company anywhere in
the continental United States and he will be unable to solicit
any of the Companys employees or customers for a period of
two years.
Employment
agreement with Mr. Richmond L. Taylor
The employment and non-compete agreement between Hanger and
Richmond L. Taylor, Executive Vice President of the Company and
Chief Operating Officer of the Companys patient-care
subsidiary, as amended to comply with Internal Revenue Code
Section 409A, has a five-year term which ends
April 17, 2008. Thereafter, the agreement is automatically
renewed for successive one-year terms until terminated by either
party.
The employment agreement entitles Mr. Taylor to certain
perquisites that have been offered to him to complete his
overall annual compensation package. As shown in the Summary
Compensation Table, the value of these perquisites in 2006 was
$12,745. These benefits include:
|
|
|
|
|
Premiums for supplemental long-term disability insurance;
|
|
|
|
Premiums for supplemental life insurance equal to two times his
salary; and
|
|
|
|
A Company-provided automobile.
|
25
Mr. Taylor is a participant in our Supplemental Executive
Retirement Plan. Pursuant to the agreement, his benefit under
this plan is equal to 80% of his final average base salary based
on the three highest years of the last five years of his
employment assuming normal retirement age of 65.
The change in control, severance and non-compete provisions in
Mr. Taylors agreement are generally the same as those
contained in Mr. McHenrys employment agreement,
except that the non-compete provisions only apply for
18 months following termination of employment.
Employment
agreement with Mr. Ron May
Ron May entered into an annually renewing employment agreement
with the Company dated as of January 1, 2003.
Mr. May receives certain perquisites that have been offered
to him to complete his overall annual compensation package
although not contractually required as a provision of his
agreement. As shown in the Summary Compensation Table, the value
of these perquisites in 2006 was $11,489. These benefits include:
|
|
|
|
|
Premiums for supplemental life insurance equal to one times his
salary; and
|
|
|
|
A Company-provided automobile.
|
Mr. May is a participant in our Supplemental Executive
Retirement Plan. Pursuant to the agreement, his benefit under
this plan is equal to 65% of his final average base salary based
on the three highest years of the last five years of his
employment assuming normal retirement age of 65.
The severance provisions in Mr. Mays agreement
provide that in the event that Mr. Mays employment is
terminated by reason of disability, a change of control or
without cause, then Mr. May shall receive a payment equal
to 18 months of his then base salary. In the event of a
change of control, Mr. May will receive a payment equal to
any excise, income and other taxes resulting from the imposition
of parachute penalties of the Internal Revenue Code or
applicable state tax law.
Mr. Mays agreement also contains non-compete and
non-solicitation provisions that provide that upon the
termination of his employment, Mr. May will be unable to
engage in any business that is competitive with the Company
anywhere in the continental United States and will be unable to
solicit any of our employees or customers for a period of
24 months after the date of termination.
Retirement
benefits
Our named executive officers are eligible to participate in the
Companys nonqualified Supplemental Executive Retirement
Plan (SERP). This benefit is intended to encourage
and reward the long-term commitment of our named executive
officers to the Company.
The SERP is a nonqualified, unfunded plan that provides
retirement benefits for executive officers and key employees of
the Company as designated by the Compensation Committee. The
plan contains provisions to ensure its compliance with Internal
Revenue Code Section 409A.
The SERP benefit is determined by the benefit percentage
assigned by the Compensation Committee to an executive and is
not primarily determined on the basis of average compensation
and years of service. Benefits accrue pro rata over the number
of years (not to exceed 20) from a participants
initial coverage by the SERP until the participant reaches the
age of 65. Vesting is at the rate of 20% per year of
employment with the Company. The SERP benefit, once calculated,
is paid out annually for a 15 year period, commencing after
a participants retirement from the Company, with no social
security reduction or other offset. Upon the death of a
participant, any unpaid vested benefits will be paid to the
designated beneficiary of the participant. If a participant
retires from the Company before reaching the age of 65, then the
benefits of such participant under the SERP will be subject to a
reduction for early commencement.
Upon the occurrence of a change in control of the Company, as
defined in the SERP, all actively employed participants will be
deemed to be 100% vested and the vested, accrued benefit will be
funded via a Rabbi Trust in an amount equal to the present value
of the accrued benefits. Periodic payments may be made to the
trust so the trusts
26
assets continue to equal the present value of the accrued
benefits. The trust is subject to the Companys
creditors claim in the event of the Companys
insolvency.
The estimated present value of these benefits at age 65 for
each of our named executive officers is shown in the Pension
Benefits Table. The projected change (December 2006 versus
December 2005) in the present value of this benefit is
shown in the Summary Compensation Table.
Other
Compensation-Related Policies
Securities
Trading Policy
We have a policy that executive officers and directors may not
purchase or sell Company stock when they may have nonpublic
material information. In addition, this policy provides that no
director or officer may sell short or engage in transactions in
put or call options relating to securities of the Company.
Stock
Ownership Guidelines
Whereas we strongly encourage our named executive officers to
maintain an ownership interest primarily through annual grants
of restricted shares, we have no formal stock ownership
guidelines or requirements in place.
Compensation
Recovery Policy
The Committee has instituted a policy that it will evaluate in
appropriate circumstances whether to seek the reimbursement of
certain compensation awards paid to an executive officer if such
executive engages in activities that caused or partially caused
a restatement of financial results. If circumstances warrant, we
will seek to require an executive officer to reimburse the
Company for certain portions of the executive officers
compensation for the relevant period, as provided by law.
Limitations
on Deductibility of Compensation
Section 162(m) of the Internal Revenue Code provides that
publicly-held companies may not deduct, in any taxable year,
compensation in excess of $1 million paid to the CEO and
the four other most highly compensated executive officers of the
Company which is not performance-based as defined in
that section.
We are taking measures, including the proposed amendment to the
2002 Stock Incentive Plan, to ensure that whenever possible the
performance-based compensation paid to our named executive
officers is deductible under Section 162(m). However, we
retain the authority to exercise discretion in payments made to
our named executive officers which under some circumstances may
result in compensation not being deductible. With shareholder
approval, the awards to be granted under the Companys 2002
Stock Incentive and Bonus Plan may qualify as
performance-based compensation. Compensation
currently paid by the Company which is not
performance-based has been less than the amount of
the deduction limit and such compensation therefore, qualifies
for deductibility under Section 162(m).
Compensation
Committee Report
The compensation committee of the board of directors has
reviewed and discussed the above Compensation
Discussion & Analysis with management and, based on
such review and discussion, has recommended to the board of
directors that the Compensation Discussion & Analysis
be included in the companys proxy statement.
Eric Green (Chair)
Thomas P. Cooper, M.D.
Edmund E. Charrette, M.D.
27
PROPOSAL TWO
APPROVAL OF AMENDMENT TO 2002 STOCK INCENTIVE PLAN
On January 28, 2002, the Board of Directors of the Company
approved, and on May 30, 2002, the shareholders of the
Company ratified the adoption of, the Companys 2002 Stock
Option Plan (the 2002 Plan) and the authorization of
a total of 1,500,000 shares of Common Stock to underlie
options granted and to be granted under the 2002 Plan. The 2002
Plan replaced the Companys expired 1991 Stock Option Plan
(the 1991 Plan). The 2002 Plan currently provides
for (i) the granting to employees of the Company of both
incentive stock options (ISOs) under
Section 422 of the Internal Revenue Code of 1986, as
amended (the Code) and non-qualified stock options
(NQSOs) which do not qualify as incentive stock
options under Section 422 of the Code. (ISOs and NQSOs
previously granted under the 1991 Plan and ISOs and NQSOs
granted under the 2002 Plan are collectively referred to
hereinafter as Options.). On February 6, 2003,
the Board of Directors of the Company approved, and on
May 30, 2003, the shareholders of the Company ratified, an
amendment to the 2002 Plan to provide for the grant of
restricted stock awards under the 2002 Plan in addition to the
existing provisions of the 2002 Plan relating to the issuance of
Options and, accordingly, to rename the 2002 Plan to be the 2002
Stock Incentive (rather than Option) Plan. On March 23,
2006, the Board of Directors of the Company approved, and on
May 12, 2006, the shareholders of the Company ratified, an
amendment to the 2002 Plan to increase the number of shares of
Common Stock authorized for issuance under the 2002 Plan by
2,700,000 shares.
On March 19, 2007, the Board of Directors of the Company
approved an amendment to effect certain changes to the 2002
Plan, most notably the incorporation of the Companys
current annual incentive plan for certain executive officers
into the 2002 Plan. The proposed amendment would result in the
following changes to the 2002 Plan:
|
|
|
|
|
Addition of performance-based cash awards (Incentive
Awards);
|
|
|
|
Limitation on the number of Options, shares of restricted stock,
annual Incentive Awards and long-term Incentive Awards that an
individual can receive during any calendar year;
|
|
|
|
Addition of a list of specific performance goals that the
Company may use for the provision of Awards under the 2002 Plan;
|
|
|
|
Limitation on the total number of shares of stock issued
pursuant to the exercise of ISOs;
|
|
|
|
Addition of a provision allowing for the Company to institute a
compensation recovery policy, which would allow the Compensation
Committee, in appropriate circumstances, to seek reimbursement
of certain compensation realized under Awards granted under the
2002 Plan; and
|
|
|
|
Inclusion of customary boilerplate provisions.
|
Approval of this amendment to the 2002 Plan by the holders of a
majority of the Companys outstanding shares of Common
Stock present or represented at the annual meeting of
stockholders is required for the adoption of such amendment. The
description of the material provisions of the 2002 Plan
contained in this Proxy Statement, as amended by such proposed
amendment thereto, including the changing of the name of the
2002 Plan to the Amended and Restated 2002 Stock Incentive
and Bonus Plan, is qualified by reference to the full
provisions of the 2002 Plan, a copy of which is set forth as
Appendix 1 to this Proxy Statement.
Rationale
for Amendment
The primary reason for this amendment is the formalization of
the Companys current annual incentive plan for certain
executive officers, which plan shall continue to be administered
in a manner consistent with the Companys past practices,
in the form of Incentive Awards to be granted pursuant to the
2002 Plan. In addition, the amendment allows Incentive Awards
and equity awards granted under the 2002 Plan to qualify as
performance-based compensation under Code Section 162(m),
thereby assuring the Companys deduction for amounts
payable or the value of shares issued under such awards. The
amendment to the 2002 Plan does not confer any additional awards
on the participants but is simply intended to formally document
the limits on amounts payable and the performance goals that may
be used under the Companys current annual incentive plan
and equity awards in accordance with Section 162(m) of the
Code.
28
Administration
The 2002 Plan will continue to be administered by the
Compensation Committee (the Committee) consisting of
three directors appointed by the Board. The members of the
Committee, who presently are Eric Green (Chair), Thomas P.
Cooper, M.D. and Edmond E. Charrette, M.D., are not
eligible to receive Options, restricted stock awards or
Incentive Awards (each, an Award) under the 2002
Plan. The Committee has the authority to determine the employees
to whom Awards are granted and, subject to the provisions of the
2002 Plan, the terms of Awards, including whether such an Option
is to be an ISO or NQSO and the amount payable upon achievement
of specified performance goals under an Incentive Award.
Purpose
The purpose of the 2002 Plan will continue to be to attract,
retain and motivate officers and key employees of the Company
and its subsidiaries and to provide a means by which such
persons may be given an opportunity to acquire a proprietary
interest in the Company through the ownership of Common Stock
through the exercise of stock Options granted under the 2002
Plan or the receipt of restricted stock awards under the 2002
Plan.
Eligible
Employees
The 2002 Plan will continue to provide for the granting of
Options and restricted stock awards to officers and key
employees of the Company and its subsidiaries selected by the
Committee. The 2002 Plan will also now provide for the granting
of Incentive Awards to officers and key employees of the Company
and its subsidiaries selected by the Committee. Approximately
200 persons are currently eligible to participate under the
stock incentive portion of the 2002 Plan. No decision has been
made by the Committee as to when, to whom or in what amounts
Awards will be granted this year or any future year under the
2002 Plan.
Limitations
on Grants
Subject to adjustment upon a change in capitalization, the
Committee shall not grant to an individual during any calendar
year: (i) Options for more than 270,000 shares of
Common Stock; (ii) an award of restricted stock relating to
more than 270,000 shares of Common Stock; (iii) an
annual Incentive Award that would result in payment of more than
$1,000,000; or (iv) a long-term Incentive Award that would
result in payment of more than $1,000,000.
Authorized
Shares
A total of 4,200,000 shares of Common Stock are authorized
by the Companys Board of Directors and approved by the
Companys stockholders for possible issuance under the 2002
Plan, subject to adjustment as provided under the 2002 Plan. The
total number of shares of Common Stock issued pursuant to the
exercise of ISOs shall not exceed 1,050,000 in the aggregate,
subject to adjustment in accordance with the 2002 Plan. As of
March 8, 2007, a total of 2,198,419 shares of Common
Stock remain available for issuance as either Options or
restricted shares. No Options were issued under the 2002 Plan
during the year ended December 31, 2006. A total of
350,000 restricted shares were issued under the 2002 Plan,
with an aggregate fair market dollar value equal to $2,793,000,
to all named executive officers of the Company during 2006. A
total of 392,250 restricted shares were issued under the 2002
Plan, with an aggregate dollar value equal to $3,112,105, to all
other employees of the Company during 2006. Shares of Common
Stock subject to Options that lapse or are cancelled or subject
to restricted stock awards that are forfeited will continue to
become available for issuance pursuant to future Options or
restricted stock awards granted under the 2002 Plan.
Options
Granted Under the 2002 Plan
The 2002 Plan will continue to provide for the issuance of ISOs
and NQSOs. As discussed below under Tax Consequences
Regarding Options, the Company would be able to recognize
certain deductions in connection with NQSOs that may not be
recognized in the case of ISOs.
29
Option
Exercise and Payment
The amount (valued at the time of grant) of an ISO that vests in
any one calendar year may not exceed $100,000. Furthermore, no
ISO may be granted under the 2002 Plan to any person who, as of
the time of the grant, owns capital stock of the Company
possessing more than 10% of the total combined voting power of
the Company, unless the exercise price of the ISO is at least
110% of the fair market value on the date of grant of the shares
of Common Stock subject to the ISO, and the term of the ISO does
not exceed five years from the date of grant.
The exercise price of ISOs as well as NQSOs under the 2002 Plan
may not be less than the fair market value of the Common Stock
on the date of grant of the Option. In some cases, as discussed
above, the exercise price of ISOs may not be less than 110% of
the fair market value of the Common Stock on the date of grant.
Fair market value is defined under the 2002 Plan
generally to mean the reported last sale price of the Common
Stock on the date immediately preceding the date for which the
value is being determined, as reported by the New York Stock
Exchange (or such other national securities exchange or
inter-dealer quotation system on or in which the shares of
Common Stock are listed or included in the future). The 2002
Plan prohibits the back-dating of Options.
In the event of a proposed merger, consolidation, dissolution or
liquidation of the Company, each Option will terminate unless
otherwise provided by the Board of Directors. If the Board makes
an Option terminate upon a merger or sale of assets, the Board
will notify the optionee that the Option will be exercisable in
full at that time for a period of 30 days from the date of
such notice and the Option will terminate upon the expiration of
such period.
The exercise price of Options granted under the 2002 Plan may be
paid for (i) in cash, (ii) in shares of Common Stock
already owned by the optionee and valued at their fair market
value on the date of exercise of the Option, or (iii) by a
combination of (i) and (ii) above, in the manner
provided in the Option agreement entered into in connection with
each Option. No Option granted under the 2002 Plan may be
exercised after the expiration of 10 years from the date it
was granted.
Subject to the above limitations, provisions relating to the
time or times at which an Option may be exercisable will be
included in the Option agreement entered into by the Company and
an optionee upon the granting of an Option. Options granted
under the 2002 Plan will be non-transferable by the optionee
otherwise than by will or the laws of descent and distribution
and will be exercisable during the optionees lifetime only
by him or her.
Restricted
Stock Granted under the 2002 Plan
The 2002 Plan will continue to provide for the issuance of
awards of restricted stock. The shares of Common Stock granted
under the 2002 Plan will be restricted because they will be
subject to whatever restrictions, including but not limited to
vesting periods, as may be determined by the Committee, although
the 2002 Plan requires that a restricted stock award that vests
upon attainment of performance goals have a vesting period of at
least one year and in any other case have a ratable vesting
period of at least three years. If the recipient employee ceases
to be an employee of the Company (except in cases of the
employees death, total or permanent disability or a change
in control of the Company) prior to the date on which all the
restrictions on the restricted shares have been satisfied or
expired, then such employee will forfeit all such restricted
shares as to which such restrictions have not been satisfied or
expired prior to that time. For an award of restricted stock
that is intended to be performance-based under
Section 162(m) of the Code, the restricted stock must vest
upon the attainment of one or more of the performance goals set
forth below under the heading Performance Goals.
In the event of a proposed merger, consolidation, liquidation or
dissolution, the Board will provide the stockholder with written
notice at least 30 days prior to such event. All remaining
restricted shares shall fully vest and all restrictions shall be
removed as of the date such notice is given.
Incentive
Award Agreements
The 2002 Plan provides for the grant of Incentive Awards. Each
Incentive Award made under the 2002 Plan shall contain such
terms and conditions, not inconsistent with the 2002 Plan, as
the Committee considers appropriate, including but not limited
to the performance goal(s), performance period (which must be a
period of one year or less for annual Incentive Awards, and more
than one year for long-term Incentive Awards), the potential
amount payable in cash or Common Stock, and the timing of
payment. All or a portion of the amount
30
subject to the Incentive Award must be contingent on the
achievement or partial achievement of one or more performance
goals during the performance period, although the Committee may
specify that all or a portion of the performance goals subject
to an Incentive Award are deemed achieved upon a
participants death, disability or such other circumstances
as the Committee may specify.
Performance
Goals
For purposes of the 2002 Plan, performance goals
means any goals the Committee establishes that relate to the
performance of the Company or any one or more of its
subsidiaries, or other business units, including net sales, cost
of sales, gross income, gross revenue, operating income,
earnings (before interest, taxes, depreciation
and/or
amortization), income from continuing operations, net income,
earnings per share (including diluted earnings per share), fair
market value of a share of Common Stock, cash flow, net cash
provided by operating activities, ratio of debt to debt plus
equity, return on shareholder equity, return on invested
capital, return on average total capital employed, return on net
assets employed before interest and taxes, operating working
capital, average accounts receivable, average inventories,
economic value added and customer satisfaction. As to each
performance goal, the relevant measurement of performance shall
be computed in accordance with generally accepted accounting
principles, if applicable, but, unless otherwise determined by
the Committee, will exclude the effects of certain extraordinary
events, such as gains or losses on the disposition of a business
or operating unit or changes in tax or accounting regulations or
laws. In the case of Awards that the Committee determines will
not be considered performance-based compensation
under Section 162(m) of the Code, the Committee may
establish other performance goals not listed in the 2002 Plan,
including subjective goals.
During the year ended December 31, 2006, the Company
granted Incentive Awards to its named executive officers with an
aggregate value of $427,620.
For a detailed discussion of all Awards granted to our named
executive officers, please see the discussion set forth under
Compensation Discussion & Analysis and
Compensation Related Matters included in this Proxy
Statement.
Compensation
Recovery Policy
The 2002 Plan provides that the Committee may institute a policy
that, in appropriate circumstances, it will evaluate whether to
seek the reimbursement of certain compensation realized under
Awards granted under the 2002 Plan to an executive officer if
such executive officer engages in activities that caused or
partially caused a restatement of the Companys financial
results. In such a case, the Company shall have the right,
notwithstanding any provision of the 2002 Plan, any Award or any
Award agreement to the contrary, to require the executive
officer to reimburse the Company for the amount of compensation
paid (including the value of any shares of Common Stock issued)
under the 2002 Plan for the relevant period, as provided by law.
Adjustments
Upon Changes in Capitalization
In the event any change in capitalization of the Company results
from a stock split or payment of a stock dividend or any other
increase or decrease in the number of shares of Common Stock
effected without the receipt of consideration, appropriate
adjustments will be made (i) to the shares of Common Stock
reserved for the grant of Options and restricted shares under
the 2002 Plan; (ii) the maximum number of shares of Common
Stock with respect to which an employee may receive an Option or
award of restricted stock; (iii) the shares of Common Stock
then included in each outstanding Option granted under the 2002
Plan; and (iv) the exercise price of each outstanding
Option granted under the 2002 Plan.
Amendment
and Termination of the 2002 Plan
The Board of Directors may amend the 2002 Plan at any time or
from time to time, or may terminate it without the approval of
stockholders; provided, however, that the approval of the
holders of a majority of the outstanding shares of the Company
entitled to vote is required for any amendment which would
(i) materially increase the benefits accruing to
participants under the 2002 Plan, (ii) materially increase
the number of shares of Common Stock which may be issued under
the 2002 Plan, or (iii) materially modify the requirements
as to eligibility for
31
participation in the 2002 Plan or expand the list of performance
goals. No such action by the Board of Directors or shareholders
may unilaterally alter or impair any Option or restricted shares
previously granted under the 2002 Plan without the consent of
the recipient employee.
Tax
Consequences Regarding Options
The grant of an Option under the 2002 Plan creates no income tax
consequences to the key employee or the Company. A key employee
who is granted a NQSO will generally recognize ordinary income
at the time of exercise in an amount equal to the excess of the
fair market value of the Common Stock at such time over the
exercise price. The Company generally will be entitled to a
deduction in the same amount and at the same time ordinary
income is recognized by the key employee. A subsequent
disposition of the Common Stock will give rise to capital gain
or loss to the extent the amount realized from the sale differs
from the tax basis, i.e., the fair market value of the Common
Stock on the date of exercise. This capital gain or loss will be
a long-term capital gain or loss if the Common Stock has been
held for more than one year from the date of exercise.
In general, a key employee will recognize no income or gain as a
result of exercise of an ISO (except that the alternative
minimum tax may apply). Except as described below, any gain or
loss realized by the key employee on the disposition of the
Common Stock acquired pursuant to the exercise of an ISO will be
treated as a long-term capital gain or loss and no deduction
will be allowed to the Company. If the key employee fails to
hold the shares of Common Stock acquired pursuant to the
exercise of an ISO for at least two years from the date of grant
of the ISO and one year from the date of exercise, the key
employee will recognize ordinary income at the time of the
disposition equal to the lesser of (a) the gain realized on
the disposition or (b) the excess of the fair market value
of the shares of Common Stock on the date of exercise over the
exercise price. The Company generally will be entitled to a
deduction in the same amount and at the same time ordinary
income, if any, is recognized by the key employee. Any
additional gain realized by the key employee over the fair
market value at the time of exercise will be treated as a
capital gain. This capital gain will be a long-term capital gain
if the Common Stock has been held for more than one year from
the date of exercise.
Tax
Consequences Regarding Restricted Stock
A key employee of the Company will not recognize income at the
time an award of restricted stock is made under the Incentive
Plan unless he or she makes the election described below. If the
key employee does not make this election, then the key employee
will recognize ordinary income when all the restrictions on the
restricted stock lapse. The amount of income recognized equals
the fair market value of the restricted stock on the date that
all of the restrictions lapse reduced by the amount, if any,
paid by the key employee for the restricted stock. The Company
generally will be entitled to a deduction in the same amount and
at the same time the key employee recognizes income. Any
otherwise taxable disposition of the restricted stock after the
applicable restrictions lapse will result in capital gain or
loss (long-term or short-term depending on the length of time
the shares of restricted stock are held after the date that the
restrictions lapse).
A key employee may, within 30 days after the date of the
award of restricted stock, elect to recognize ordinary income as
of the date of the award under Internal Revenue Code
Section 83(b) in an amount equal to the fair market value
of the restricted stock on the date of the award, reduced by the
amount, if any, the key employee pays for the restricted stock.
The Company generally will be entitled to a corresponding
deduction in the same amount and at the same time the key
employee recognizes income. Any otherwise taxable disposition of
restricted stock (other than by forfeiture) will result in
capital gain or loss (long-term or short-term depending on the
length of time the shares of restricted stock are held after the
grant date of the restricted stock). If the key employee makes
this election and subsequently forfeits the restricted stock,
then the key employee will not be entitled to deduct any loss
except to the extent of the amount, if any, the key employee
paid for the restricted stock. The Company is required, however,
to include as ordinary income the amount of the deduction the
Company previously claimed with respect to the forfeited shares.
32
Code
Section 409A
We have structured the 2002 Plan with the intention that all
awards granted under the 2002 Plan will be exempt from Code
Section 409A. If an award granted under the 2002 Plan were
subject to Section 409A, then, unless certain requirements
set forth in Code Section 409A are complied with, holders
of such awards may be taxed earlier than would otherwise be the
case (e.g., at the time of vesting instead of the time of
payment) and may be subject to an additional 20% penalty tax
(and, potentially, certain interest penalties).
Code
Section 162(m)
In general, Code Section 162(m) denies a publicly held
corporation a deduction for U.S. federal income tax
purposes for compensation in excess of $1 million per year
per person to its chief executive officer and the other four
highest paid officers whose compensation is disclosed in its
proxy statement. Certain performance-based compensation, the
material terms of which are disclosed to and approved by
stockholders, is not, however, subject to this limitation on
deductibility. We have structured the 2002 Plan with the
intention that awards would generally be qualified
performance-based compensation and would be deductible without
regard to the limitations otherwise imposed by Code
Section 162(m).
Other
Considerations
Awards that are granted, accelerated or enhanced upon the
occurrence of a change of control may give rise, in whole or in
part, to excess parachute payments within the meaning of Code
Section 280G to the extent that such payments, when
aggregated with other payments subject to Code
Section 280G, exceed the limitations contained in that
provision. Such excess parachute payments would not be
deductible by us and would be subject to an excise tax of
20 percent.
The foregoing summary of the federal income tax consequences of
the 2002 Plan is based on present federal tax law and
regulations. The summary does not purport to be complete or
applicable to every specific situation.
Transferability
Awards granted under the 2002 Plan will be non-transferable
other than by will or the laws of descent and distribution.
Restricted shares of Common Stock granted under the 2002 Plan
will be non-transferable until all restrictions on such shares
have been satisfied or expired.
THE BOARD OF DIRECTORS RECOMMENDS THAT SHAREHOLDERS VOTE IN
FAVOR OF THE PROPOSED AMENDMENT TO THE 2002 STOCK INCENTIVE
PLAN.
PROPOSAL THREE
APPROVAL OF AMENDMENT TO THE 2003 NON-EMPLOYEE
DIRECTORS STOCK INCENTIVE PLAN
The 2003 Non-Employee Directors Stock Incentive Plan (the
2003 Plan), as amended, was approved by the Board of
Directors on March 23, 2006, and ratified by the
shareholders on May 12, 2006. The 2003 Plan currently
provides for an automatic annual grant to each eligible director
of 8,500 shares of restricted stock, with such restricted
shares vesting over a period of three years. Directors also may
elect to receive 110% of his or her annual director fee in
shares of restricted stock rather than cash. In addition, the
2003 Plan provides for an automatic annual grant of 2,000
restricted shares of Common Stock to the lead non-management
director.
The compensation of directors pursuant to the 2003 Plan is
closely aligned with the Best Practices recommended by the
National Association of Corporate Directors, including:
|
|
|
|
|
A clear process, with independent consultants, was used to
determine the appropriate compensation program for the
non-employee directors.
|
|
|
|
A substantial target for stock ownership by each director, in a
pre-determined timeframe, has been established. Each director is
expected to own $150,000 of Hanger stock within five years.
|
33
|
|
|
|
|
The directors are paid only in cash or equity. There are no
existing benefit programs established for the directors.
|
|
|
|
Equity makes up substantially more than half of the overall
compensation for the directors.
|
|
|
|
The proxy fully discloses the value of all of the elements of
compensation for the directors.
|
The proposed amendment to the 2003 Plan, which was approved by
the Board of Directors on March 19, 2007, primarily changes
the 2003 Plan by providing for the issuance by the Company of
restricted stock units (RSUs) to its non-employee
directors, at the option of such director. The RSUs effectively
allow the director to elect to defer receipt of the shares of
restricted stock which the director would ordinarily receive on
an annual basis until (i) the January 15th of the
year following the calendar year in which the director
terminates service on the Board of Directors or (ii) the
fifth, tenth, or fifteenth anniversary of the annual meeting
date on the election form for that year. The director will have
the opportunity to elect to receive his or her annual grant of
restricted stock, including shares to be received in lieu of the
annual director fee, in the form of RSUs, with such election to
take place on or prior to the date of the annual meeting of
stockholders for such year.
The proposed amendment to the 2003 Plan is designed to continue
to maintain the Companys ability to attract and retain the
services of experienced and highly qualified outside directors
and to increase their proprietary interest in the Companys
continued success. Approval of the proposed amendment to the
2003 Plan by the holders of a majority of the Companys
outstanding shares of Common Stock present or represented at the
annual meeting of stockholders is required for the adoption of
the amendment to the 2003 Plan. The following description of the
material provisions of the 2003 Plan is qualified by reference
to the full provisions of the 2003 Plan, a copy of which is set
forth as Appendix 2 to this Proxy Statement.
Administration
The 2003 Plan will continue to be administered by the
Compensation Committee of the Board of Directors of the Company.
Although the Committee will be authorized to interpret the 2003
Plan and establish rules relating to its implementation, the
Committees administrative functions will be ministerial in
view of the 2003 Plans explicit provisions described
below, including those related to eligibility for restricted
stock and RSU grants and predetermination of the timing, pricing
and amount of such grants. Furthermore, the Committee may not
amend the 2003 Plan or take any action that would materially
increase the benefits accruing to participants under the 2003
Plan.
Eligibility
Directors of the Company who are not employed by the Company or
any affiliate of the Company will be eligible to receive stock
grants under the 2003 Plan. Seven of the Companys present
directors (i.e., Edmond E. Charrette, M.D.,
Thomas P. Cooper, M.D., Cynthia Feldmann, Eric Green, Isaac
Kaufman, Bennett Rosenthal and H.E. Thranhardt) are currently
eligible to participate in the 2003 Plan and will be eligible to
participate under the 2003 Plan following their reelection.
Authorized
Shares
Subject to adjustment as provided under the 2003 Plan, a total
of 500,000 shares of Common Stock are reserved for possible
issuance under the 2003 Plan upon either the exercise of options
or the grant of restricted stock awards or RSU awards under the
2003 Plan. In the event of the expiration or termination of an
option prior to exercise, the shares subject to such option will
become available for the grant of additional restricted shares
or RSUs under the 2003 Plan. In the event the recipient director
of a restricted stock or RSU grant ceases to be a director of
the Company prior to the vesting of the restricted stock or RSU
as described below, then the shares subject to such grant will
become available for the grant of additional restricted shares
or RSUs under the 2003 Plan. Adjustments will be made in the
number of shares subject to the 2003 Plan, the number of shares
subject to outstanding options, the exercise price of
outstanding options and the number of shares subject to
subsequent grants of restricted stock and RSUs, in each case to
reflect changes in the Companys Common Stock through
changes in the corporate structure or capitalization such as
through a stock dividend, stock split or merger.
34
Grants
under the 2003 Plan
The 2003 Plan, as amended pursuant to the proposed amendment,
permits the granting of restricted shares of Common Stock and
RSUs to eligible directors of the Company, as explained in
greater detail below.
Amount and Terms of Option Grants.
No further
grants of options to purchase Common Stock will be granted
pursuant to the 2003 Plan. The exercise price of each previously
granted option was equal to 100% of the fair market value per
share of the Common Stock on the date prior to the date that the
option was granted, which was the closing sale price of the
shares as reported by the New York Stock Exchange. Each option
vests over a three-year period from the date of grant of such
option. Each option will expire ten years from the date of
grant; provided, however, that (i) in the event of the
termination of a directors service other than by reason of
total and permanent disability, death or retirement, the then
outstanding options of such holder will expire three months
after such termination, and (ii) in the event of the
termination of a directors service by reason of total and
permanent disability, death or retirement, the then outstanding
options of such holder will immediately vest and expire one year
after such termination. Options immediately vest and become
fully exercisable in the event a
30-day
notice of a merger or consolidation of the Company is given to
optionees pursuant to the 2003 Plan. The option exercise price
must be paid in full in cash or shares of Common Stock upon the
exercise of the option, or in a combination of cash and shares.
No option grants were made under the 2003 Plan during the year
ended December 31, 2006.
Amount and Terms of Restricted Stock and RSU
Grants.
The proposed amendment to the 2003 Plan
will allow for the directors of the Company to elect whether to
receive the annual grants set forth in more detail below in the
form of shares of restricted stock or RSUs. The 2003 Plan will
provide for a grant of 8,500 restricted shares of Common Stock
or RSUs to be made automatically on an annual basis to each
eligible director on the fourth business day following the date
of each annual meeting of stockholders at which the eligible
director is elected. In the event a director is appointed to the
Board of Directors to fill a vacancy occurring between annual
meetings of stockholders, then such director will be
automatically granted restricted shares of Common Stock on the
fourth business day following the date on which the eligible
director is appointed to the Board to fill such vacancy, with
the number of restricted shares of Common Stock being equal to a
pro-rata portion of the annual grant amount of
8,500 shares. In addition, the proposed amendment to the
2003 Plan will provide for an automatic annual grant of 2,000
restricted shares of Common Stock or RSUs to the lead
non-management director. The shares and RSUs will be
restricted because they will be subject to a three
year vesting period, with one-third of the restricted shares or
RSUs vesting at the end of each of the first three years
following the date of grant. If the recipient director ceases to
be a director of the Company prior to the date which is three
years after the date of grant of such restricted shares to that
director (other than because of death, total and permanent
disability, a change in control of the Company or such
directors retirement), then such director will forfeit all
such restricted shares or RSUs which have not vested prior to
that time unless such restricted shares or RSUs vest on or
before the date which is ninety days after such termination.
However, in the event of the termination of a directors
service prior to the end of such three-year vesting period by
reason of total and permanent disability, death, a change in
control of the Company or such directors retirement, then
such restricted shares or RSUs shall vest immediately at that
time. As of March 8, 2007, a total of 278,565 shares
of Common Stock remain available for issuance as restricted
shares under the 2003 Plan. If the director nominees are elected
and the amendment to the 2003 Plan is approved at this 2007
annual meeting of stockholders, then each of the eligible
directors identified above will be granted 8,500 restricted
shares of Common Stock or RSUs, for a total of
59,500 shares, on May 16, 2007. Additional shares may
also be granted in lieu of the cash retainer portion of each
directors compensation.
During the year ended December 31, 2006, a total of 92,012
restricted shares of Common Stock were issued under the 2003
Plan, with such restricted shares having a dollar value of
$692,580.
Common
Stock in Lieu of Director Fees
The proposed amendment to the 2003 Plan will allow for the
directors of the Company to elect whether to receive their
annual director fees set forth in more detail below in the form
of shares of restricted stock or RSUs. Non-employee directors of
the Company receive an annual director fee (currently $30,000)
for their service on the Board of Directors of the Company, in
addition to other fees payable to directors for their service on
the Board and its committees, all as discussed in greater detail
in this Proxy Statement under Director Compensation.
Under the
35
2003 Plan, each director of the Company may elect to receive all
of his or her annual director fee in the form of restricted
shares of Common Stock or RSUs to be issued to such director in
the number of whole shares of Common Stock which is equal to
(i) the amount of such annual director fee divided by
(ii) the closing sale price per share of the Common Stock
as reported by the New York Stock Exchange on the third business
day following the date of each annual meeting of stockholders at
which the eligible director is elected. In the event a director
is appointed to the Board of Directors to fill a vacancy
occurring between annual meetings of stockholders, then such
director will be entitled to receive a pro-rata portion of his
or her annual director fee, with such director being able to
elect to receive such pro-rata portion of the annual director
fee in the form of restricted shares of Common Stock to be
issued to such director in the number of whole shares of
restricted Common Stock which is equal to (i) the amount of
such director fee divided by (ii) the closing sale price
per share of the Common Stock as reported by the New York Stock
Exchange on the third business day following the date on which
the eligible director is appointed to the Board to fill such
vacancy. The restricted shares of Common Stock or RSUs received
by such a director in lieu of his or her annual director fee
will be restricted shares because they will be subject to a
three year vesting period, with one-third of such restricted
shares or RSUs to vest at the end of each of the first three
years following the date of grant. If the recipient director
ceases to be a director of the Company prior to the date which
is three years after the date of issuance of such restricted
shares or RSUs to that director (other than because of death,
total and permanent disability, a change in control of the
Company or such directors retirement), then such director
will forfeit all such restricted shares or RSUs which have not
vested prior to that time unless such unvested restricted shares
or RSUs vest on or before the date which is ninety days after
such termination. However, in the event of the termination of a
directors service prior to the end of such three-year
vesting period by reason of total and permanent disability,
death, a change in control of the Company or such
directors retirement, then such restricted shares or RSUs
shall vest immediately at that time.
Further, in the event a director elects to receive his or her
annual director fee in restricted shares or RSUs under the 2003
Plan, then such director will also receive an additional number
of restricted shares or RSUs in an amount equal to ten percent
of the number of restricted shares or RSUs the director received
in lieu of his or her annual director fee. The restricted shares
or RSUs received by such a director in lieu of his or her annual
director fee will be restricted shares or RSUs because they will
be subject to a three-year vesting period, with one-third of
such restricted shares or RSUs to vest at the end of each of the
first three years following the date of grant. If the recipient
director ceases to be a director of the Company prior to the
date which is three years after the date of issuance of such
restricted shares to that director (other than because of death,
total and permanent disability, a change in control of the
Company or such directors retirement), then such director
will forfeit all such restricted shares or RSUs which have not
vested prior to that time unless such unvested restricted shares
or RSUs vest on or before the date which is ninety days after
such termination. However, in the event of the termination of a
directors service prior to the end of such three-year
vesting period by reason of total and permanent disability,
death, a change in control of the Company or such
directors retirement, then such restricted shares or RSUs
shall vest immediately at that time.
Administration
of RSUs
The proposed amendment to the 2003 Plan will include detailed
provisions governing the administration by the Company of the
RSUs, a summary of which is set forth below.
Election
to Receive RSUs.
On or before the date of each annual meeting of stockholders of
the Company each eligible director of the Company at which such
director is elected may elect to receive as RSUs (i) such
directors annual issuance of restricted shares, including
any additional grants of restricted shares for the lead
non-management director
and/or
(ii) all of such directors annual fee for the
upcoming year, including an additional number of RSUs in an
amount equal to ten percent of the number of RSUs the director
received in lieu of his or her annual director fee. The election
to receive RSUs and their time of payment shall be set forth in
an election form to be submitted to the Company during the
thirty day period ending with the date of the annual meeting of
stockholders pursuant to which such director is elected to serve
for the following year. An eligible director must make a new
election for each year for which such director is elected to
serve for the following year and wishes to receive RSUs. Each
such election shall be irrevocable. The times of payment from
which such director may choose each year are on or about
(i) the
36
January 15th of the year following the calendar year
in which such director terminates service on the Board of
Directors, or (ii) the fifth, tenth, or fifteenth
anniversary of the annual meeting date on the election form for
that year.
RSU
Separate Accounts
The Company shall maintain separate bookkeeping accounts to
reflect each directors RSUs credited for each year and the
time of payment selected by such director for that separate
account. As of the date the Company pays any dividend (whether
in cash or in kind) on shares of Common Stock, such
directors accounts shall be credited with that number of
RSUs equal to the ratio of (1) the aggregate value of the
dividend that would have been payable on the vested RSUs held by
the account immediately prior to such payment date had the
shares of stock represented by such RSUs been outstanding as of
such payment date to (2) the fair market value per share of
stock on such date. Subject to the occurrence of a change in
control event, amounts credited to a directors accounts
shall be distributed in whole shares of stock (with fractional
shares to be paid in cash), with such payment to made in one
lump sum at the time specified in the election form establishing
each such account. The separate accounts of the directors
established pursuant to the 2003 Plan shall not be secured by
any separate fund or trust or moneys set aside in any form. To
the extent that any person acquires a right to receive deferred
compensation from the Company pursuant to the 2003 Plan, such
right shall be no greater than that of an unsecured general
creditor of the Company.
Each electing director shall have the right to designate a
beneficiary to receive a lump sum payment equal to the remaining
balance of all of the directors accounts in the event of
the death of such director. In the event that such director
fails to designate a beneficiary prior to such directors
death, the Company will pay to the estate of such director a
lump sum payment equal to the remaining balance of all of the
directors accounts. The aforementioned payments shall be
made on or about the January 15th of the year
following the calendar year in which the date of death occurs,
or if later, the sixth month anniversary of the date of death.
In the event that a change in control (as such term is defined
in the 2003 Plan) occurs prior to the complete distribution of a
directors separate accounts, then any portion of such
accounts that has not already been distributed (including
previously unvested amounts) shall be distributed in a single
lump sum amount to the director (or, as applicable, to his or
her beneficiary) immediately following the change in control.
Tax
Consequences Regarding Options
Stock options granted under the 2003 Plan are nonqualified
options that are not intended to qualify as incentive stock
options under Section 422 of the Internal Revenue Code. The
grant of stock options creates no income tax consequences to the
non-employee director or the Company. A non-employee director
who is granted a non-qualified stock option will generally
recognize ordinary income at the time of exercise in an amount
equal to the excess of the fair market value of the Common Stock
at such time over the exercise price. The Company will be
entitled to a deduction in the same amount and at the same time
as ordinary income is recognized by the non-employee director. A
subsequent disposition of the Common Stock will give rise to
capital gain or loss to the extent the amount realized from the
sale differs from the tax basis, i.e., the fair market value of
the Common Stock on the date of exercise. This capital gain or
loss will be a long-term capital gain or loss if the Common
Stock has been held for more than one year from the date of
exercise.
Tax
Consequences Regarding Restricted Stock and RSUs
A non-employee director of the Company will generally not
recognize income at the time an award of restricted stock or
RSUs is made under the 2003 Plan and the Company is not
generally entitled to a deduction a the time of grant. Instead,
the non-employee director generally will recognize ordinary
income, and the Company is generally entitled to a deduction,
when all the restrictions on the restricted stock lapse or on
the date on which the stock is issued or cash is paid in the
case of RSUs. The amount of income recognized and the amount of
the Companys deduction equals the fair market value of the
restricted stock on the date that all of the restrictions lapse,
or on the date on which the stock is issued or cash is paid in
the case of RSUs, reduced by an amount, if any, paid (or deemed
to have been paid) by the non-employee director for the
restricted stock or RSUs. Any otherwise taxable disposition of
the restricted stock after the applicable restrictions lapse, or
of the shares issued in payment of the
37
RSUs, will result in capital gain or loss (long-term or
short-term depending on the length of time the shares of stock
are held after the date that the restrictions lapsed or the
stock is issued in the case of RSUs). If the non-employee
director forfeits the restricted stock, then the non-employee
director will not be entitled to deduct any loss except to the
extent of the amount, if any, the non-employee director paid (or
is deemed to have paid) for the restricted stock.
A non-employee director may, within 30 days after the date
of the award of restricted stock, elect to recognize ordinary
income as of the date of the award in an amount equal to the
fair market value of the restricted stock on the date of the
award, reduced by the amount, if any, the non-employee director
pays for the restricted stock. The Company generally will be
entitled to a corresponding deduction in the same amount and at
the same time as the non-employee director recognizes income.
Any otherwise taxable disposition of restricted stock (other
than by forfeiture) will result in capital gain or loss
(long-term or short-term depending on the length of time the
shares of restricted stock are held after the grant date of the
restricted stock). If the non-employee director makes this
election and subsequently forfeits the restricted stock, then
the non-employee director will not be entitled to deduct any
loss except to the extent of the amount, if any, the
non-employee director paid (or is deemed to have paid) for the
restricted stock. The Company is required, however, to include
as ordinary income the amount of the deduction the Company
previously claimed with respect to the forfeited shares.
The foregoing summary of the federal income tax consequences of
the 2003 Plan is based on present federal tax law and
regulations. The summary does not purport to be complete or
applicable to every specific situation.
Transferability
Options granted under the 2003 Plan will be non-transferable
other than by will or the laws of descent and distribution.
Restricted shares issued under the 2003 Plan will be
non-transferable until vested. RSUs remain non-transferable
prior to payment.
THE BOARD OF DIRECTORS RECOMMENDS THAT SHAREHOLDERS VOTE IN
FAVOR OF THE PROPOSED AMENDMENT TO THE 2003 NON-EMPLOYEE
DIRECTORS STOCK INCENTIVE PLAN.
AUDIT
COMMITTEE REPORT
The Audit Committee of the Companys Board of Directors,
which currently consists of Cynthia L. Feldmann (Chair), Eric
Green and Isaac Kaufman, is governed by its charter, a copy of
which is available on the Companys website,
www.hanger.com. All the members of the Audit Committee are
independent under the rules of the Securities and
Exchange Commission and the listing standards of the New York
Stock Exchange, which means that they do not receive any
consulting, advisory or other compensatory fee from the Company
other than board or committee fees, they are not
affiliated persons of the Company and they have no
relationship to the Company that may interfere with the exercise
of their independence from management of the Company.
Furthermore, each audit committee member is deemed by the Board
of Directors to be financially literate and at least one member
has accounting or related financial management expertise, as
called for by New York Stock Exchange listing standards. The
Board of Directors has determined that each of Cynthia L.
Feldmann and Isaac Kaufman is considered to be an audit
committee financial expert within the meaning of the rules
of the Securities and Exchange Commission.
The Audit Committee reviewed and discussed the Companys
audited financial statements for the year ended
December 31, 2006 with management of the Company and its
independent auditing firm, PricewaterhouseCoopers LLP
(PwC). In that connection, the Audit Committee
discussed with PwC the matters required to be discussed by
Statement of Accounting Standards No. 61, as amended
(SAS 61). SAS 61 requires an auditor to communicate
certain matters relating to the conduct of an audit to the Audit
Committee, including: (i) methods used to account for
significant unusual transactions; (ii) the effect of
significant accounting policies in controversial or emerging
areas for which there is a lack of authoritative guidance or
consensus; (iii) the process used by management in
formulating particularly sensitive accounting estimates and the
basis for the auditors conclusions regarding the
reasonableness of those estimates; (iv) any disagreements
with management regarding the application of accounting
principles, the basis for managements accounting
estimates, the disclosures in the financial statements and the
wording of the auditors report; (v) the
auditors judgments about the quality, and not just the
acceptability, of the Companys accounting principles as
applied in its financial reporting; and (vi) the
consistency of application of the accounting principles and
underlying estimates and the clarity, consistency and
completeness of the accounting information contained in the
financial statements, including
38
items that have a significant impact on the representational
faithfulness, verifiability and neutrality of the accounting
information.
In addition, the Audit Committee received from PwC the written
disclosures and the letter required by Independence Standards
Board Standard No. 1 (ISB 1) and discussed
PwCs independence with PwC. Pursuant to ISB 1, PwC
(i) disclosed to the Audit Committee all relationships
between PwC and its related entities that in PwCs
professional judgment may reasonably be thought to bear on
independence, and (ii) confirmed in the letter that, in its
professional judgment, it is independent of the Company.
Based on the above-referenced review and discussions, the Audit
Committee recommended to the Board of Directors that the
financial statements be included in the Companys Annual
Report on
Form 10-K
for the year ended December 31, 2006, for filing with the
Securities and Exchange Commission.
The following describes the Audit Committees policies and
procedures regarding pre-approval of the engagement of the
Companys independent auditor to perform audit as well as
permissible non-audit services for the Company. For audit
services, the independent auditor will provide the Committee
with an engagement letter during the second calendar quarter of
each year outlining the scope and cost of the audit services
proposed to be performed in connection with the audit of the
current fiscal year. If agreed to by the Committee, the
engagement letter will be formally accepted by the Committee at
an Audit Committee meeting held as practicably as possible
following receipt of the engagement letter and fee estimate.
For non-audit services, Company management may submit to the
Committee for approval the list of non-audit services that it
recommends the Committee allow the Company to engage the
independent auditor to provide for the fiscal year. The list of
services must be detailed as to the particular service and may
not call for broad categorical approvals. Company management and
the independent auditor will each confirm to the Committee that
each non-audit service on the list is permissible under all
applicable legal requirements. In addition to the list of
planned non-audit services, a budget estimating non-audit
service spending for the fiscal year may be provided. The
Committee will consider for approval both the list of
permissible non-audit services and the budget for such services.
The Committee will be informed routinely as to the non-audit
services actually provided by the independent auditor pursuant
to this pre-approval process.
To ensure prompt handling of unexpected matters, the Committee
delegates to its Chairperson the authority to approve the
auditors engagement for non-audit services with fees of up
to $50,000, and to amend or modify the list of approved
permissible non-audit services and fees of up to $50,000. The
Chairperson will report any action taken pursuant to this
delegation to the Committee at its next Committee meeting.
All audit and non-audit services provided to the Company are
required to be pre-approved by the Committee. The Chief
Financial Officer of the Company will be responsible for
tracking all independent auditor fees against the budget for
such services and report at least annually to the Audit
Committee.
Audit Committee of the Board of Directors:
Cynthia L. Feldmann, Chair
Eric Green
Isaac Kaufman
39
Audit and
Non-Audit Fees
Audit
Fees
The aggregate fees billed by PricewaterhouseCoopers LLP for each
of the last two fiscal years for professional services rendered
for audit services totaled $2,008,963 in 2005 and $1,550,000 in
2006, including fees associated with the audit of the
Companys annual financial statements, the audit of the
Companys internal control over financial reporting and the
review of financial statements included in the Companys
Quarterly Reports on
Form 10-Q.
Audit-Related
Fees
The aggregate fees billed by PricewaterhouseCoopers LLP for each
of the last two fiscal years for assurance and related services
reasonably related to the performance of audit or review of the
Companys financial statements other than those reported in
the foregoing Audit Fees subsection were $45,165 in
2005 and $352,000 in 2006. In 2005, such fees related to the
employee benefit plan audit, the 2006 Proxy and expenses. In
2006, such fees related to the employee benefit plan audit, the
2007 Proxy and the 2006 debt re-financing.
Tax
Fees
The aggregate fees billed by PricewaterhouseCoopers LLP for each
of the last two fiscal years for professional services rendered
for tax compliance, tax advice and tax planning were $0 in 2005
and $0 in 2006.
All
Other Fees
PricewaterhouseCoopers LLP did not bill the Company in either of
the last two fiscal years for any products and services other
than those reported in the foregoing subsections.
Attendance
at Annual Meeting
Representatives of the Companys independent accountants
are expected to attend the 2007 Annual Meeting.
40
PRINCIPAL
STOCKHOLDERS
The following table sets forth the number of shares of Common
Stock beneficially owned as of March 13, 2007 by:
(i) each person known by Hanger to be the beneficial owner
of 5% or more of such class of securities, (ii) each
director and nominee for director of Hanger, (iii) each of
the above-listed officers and (iv) all directors, nominees
and officers of Hanger as a group.
|
|
|
|
|
|
|
|
|
|
|
Number of
|
|
|
Percent of
|
|
|
|
Shares of
|
|
|
Outstanding
|
|
Directors, Officers and 5% Shareholders
|
|
Common Stock(1)
|
|
|
Common Stock(1)
|
|
|
Ares Management, L.L.C.(2)
|
|
|
6,813,757
|
|
|
|
23.5
|
%
|
Dimensional Fund Advisors,
Inc.(3)
|
|
|
2,050,000
|
|
|
|
8.5
|
%
|
Greywolf Capital Management,
L.P.(4)
|
|
|
1,665,000
|
|
|
|
7.0
|
%
|
Putnam Investment Management,
L.L.C(5)
|
|
|
1,575,000
|
|
|
|
6.6
|
%
|
Lazard Asset Management, L.L.C.(6)
|
|
|
1,550,000
|
|
|
|
6.5
|
%
|
Prides Capital, L.L.C.(7)
|
|
|
1,470,000
|
|
|
|
6.2
|
%
|
Ivan R. Sabel, CPO(8)
|
|
|
864,646
|
|
|
|
3.8
|
%
|
Thomas F. Kirk(9)
|
|
|
664,000
|
|
|
|
2.9
|
%
|
H.E. Thranhardt, CPO(10)
|
|
|
379,280
|
|
|
|
1.7
|
%
|
Richmond L. Taylor(11)
|
|
|
317,995
|
|
|
|
1.4
|
%
|
George E. McHenry(12)
|
|
|
174,278
|
|
|
|
0.8
|
%
|
Thomas P. Cooper, M.D.(13)
|
|
|
64,225
|
|
|
|
0.3
|
%
|
Edmond Charrette, M.D.(14)
|
|
|
48,993
|
|
|
|
0.2
|
%
|
Ron May(15)
|
|
|
24,897
|
|
|
|
0.1
|
%
|
Eric Green(16)
|
|
|
22,475
|
|
|
|
0.1
|
%
|
Cynthia L. Feldmann(17)
|
|
|
20,214
|
|
|
|
0.1
|
%
|
Isaac Kaufman(18)
|
|
|
8,245
|
|
|
|
0.0
|
%
|
Bennett Rosenthal(19)
|
|
|
0
|
|
|
|
0.0
|
%
|
All directors, nominees and
officers as a group (18 persons)(20)
|
|
|
2,627,258
|
|
|
|
10.6
|
%
|
|
|
|
(1)
|
|
Assumes in the case of each stockholder listed in the above list
that all presently exercisable warrants or options held by such
stockholder were fully exercised by such stockholder and all
shares of convertible preferred stock held by such stockholder
were converted into shares of common stock by such stockholder,
without the exercise of any warrants or options or conversion of
preferred stock held by any other stockholders. With respect to
each company listed above, the amounts represent the number of
shares beneficially owned, as disclosed in company reports
regarding beneficial ownership filed with the Securities and
Exchange Commission.
|
|
(2)
|
|
The address of Ares Management, L.L.C. is 1999 Avenue of the
Stars, Suite 1900, Los Angeles, CA 90067.
|
|
(3)
|
|
The address of Dimensional Fund Advisors is 1299 Ocean
Avenue, Santa Monica, CA 90401.
|
|
(4)
|
|
The address of Greywolf Capital Management, L.P. is 4
Manhattanville Road, Suite 201, Purchase, NY 10577.
|
|
(5)
|
|
The address of Putnam Investment Management, L.L.C. is 100
Financial Park, Franklin, MA 02038.
|
|
(6)
|
|
The address for Lazard Asset Management L.L.C. is 30 Rockefeller
Plaza, New York, NY 10112.
|
|
(7)
|
|
The address of Prides Capital, L.L.C. is 200 High Street,
Suite 700, Boston, MA 02110
|
|
(8)
|
|
Includes 173,546 shares owned directly by Mr. Sabel,
690,000 shares subject to exercisable options to purchase
shares from the Company and 1,100 shares held in his
spouses IRA, and excludes 185,000 shares subject to
unvested restricted stock that have not yet become exercisable.
|
|
(9)
|
|
Includes 14,000 shares owned directly by Mr. Kirk and
650,000 shares subject to exercisable options to purchase
shares from the Company and excludes 110,000 shares subject
to unvested restricted stock that have not yet become
exercisable.
|
41
|
|
|
(10)
|
|
Includes 240,549 shares owned directly by
Mr. Thranhardt, 45,783 shares subject to exercisable
options to purchase shares from the Company, 35,543 shares
owned indirectly by him as trustee for members of his family,
and 57,405 shares owned indirectly by him as general
partner of a family partnership; excludes 13,625 shares
subject to unvested options and restricted stock that have not
yet become exercisable.
|
|
(11)
|
|
Includes 2,995 shares owned directly by Mr. Taylor,
315,000 shares subject to exercisable options to purchase
shares from the Company, and excludes 52,500 shares subject
to unvested restricted stock that have not yet become
exercisable.
|
|
(12)
|
|
Includes 3,278 shares owned directly by Mr. McHenry,
171,000 shares subject to exercisable options to purchase
shares from the Company, and excludes 61,250 shares subject
to unvested restricted stock that have not yet become
exercisable.
|
|
(13)
|
|
Includes 27,459 shares owned directly by Mr. Cooper,
36,766 shares subject to exercisable options to purchase
shares from the Company, and excludes 21,966 shares subject
to unvested options and restricted stock that have not yet
become exercisable.
|
|
(14)
|
|
Includes 8,745 shares owned directly by Mr. Charrette,
40,248 shares subject to exercisable options to purchase
shares from the Company, and excludes 18,002 shares subject
to unvested options and restricted stock that have not yet
become exercisable.
|
|
(15)
|
|
Includes 1,897 shares owned directly by Mr. May,
23,000 shares subject to exercisable options to purchase
shares from the Company, and excludes 34,500 shares subject
to unvested restricted stock that have not yet become
exercisable.
|
|
(16)
|
|
Includes 10,709 shares owned directly by Mr. Green,
11,766 shares subject to exercisable options to purchase
shares from the Company, and excludes 19,966 shares subject
to unvested options and restricted stock that have not yet
become exercisable.
|
|
(17)
|
|
Includes 9,952 shares owned directly by Ms. Feldmann,
10,262 shares subject to exercisable options to purchase
shares from the Company, and excludes 19,966 shares subject
to unvested options and restricted stock that have not yet
become exercisable.
|
|
(18)
|
|
Includes 5,889 shares owned directly by Mr. Kaufman,
2,356 shares subject to exercisable options to purchase
shares from the Company, and excludes 17,590 shares subject
to unvested options and restricted stock that have not yet
become exercisable.
|
|
(19)
|
|
Excludes 4,250 shares subject to unvested restricted stock
that have not yet become exercisable by Mr. Rosenthal.
|
|
(20)
|
|
Includes 606,077 shares owned directly or controlled by
directors and officers of the Company, a total of
2,021,181 shares subject to exercisable options held by
directors and officers of the Company to purchase shares from
the Company, and excludes a total of 643,865 shares subject
to unvested options and restricted stock held by such persons
that have not yet become exercisable.
|
42
LEGAL
PROCEEDINGS
On September 8, 2005, a derivative action was filed against
the Company and certain of its current and former directors in
the United States District Court for the Eastern District of New
York. The lawsuit, which is encaptioned
Green Meadows
Partners, LLP v. Ivan R. Sabel, et al
, No. CV
05 4259 (E.D.N.Y.), alleges that Hangers directors
breached their fiduciary duties to the Company in connection
with allegations that the revenues of the Company were inflated
through certain billing improprieties at one of the
Companys facilities. On that basis, the Green Meadows
complaint purports to assert claims against the individual
defendants, on behalf of the Company, for contribution in
connection with a Consolidated Securities Class Action suit
encaptioned In re Hanger Orthopedic Group, Inc. Securities
Litigation,
No. 1:04-cv-2585,
which suit is related to the allegations discussed above;
forfeiture of certain bonuses and other incentive-based or
equity-based compensation pursuant to Section 304; breach
of fiduciary duty; unjust enrichment; and abuse of
control. The complaint seeks unspecified compensatory
damages, restitution and disgorgement, injunctive relief, and
award of attorneys fees and costs. After the transfer of
the Consolidated Securities Class Action to the
U.S. District Court for the District of Maryland Southern
Division, the parties agreed to the transfer of the Green
Meadows Partners case to the District of Maryland and to stay
the case pending the outcome of the defendants motion to
dismiss the Consolidated Securities Class Action case. The
Consolidated Securities Class Action was dismissed with
prejudice by the U.S. District Court for the District of
Maryland Southern Division on March 16, 2007.
SECTION 16(a)
BENEFICIAL OWNERSHIP REPORTING COMPLIANCE
Section 16(a) of the Securities Exchange Act of 1934, as
amended, requires the Companys officers and directors, and
persons who beneficially own more than 10% of a registered class
of the Companys equity securities, to file initial reports
of securities ownership on Form 3 and reports of changes in
such ownership on Forms 4 and 5 with the Securities and
Exchange Commission. Based solely on a review of the copies of
such reports furnished to the Company during the most
recently-completed fiscal year, we believe that all reports of
securities ownership and changes in such ownership required to
be filed during 2006 were timely filed.
43
YEAR 2008
STOCKHOLDER PROPOSALS
Proposals of stockholders intended to be presented at the 2008
Annual Meeting, which presently is expected to be held in May
2008, must be received by the Secretary of the Company, Two
Bethesda Metro Center, Suite 1200, Bethesda, Maryland
20814, no later than December 7, 2007 (i.e., at least
120 days prior to the expected date of the mailing of the
proxy statement), in order for them to be considered for
inclusion in the 2008 Proxy Statement. A shareholder desiring to
submit a proposal to be voted on at next years Annual
Meeting, but not desiring to have such proposal included in next
years Proxy Statement relating to that meeting, should
submit such proposal to the Company by February 15, 2008
(i.e., at least 45 days prior to the expected date of the
mailing of the Proxy Statement). Failure to comply with that
advance notice requirement will permit management to use its
discretionary voting authority if and when the proposal is
raised at the Annual Meeting without having had a discussion of
the proposal in the Proxy Statement.
OTHER
MATTERS
Management is not aware of any other matters to be considered at
the Annual Meeting. If any other matters properly come before
the Annual Meeting, the persons named in the enclosed Proxy will
vote said Proxy in accordance with their discretion.
By Order of the Board of Directors
HANGER ORTHOPEDIC GROUP, INC.
George E. McHenry
Chief Financial Officer and Corporate
Secretary
April 10, 2007
44
Appendix
1
HANGER
ORTHOPEDIC GROUP, INC.
AMENDED AND RESTATED
2002 STOCK INCENTIVE AND BONUS PLAN
(As proposed to be amended)
1.
Purpose
.
The purpose of the
2002 Stock Incentive and Bonus Plan (the Plan) of
Hanger Orthopedic Group, Inc. (the Company) is to
make shares of the common stock, $.01 par value per share
(the Stock), of the Company available for issuance
as restricted stock
and/or
for
purchase under stock options granted to, and to provide for the
grant of performance-based cash awards (Incentive
Awards) to, selected officers and key employees of the
Company or subsidiaries of the Company, upon terms which will
give them an added incentive to continue service with the
Company and a more direct interest in the future success of its
operations. The options granted hereunder shall be either
incentive stock options (ISOs) within the meaning of
Section 422A of the Internal Revenue Code of 1986, as
amended (the Code), or nonqualified stock options
(NQSOs). ISOs and NQSOs collectively are referred to
hereinafter as Options.
2.
Administration
.
|
|
|
|
a)
|
The Committee
.
The Plan shall be
administered by the Compensation Committee (the
Committee) of the Board of Directors of the Company
(the Board) composed of not less than three
directors of the Company, who shall be appointed by and serve at
the pleasure of the Board. A majority of the Committee shall
constitute a quorum and the acts of a majority of the members
present at any meeting at which a quorum is present, or acts
approved in writing by a majority of the Committee, shall be the
acts of the Committee. Each member of the Committee shall be
ineligible to be granted Options or shares of restricted Stock
under the Plan and shall otherwise be a disinterested
person within the meaning of
Rule 16b-3(c)(2)(i)
under the Securities Exchange Act of 1934, as amended and an
outside director within the meaning of
Section 162(m) of the Code. The Committee shall keep
minutes of its meetings.
|
|
|
b)
|
Authority of the Committee
.
Subject to
the provisions of the Plan, the Committee shall have full
authority and power to determine the employees to whom awards of
Options, restricted Stock
and/or
Incentive Awards (each, an Award) shall be granted,
and the terms and conditions of an Award, including but not
limited to the number of shares of Stock to be included in each
Option, the number of shares of Stock to be included in each
grant of restricted Stock, the exercise price at which the
shares of Stock included under an Option may be purchased, the
Option period and time(s) and manner of exercise, whether the
Option shall be an ISO or a NQSO, the restrictions applicable to
any and all shares of restricted Stock granted under this Plan,
and the amount payable upon achievement of specified performance
goals under an Incentive Award. All decisions of the Committee
may be reviewed by the Board and modified or overruled within
ten (10) days after the date of the Committees
decision; provided, however, that the Board shall have no power
to modify or overrule a decision of the Committee with respect
to the grant of an Option or the grant of restricted shares of
Stock once the Committee has made a grant of such Option
and/or
restricted shares of Stock pursuant to this Plan or to modify or
overrule a decision of the Committee with regard to an Award
that is intended to qualify as performance-based compensation
under Section 162(m) of the Code. Nothing contained in this
Plan shall be construed to give any employee the right to be
granted or receive an Award, or to insist upon the inclusion of
any term or condition in any Award , except such as may be
authorized by the Committee. The Committee shall have the
authority and power to adopt such rules and regulations and to
take such action as it shall consider advisable for the
administration of this Plan. The Committee shall have the
authority and power to construe, interpret and administer this
Plan, and the decisions of the Committee shall be final and
binding upon the Company, its employees, Award holders, and all
other persons. No member of the Committee shall incur any
liability by reason of any action or determination made in good
faith with respect to this Plan or any Award.
|
3.
Participation
.
|
|
|
|
a)
|
Eligible Employees
.
Selected officers
and key employees of the Company or subsidiaries of the Company
who are, in the sole opinion of the Committee, from time to time
primarily responsible for the management of, or in a position to
contribute materially to the growth and financial success of the
Company and its subsidiaries (including employees who are
members of the Board) shall be eligible to receive one or more
Awards as determined by the Committee. From such eligible
employees, the Committee shall from time to time choose those to
whom Award(s) shall be granted. An employee who has been granted
an Award under this Plan may, if he or she is otherwise
eligible, be granted an additional Award if the Committee shall
so determine.
|
|
|
b)
|
Limitations
.
|
|
|
|
|
(i)
|
Subject to adjustment as provided in Section 8, the
Committee shall not grant to an individual during any calendar
year: (A) Options for more than 270,000 shares of
Stock; (B) an award of restricted Stock relating to more
than 270,000 shares of Stock; (C) an annual Incentive
Award that would result in payment of more than $1,000,000; and
(D) a long-term Incentive Award that would result in
payment of more than $1,000,000.
|
|
|
|
|
(ii)
|
Except as permitted below, no ISO may be granted under the Plan
to any employee who, immediately before the granting of such
ISO, owns directly or indirectly Stock possessing more than
10 percent of the total combined voting power or value of
all classes of capital stock of the Company. An ISO may be
granted to an employee in excess of the 10 percent limit if
such ISO has an exercise price of at least 110 percent of
the fair market value of the Stock subject to such ISO on the
date of grant and if such ISO by its terms is not exercisable
after the expiration of five years from the date such ISO is
granted.
|
|
|
|
|
(iii)
|
The aggregate fair market value (determined as of the time an
ISO is granted) of the Stock for which any employee may be
granted ISOs in any calendar year (under this Plan and all other
incentive stock option plans of the employer corporation and its
parent and subsidiary corporations, if any) may exceed $100,000;
provided, however, that the amount (valued at the time of grant)
of an ISO that vests in any one calendar year may not exceed
$100,000. To the extent such limit is exceeded, the ISO will
automatically be treated as an NQSO.
|
4.
Stock Option Agreements
.
Each
Option granted under the Plan shall be evidenced by a written
stock option agreement (Option Agreement) which
shall be entered into by the Company and the employee to whom
the Option is granted (the Option Holder), and which
shall contain the following terms and conditions, as well as
such other terms and conditions not inconsistent therewith, as
the Committee may consider appropriate in each case.
|
|
|
|
a)
|
Price
.
The price at which each share of
Stock covered by an Option may be purchased shall be determined
in each case by the Committee and set forth in the Option
Agreement. In no event shall the price be less than
100 percent of the Fair Market Value of the Stock on the
date prior to the date the Option is granted. Fair Market
Value means (i) if the Stock is listed on a national
securities exchange, the last sale price of the Stock as
reported by the consolidated tape of such exchange on the date
prior to the date of grant of the Option, or, if there is no
Stock transaction on such date, on the immediately preceding
date on which there is a Stock transaction; (ii) if the
Stock is included in the NASDAQ National Market System, the last
sale price of the Stock as reported thereby on the date prior to
the date of grant of the Option or, if there is no Stock
transaction on such date, on the immediately preceding date on
which there is a Stock transaction; or (iii) if the Stock
is not listed on a national securities exchange or included in
the NASDAQ National Market System, the mean of the highest and
lowest bid prices for the Stock in the
over-the-counter
market on the date prior to the date of grant of the Option or
the value determined to be fair and reasonable by the Committee
consistent with the provisions of Section 409A of the Code.
|
|
|
b)
|
Duration of Options
.
Each Option
Agreement shall state the period of time, determined by the
Committee, within which the Option may be exercised by the
Option Holder. Such period must end,
|
2
|
|
|
|
|
in all cases, not more than 10 years from the date such
Option is granted. An ISO shall be treated as outstanding until
it is exercised in full or expires by reason of time.
|
|
|
|
|
c)
|
Transferability
.
Each Option Agreement
shall provide that the Option granted therein is not
transferable by the Option Holder except by will or pursuant to
the laws of descent and distribution and that such Option is
exercisable during the Option Holders lifetime only by
such Option Holder.
|
|
|
d)
|
Nature and Exercise of, and Payment for,
Option
.
Each Option Agreement shall specify
whether the Option is an ISO or NQSO and shall provide that the
method for exercising the Option granted therein shall be by
delivery to the Company of written notice specifying the number
of shares of Stock with respect to which such Option is
exercised. If requested by the Company, such notice shall
contain the Option Holders representation that he is
purchasing the Stock for investment purposes only and his
agreement not to sell any Stock so purchased in any manner which
is in violation of the Securities Act of 1933, as amended, or
any applicable state law. Such restrictions, or notice thereof,
shall be placed on the certificates representing the Stock so
purchased. The purchase of such Stock shall take place at the
principal offices of the Company within 20 days following
delivery of such notice. The purchase price of Stock upon
exercise of any Option shall be paid in full (a) in cash,
(b) in Stock valued at its fair market value on the date of
exercise of the Option, or (c) by a combination of
(a) and (b), in the manner provided in the Option
Agreement. Certificates for such shares of Stock tendered in
payment shall be in a form for good delivery and, if the
certificates were issued pursuant to the exercise of an ISO, the
Option Holder must have held the tendered shares for at least
one year.
|
|
|
e)
|
Date of Grant
.
An Option shall be
considered as having been granted on the date the Committee
decides to grant the Option, which date shall not be prior to
the date the Committee takes action.
|
|
|
|
|
f)
|
Notice of Sale of Stock;
Withholding
.
Each Option Agreement shall
provide (i) that the Option Holder shall notify the Company
in writing if Stock acquired under an ISO is disposed
of within the meaning of Section 422A of the Code
within two years after the date of the grant of the ISO or
within one year after the transfer of such Stock to the Option
Holder; and (ii) the Option Holder shall make
appropriate arrangements with the Company to provide for the
amount of withholding required by the Code and applicable state
income tax laws as a result of the exercise of an NQSO or any
disqualifying disposition of Stock purchased under an ISO.
|
5.
Restricted Stock
Agreements
.
Each restricted share of Stock
issued under this Plan shall be evidenced by a written
restricted stock agreement (Restricted Stock
Agreement) which shall be entered into by the Company and
the employee to whom the shares of restricted Stock are granted
(the Restricted Stock Holder), and which shall
contain such terms and conditions, as well as such other terms
and conditions not inconsistent therewith, as the Committee may
consider appropriate in each case, including but not limited to
vesting periods and other restrictions applicable to such shares
of Stock, restrictions on transferability prior to the
expiration of such vesting periods and any other restrictions
imposed by the Committee on such shares and any conditions
relating to minimum periods of continuing service to and
employment by the Company. Restricted Stock awards granted under
the Plan will be subject to vesting requirements as follows:
(i) the minimum performance period for performance-based
awards will be one year; and (ii) time-based awards will
vest ratably over a period of at least three years. For an award
of restricted Stock that is intended to be performance-based
under Section 162(m) of the Code, the performance goals
described in Section 6 shall be used. Unless otherwise
provided in a Restricted Stock Agreement, a Restricted Stock
Holder shall have no rights as a stockholder with respect to any
unvested shares of Stock granted hereunder until the date such
shares become vested in the holder, and no credit or adjustment
will be made for dividends or other rights for which the record
date is prior to the date of the vesting of such shares of
restricted Stock, other than adjustments authorized under
Section 8.
6.
Incentive Award
Agreements
.
Each Incentive Award made under
this Plan shall be evidenced by a written Incentive Award
agreement or other writing (Incentive Award
Agreement) which shall contain such terms and conditions,
as well as such other terms and conditions not inconsistent
herewith, as the Committee may consider appropriate in each
case, including but not limited to the Performance Goal(s),
performance period (which must be a period of one year or less
for annual Incentive Awards, and more than one year for
long-term Incentive Awards), the potential amount payable in
cash or Stock, and the timing of payment, provided that the
Committee must require
3
that payment of all or any portion of the amount subject to the
Incentive Award is contingent on the achievement or partial
achievement of one or more Performance Goals during the
performance period, although the Committee may specify that all
or a portion of the Performance Goals subject to an Incentive
Award are deemed achieved upon a Participants death,
disability or retirement, or such other circumstances as the
Committee may specify.
Performance Goals
means any goals the
Committee establishes that relate to one or more of the
following with respect to the Company or any one or more of its
subsidiaries, or other business units: net sales; cost of sales;
gross income; gross revenue; operating income; earnings before
taxes; earnings before interest and taxes; earnings before
interest, taxes, depreciation and amortization; income from
continuing operations; net income; earnings per share; diluted
earnings per share; Fair Market Value; cash flow; net cash
provided by operating activities; net cash provided by operating
activities less net cash used in investing activities; ratio of
debt to debt plus equity; return on shareholder equity; return
on invested capital; return on average total capital employed;
return on net assets employed before interest and taxes;
operating working capital; average accounts receivable
(calculated by taking the average of accounts receivable at the
end of each month); average inventories (calculated by taking
the average of inventories at the end of each month); economic
value added; and customer satisfaction. As to each Performance
Goal, the relevant measurement of performance shall be computed
in accordance with generally accepted accounting principles, if
applicable, but, unless otherwise determined by the Committee,
will exclude the effects of (i) extraordinary, unusual
and/or
non-recurring items of gain or loss, (ii) gains or losses
on the disposition of a business or operating unit,
(iii) changes in tax or accounting regulations or laws, or
(iv) the effect of a merger or acquisition, that in each
case the Company identifies in its audited financial statements,
including footnotes, or the Managements Discussion and
Analysis section of the Companys annual report. In the
case of Awards that the Committee determines will not be
considered performance-based compensation under
Section 162(m) of the Code, the Committee may establish
other Performance Goals not listed in this Plan, including
subjective goals.
7.
The Stock
.
The total number of
shares of Stock as to which Options and restricted shares of
Stock may be granted under this Plan shall not exceed 4,200,000
in the aggregate, except as such number of shares shall be
adjusted in accordance with the provisions of Section 8
hereof. The total number of shares of Stock issued pursuant to
the exercise of ISOs shall not exceed 1,050,000 in the
aggregate, except as such number of shares shall be adjusted in
accordance with the provisions of Section 8 hereof. If any
outstanding Option under the Plan shall expire or be terminated
for any reason before the end of the
10-year
period during which Options may be granted hereunder
and/or
if
any shares of restricted Stock are forfeited, then the shares of
Stock allocable to the unexercised portion of such Option and
the shares of restricted Stock which are forfeited, may again be
included in an Option or be available for grant as restricted
shares of Stock under the Plan. The Company shall at all times
retain as authorized and unissued Stock at least the number of
shares from time to time included in outstanding Options and
grants of restricted shares of Stock under this Plan, or
otherwise assure itself of its ability to perform its
obligations under this Plan.
8.
Adjustments
.
|
|
|
|
a)
|
Adjustments by Stock Split, Stock Dividend,
Etc
.
If the Company shall at any time
increase or decrease the number of its outstanding shares of
Stock, or change in any way the rights and privileges of such
shares, by means of the payment of a Stock dividend or the
making of any other distribution upon such shares payable in
Stock, or through a Stock split or subdivision of shares, or a
consolidation or combination of shares, or through a
reclassification or recapitalization involving the Stock, then
the numbers, rights and privileges of the following shall be
increased, decreased or changed in like manner as if they had
been issued and outstanding, fully paid and non-assessable at
the time of such occurrence: (i) the shares of Stock as to
which Options (including ISOs) and restricted shares may be
granted under the Plan; (ii) the maximum number of shares
of Stock with respect to which an employee may receive an Option
or an award of restricted Stock hereunder; and (iii) the
shares of Stock then included in each outstanding Option granted
hereunder.
|
|
|
b)
|
Dividend Payable in Stock of Another Corporation,
Etc
.
If the Company shall at any time pay or
make any dividend or other distribution upon the Stock payable
in securities or other property (except money or Stock), a
proportionate part of such securities or other property shall be
set aside and
|
4
|
|
|
|
|
delivered to each Option Holder then holding an Option hereunder
upon exercise thereof and each Restricted Stock Holder upon the
satisfaction of all restrictions and terms applicable to such
shares.
|
|
|
|
|
c)
|
Apportionment of Price
.
Upon any
occurrence described in the preceding subsections (a) and
(b) of this Section 8, the total Option price under
any then outstanding Option shall remain unchanged but shall be
apportioned ratably over the increased or decreased number or
changed kinds of securities or other property subject to the
Option.
|
|
|
d)
|
Rights to Subscribe
.
If the Company
shall at any time grant to the holders of its Stock rights to
subscribe
pro
rata
for additional shares thereof
or for any other securities of the Company or of any other
corporation, there shall be added to the number of shares then
underlying each outstanding Option the Stock or other securities
which the Option Holder would have been entitled to subscribe
for if immediately prior to such grant the Option Holder had
exercised his entire Option, and the Option price shall be
increased by the amount which would have been payable by the
Option Holder for such Stock or other securities.
|
|
|
e)
|
Determination by the Committee,
Etc
.
Adjustments under this Section 8
shall be made by the Committee, whose determinations with regard
thereto shall be final and binding. No fractional shares of
Stock shall be issued on account of any such adjustment.
|
9.
Merger, Consolidation, Etc
.
|
|
|
|
a)
|
Effect of Transaction
.
Upon the
occurrence of any of the following events, if the notice
required by Section 9(b) hereof shall have first been
given, this Plan and all Options then outstanding under it shall
automatically terminate and be of no further force and effect
whatsoever, without the necessity for any additional notice or
other action by the Committee, the Board or the Company:
(i) the merger, consolidation or liquidation of the Company
or the acquisition of its assets or stock pursuant to a
nontaxable reorganization, unless the surviving or acquiring
corporation, as the case may be, shall assume the outstanding
Options or shall assume the restricted shares of Stock or shall
substitute new options
and/or
new
restricted shares for them pursuant to Section 425(a) of
the Code; (ii) the dissolution or liquidation of the
Company; (iii) the appointment of a receiver for all or
substantially all of the Companys assets or business;
(iv) the appointment of a trustee for the Company after a
petition has been filed for the Companys reorganization
under applicable statutes; or (v) the sale, lease or
exchange of all or substantially all of the Companys
assets and business.
|
|
|
b)
|
Notice of Such Occurrences
.
At least
30 days prior written notice of any event described
in Section 9(a) hereof, except the transactions described
in subsections 9(a)(iii) and (iv) as to which no notice
shall be required, shall be given by the Company to each Option
Holder and each Restricted Stock Holder theretofore granted an
Option or issued restricted shares of Stock under this Plan. The
Option Holders so notified may exercise their Options at any
time before the occurrence of the event requiring the giving of
notice, regardless of whether all conditions of exercise
relating to continuation of employment for specified periods of
time have been satisfied. Such notice shall be deemed to have
been given when delivered personally to an Option Holder, or
when mailed to an Option Holder, by registered or certified
mail, postage prepaid, at such holders last address known
to the Company. The Restricted Stock Holders so notified shall
fully vest in such shares and have all restrictions on their
restricted shares removed as of the date the notice is given.
|
10.
Expiration
.
The Plan shall
terminate whenever the Board adopts a resolution to that effect.
If not sooner terminated under the preceding sentence hereof,
the Plan shall wholly cease and expire 10 years from the
effective date hereof. After termination, no Awards shall be
granted under the Plan, but the Company shall continue to
recognize Awards previously granted.
5
11.
General Provisions
.
|
|
|
|
a)
|
Amendments, Etc
.
The Board may from
time to time amend, modify, suspend or terminate this Plan.
Nevertheless, no such amendment, modification, suspension or
termination shall (i) impair any Option theretofore granted
under this Plan or deprive any Option Holder of any shares of
Stock which he may have acquired through or as a result of the
Plan, (ii) impair any restricted shares of Stock
theretofore granted under this Plan or deprive any Restricted
Stock Holder of any restricted shares of Stock which he or she
may have acquired through or as a result of this Plan,
(iii) impair the rights of a holder of an Incentive Award
theretofore granted under this Plan, or (iv) be made
without the approval of the shareholders of the Company where
such change would (A) materially increase the benefits
accruing to Award holders under this Plan, (B) materially
increase the total number of shares of Stock which may be issued
under this Plan, or (C) materially modify the requirements
as to eligibility for participation in this Plan or expand the
list of Performance Goals. Notwithstanding the foregoing, the
Board need not obtain Award holder (or other interested party)
consent for the modification of the Plan or an Award to the
extent deemed necessary to comply with any applicable law, the
listing requirements of any principal securities exchange or
market on which the shares of Stock are then traded, or to
preserve favorable accounting treatment of any Award for the
Company.
|
The provisions of Section 409A of the Code are incorporated
herein by reference to the extent necessary for any Award that
is subject to Section 409A of the Code to comply therewith.
|
|
|
|
b)
|
Qualification under Internal Revenue Code; Limitations on
Companys Liability
.
The Company intends
that all ISOs granted under this Plan shall constitute incentive
stock options within the meaning of Section 422A of the
Code and this Plan shall be construed and administered in order
to effect such intention. The Company intends that all Awards
granted under this Plan shall either be exempt from
Section 409A of the Code or shall comply therewith.
Notwithstanding the foregoing, the Company does not guarantee to
any Award holder or any other person with an interest in an
Award that any Award intended to be an ISO shall qualify as
such, or that any Award intended to be exempt from
Section 409A of the Code shall be so exempt, or that any
Award intended to comply with Section 409A of the Code
shall so comply, and the Company shall not indemnify, defend or
hold harmless any individual with respect to the tax
consequences of any such failure.
|
|
|
c)
|
Treatment of Proceeds
.
Proceeds from
the sale of Stock pursuant to Options granted under this Plan
and/or
restricted shares granted under this Plan shall constitute
general funds of the Company.
|
|
|
d)
|
Effective Date
.
The effective date of
the Plan shall be May 30, 2002, being the date on which the
Plan was initially approved by the by shareholders of the
Company; provided, however, that the effective date of the
amendment to the Plan permitting the granting of restricted
shares of Stock under the Plan shall be May 30, 2003, being
the date on which the shareholders of the Company approved the
amendment to the Plan to permit the granting of restricted
shares of Stock under the Plan; and provided further that the
effective date of the amendment to the Plan permitting the
granting of Incentive Awards under the Plan shall be
May 10, 2007, being the date on which the shareholders of
the Company approved the amendment to the Plan permitting such
awards. ISOs previously granted under the Companys 1991
Stock Option Plan and outstanding as of the May 30, 2002
effective date of this Plan shall continue to be governed by the
terms of the Option Agreements entered into in connection with
such ISOs.
|
|
|
e)
|
Paragraph Headings
.
The paragraph
headings are included herein only for convenience and they shall
have no effect on the interpretation of the Plan.
|
|
|
|
|
f)
|
Employment
.
The issuance of an Award
shall not confer upon an employee any right with respect to
continued employment with the Company or any subsidiary. Unless
determined otherwise by the Committee, for purposes of the Plan
and all Awards, the following rules shall apply:
|
|
|
|
|
(i)
|
a Participant who transfers employment between the Company
and its subsidiaries, or between subsidiaries of the Company,
will not be considered to have terminated employment;
|
6
|
|
|
|
(ii)
|
a Participant who ceases to be employed by the Company or a
subsidiary and immediately thereafter becomes a non-employee
director of the Company or of a subsidiary, or a consultant to
the Company or any subsidiary shall not be considered to have
terminated employment until such Participants service as a
director of, or consultant to, the Company and its subsidiaries
has ceased;
|
|
|
|
|
(iii)
|
a Participant employed by a subsidiary will be considered to
have terminated employment when such entity ceases to be a
subsidiary of the Company.
|
Notwithstanding the foregoing, for purposes of an Award that is
subject to Code Section 409A, if an employees
termination of employment triggers the payment of compensation
under such Award, then the employee will be deemed to have
terminated employment upon a separation from service
within the meaning of Section 409A of the Code.
|
|
|
|
g)
|
Requirements of Law and Securities
Exchange
.
The granting of Awards and the
issuance of shares of Stock in connection with an Award are
subject to all applicable laws, rules and regulations and to
such approvals by any governmental agencies or national
securities exchanges as may be required. Notwithstanding any
other provision of this Plan or any award agreement, the Company
has no liability to deliver any shares under this Plan or make
any payment unless such delivery or payment would comply with
all applicable laws and the applicable requirements of any
securities exchange or similar entity, and unless and until the
Award holder has taken all actions required by the Company in
connection therewith. The Company may impose such restrictions
on any shares issued under the Plan as the Company determines
necessary or desirable to comply with all applicable laws, rules
and regulations or the requirements of any national securities
exchanges.
|
|
|
h)
|
Compensation Recovery Policy
.
The
Committee may institute a policy that, in appropriate
circumstances, it will evaluate whether to seek the
reimbursement of certain compensation realized under Awards
granted under the Plan to an executive officer if such executive
engages in activities that caused or partially caused a
restatement of the Companys financial results. In such a
case, the Company shall have the right, notwithstanding any
provision of the Plan, any Award or any award agreement to the
contrary, to require the executive officer to reimburse the
Company for the amount of compensation paid (including the value
of any shares of Stock issued) under the Plan for the relevant
period, as provided by law.
|
|
|
|
|
i)
|
Governing Law
.
This Plan, and all
agreements under this Plan, will be construed in accordance with
and governed by the laws of the State of Maryland, without
reference to any conflict of law principles. Any legal action or
proceeding with respect to this Plan, any Award or any award
agreement, or for recognition and enforcement of any judgment in
respect of this Plan, any Award or any award agreement, may only
be heard in a bench trial, and any party to such
action or proceeding shall agree to waive its right to a jury
trial.
|
|
|
j)
|
Limitations on Actions
.
Any legal
action or proceeding with respect to this Plan, any Award or any
award agreement, must be brought within one year (365 days)
after the day the complaining party first knew or should have
known of the events giving rise to the complaint.
|
|
|
|
|
k)
|
Construction
.
Whenever any words are
used herein in the masculine, they shall be construed as though
they were used in the feminine in all cases where they would so
apply; and wherever any words are used in the singular or
plural, they shall be construed as though they were used in the
plural or singular, as the case may be, in all cases where they
would so apply. Title of sections are for general information
only, and this Plan is not to be construed with reference to
such titles.
|
|
|
|
|
l)
|
Severability
.
If any provision of this
Plan or any award agreement or any Award (i) is or becomes
or is deemed to be invalid, illegal or unenforceable in any
jurisdiction, or as to any person or Award, or (ii) would
disqualify this Plan, any award agreement or any Award under any
law the Committee deems applicable, then such provision should
be construed or deemed amended to conform to applicable laws, or
if it cannot be so construed or deemed amended without, in the
determination of the Committee, materially altering the intent
of this Plan, award agreement or Award, then such provision
should be stricken as to such jurisdiction, person or Award, and
the remainder of this Plan, such award agreement and such Award
will remain in full force and effect.
|
7
Appendix 2
HANGER
ORTHOPEDIC GROUP, INC.
2003 NON-EMPLOYEE DIRECTORS STOCK INCENTIVE PLAN
(As proposed to be amended)
The purpose of this Amended and Restated 2003 Non-Employee
Directors Stock Incentive Plan (the Plan) of
Hanger Orthopedic Group, Inc. (the Company) is to
increase the ownership interest in the Company of non-employee
directors whose services are considered essential to the
Companys continued progress and to provide a further
incentive to serve as a director of the Company.
2.
Administration
The Plan shall be administered by the Compensation Committee of
the Board of Directors of the Company (the
Committee). Subject to the provisions of the Plan,
the Committee shall be authorized to interpret the Plan, to
establish, amend, and rescind any rules and regulations relating
to the Plan, and to make all other determinations necessary or
advisable for the administration of the Plan; provided, however,
that the Committee shall have no discretion with respect to the
selection of directors to receive awards of restricted shares or
restricted stock units (RSUs) under the Plan, the
number of shares of stock subject to any such awards of
restricted shares or RSUs under the Plan, or the time or times
at which restricted shares or RSUs may be granted, and provided
further that the Committee shall not have the authority to alter
or amend the Plan or to take any action or make any
determination that would materially increase the benefits
accruing to participants under the Plan. The determination of
the Committee in the administration of the Plan, as described
herein, shall be final and conclusive and binding upon all
persons including, without limitation, the Company, its
stockholders and persons granted options, restricted shares, or
RSUs under the Plan.
3.
Participation in the Plan
Directors of the Company who are not employees of the Company or
any affiliate of the Company shall be eligible to participate in
the Plan (Eligible Directors).
4.
Shares Subject to the Plan
Subject to adjustment as provided in Section 9, an
aggregate of 500,000 shares of Company common stock, par
value $.01 per share (the Stock), shall be
available for issuance upon the exercise of options previously
granted under the Plan and the award of restricted shares or
RSUs under the Plan. The shares of Stock deliverable upon the
exercise of options previously granted under the Plan and the
award of restricted shares or RSUs may be made available from
authorized but unissued shares or shares reacquired by the
Company, including shares purchased in the open market or in
private transactions. If any option previously granted under the
Plan shall expire or terminate for any reason without having
been exercised in full, the shares subject to, but not delivered
under, such option may again become available for the award of
restricted shares or RSUs under the Plan. Except in the case of
the total and permanent disability or death of an Eligible
Director, a Change in Control of the Company (as defined in
Section 10), or the Retirement of an Eligible Director (as
defined in Section 7(d)), if any Eligible Director who has
been awarded any restricted shares or RSUs shall cease being an
Eligible Director prior to the date on which the restricted
shares or RSUs shall have vested, then such unvested shares or
RSUs shall be cancelled and forfeited by that recipient
director, in which case such shares or units shall once again
become available under the Plan for issuance upon the exercise
of options previously granted under the Plan and the award of
restricted shares or RSUs under the Plan. No shares deliverable
to the Company in full or partial payment of the purchase price
payable pursuant to paragraph (f) of Section 6
shall become available for the grant of other options under the
Plan.
5.
Non-Statutory Stock Options
All options granted under the Plan shall be non-statutory
options not intended to qualify under Section 422A of the
Internal Revenue Code of 1986, as amended.
6.
Terms, Conditions and Form of Previously
Granted Options
Following the approval of the amended and restated provisions of
the Plan by the stockholders of the Company at the 2006 Annual
Meeting of Stockholders, options to purchase shares of Stock
shall no longer be granted under the Plan. Except as otherwise
provided under this Plan, each option previously granted under
this Plan is evidenced by a written agreement in such form as
the Committee shall have approved from time to time, which
agreements comply with and are subject to the following terms
and conditions:
|
|
|
|
(a)
|
Annual Option Grant Dates.
Options to purchase
5,000 shares of Stock (as adjusted pursuant to
Section 9) were previously granted automatically on an
annual basis to each Eligible Director as of the fourth business
day following the date of each Annual Meeting of Stockholders of
the Company at which the Eligible Director is elected.
|
|
|
|
|
(b)
|
Purchase Price.
The purchase price per share
of Stock for which each previously granted option is exercisable
is 100% of the fair market value per share of Stock on the date
prior to the date the option was granted, which was the closing
per-share price of the Stock as reported on the New York Stock
Exchange.
|
|
|
|
|
(c)
|
Exercisability and Term of Options.
Each
option previously granted under the Plan shall vest and become
exercisable as to one-third (1/3) of the shares of Common Stock
underlying the option at the end of each of the first three
years following the date of the grant. Each option previously
granted under the Plan shall expire ten years from the date of
the grant, and shall be subject to earlier termination as
hereinafter provided.
|
|
|
|
|
(d)
|
Termination of Service.
In the event of the
termination of service on the Board by the holder of any option,
other than by reason of total and permanent disability, death,
or Retirement (as defined in Section 7(d)), the then
outstanding options of such holder shall expire ninety
(90) days after such termination.
|
|
|
|
|
(e)
|
Disability, Death or Retirement.
In the event
of termination of service by reason of the total and permanent
disability or Retirement of the holder of any option, each of
the then outstanding unvested options of such holder will
immediately vest and the holder may exercise all or any portion
of such option at any time within one year after such total and
permanent disability or Retirement, but in no event after the
expiration date of the term of the option. In the event of the
death of the holder of any option, each of the then outstanding
unvested options of such holder will immediately vest and become
exercisable by the holders legal representative at any
time within a period of one year after death, but in no event
after the expiration date of the term of the option.
|
|
|
|
|
(f)
|
Payment.
Options may be exercised only upon
payment to the Company in full of the purchase price of the
shares to be delivered. Such payment shall be made in cash or in
Stock, or in a combination of cash and Stock. The sum of the
cash and the fair market value of such Stock shall be at least
equal to the aggregate purchase price of the shares to be
delivered.
|
|
|
|
|
7.
|
Terms and Conditions of Annual Restricted Stock or RSU
Issuances
|
Except as provided in this Plan, each annual issuance of
restricted shares of Stock or RSUs granted under this Plan shall
be subject to the following terms and conditions:
|
|
|
|
(a)
|
Grant Dates.
The amount of 8,500 shares
of Stock (as adjusted pursuant to Section 9) shall be
granted automatically on an annual basis to each Eligible
Director as of the fourth business day following the date of
each Annual Meeting of Stockholders of the Company at which the
Eligible Director is elected. In addition, the amount of
2,000 shares of Stock (as adjusted pursuant to
Section 9) shall be granted automatically on an annual
basis to the lead non-management director of the Board as of the
fourth business day following the date of each Annual Meeting of
Stockholders of the Company at which such director is elected to
the Board. Each Eligible Director may elect to receive all of
his or her full annual grant of restricted shares under this
subsection in the form of RSUs, subject to Section 10. In
the event a director is appointed to fill a vacancy occurring
between Annual Meetings of Stockholders of the Company, such
director shall be granted automatically as of the fourth
business day following the date of appointment a
pro rata
portion of the annual grant amount of 8,500 shares of
Stock (as adjusted pursuant to Section 9). An Eligible
Director appointed midyear may not elect to receive his or her
pro rata
grant of restricted shares in the form of RSUs.
|
2
|
|
|
|
(b)
|
Restrictions.
Each restricted share and each
RSU issued under this Plan shall be restricted as a result of
being subject to a vesting period pursuant to which one-third of
the restricted shares or RSUs vest at the end of each of the
first three years following the date of grant, and shall be
subject to forfeiture and cancellation in the event of early
termination of such vesting period as hereinafter provided.
|
|
|
|
|
(c)
|
Termination of Service.
In the event of the
termination of service on the Board by the holder of any
unvested restricted shares or RSUs, other than by reason of
total and permanent disability, death, or Retirement (as defined
in (d), below), the then unvested restricted shares or RSUs
shall be forfeited and cancelled unless such unvested restricted
shares or RSUs vest on or before the date which is ninety
(90) days after such termination.
|
|
|
|
|
(d)
|
Disability, Death, or Retirement.
In the event
of termination of service on the Board by reason of the total
and permanent disability, death, or Retirement of the holder of
any unvested restricted shares or RSUs, each of the then
unvested restricted shares or RSUs of such holder will
immediately vest in full as of the date of such total and
permanent disability, death, or Retirement. Retirement means an
Eligible Directors termination of service on the Board
after having served continuously as a Director for at least five
(5) years and after having given the Company written notice
of the Eligible Directors intent to retire no less than
one (1) year prior to the date of Retirement.
|
|
|
|
|
8.
|
Terms and Conditions of Restricted Stock or RSUs Being
Issued in Lieu of Annual Director Fees
.
|
So long as the Company pays an annual fee to Eligible Directors,
then each Eligible Director may elect to receive all of his or
her annual director fee from the Company in the form of
restricted shares of Stock or RSUs, subject to the following
terms and conditions, and, with respect to RSUs, subject also to
Section 10:
|
|
|
|
(a)
|
Restricted Stock or RSUs in Lieu of Annual Director
Fee.
Except as otherwise provided in this Plan,
each Eligible Director may elect to receive all of his or her
annual director fee from the Company in the form of restricted
shares or RSUs to be issued to such director in the number of
whole shares of Stock or RSUs which is equal to (1) the
amount of such annual director fee divided by (2) the
closing sale price per share of the Stock as reported by the New
York Stock Exchange on the third business day following the date
of each Annual Meeting of Stockholders at which the Eligible
Director is elected. The restricted shares or RSUs received by
such Eligible Director in lieu of his or her annual director fee
will be subject to the provisions of Section 7 (b),
(c) and (d) of this Plan. In the event a director is
appointed to fill a vacancy occurring between Annual Meetings of
Stockholders of the Company, such director may elect to receive
his or her annual director fee from the Company for services to
be rendered to the next Annual Meeting in the form of restricted
shares, in accordance with this subsection (a), but not
RSUs.
|
|
|
|
|
(b)
|
Additional Restricted Shares of Stock or
RSUs.
In the event an Eligible Director elects to
receive his or her annual director fee in restricted shares or
RSUs under this Plan, then such Eligible Director shall also
receive an additional number of restricted shares or RSUs, as
applicable, under this Plan in an amount equal to ten percent of
the number of restricted shares or RSUs that such Eligible
Director elected to receive in lieu of his or her annual
director fee under Section 8(a). The date of grant of such
additional restricted shares or RSUs shall be the fourth
business day following the date of each Annual Meeting of
Stockholders at which the Eligible Director is elected and all
other terms and provisions of such additional shares shall be
the same as under the provisions of Section 7 (b),
(c) and (d) of this Plan.
|
|
|
|
|
9.
|
Adjustment upon Changes in Stock
|
If there shall be any change in the Stock subject to the Plan or
to any option, restricted shares, or RSUs granted thereunder
through a merger, consolidation, reorganization,
recapitalization, stock dividend, stock split, exchange of stock
or other change in the corporate structure, appropriate
adjustments shall be made in the aggregate number and kind of
shares, RSUs, or other securities or property subject to the
Plan, and the number and kind of shares, RSUs, or other
securities or property subject to outstanding grants and in the
purchase price of outstanding options to reflect such changes.
3
|
|
|
|
10.
|
Restricted Share Unit Administration
|
|
|
|
|
(a)
|
Election to Receive Restricted Stock Units.
An
Eligible Director may elect, on or before the date of each
Annual Meeting of Stockholders of the Company at which the
Eligible Director is elected to an annual term, to receive as
RSUs the Eligible Directors annual issuance of restricted
shares, including any additional grants of restricted shares for
the lead non-management Eligible Director, for the upcoming
year. An Eligible Director may separately elect, on or before
the date of each Annual Meeting of Stockholders of the Company
at which the Eligible Director is elected to an annual term, to
receive as RSUs all of the Eligible Directors annual fee
for the upcoming year. RSUs issued for the account of an
Eligible Director pursuant to this Section (including an
additional issuances pursuant to Section 8(b)) shall be
credited to the Eligible Directors separate restricted
share unit account for that year, as described in (b), below,
and shall be paid in a single lump sum to the Eligible Director
at the time specified as part of the Eligible Directors
election for such year. The election to receive RSUs and their
time of payment shall be designated by submitting a completed
election form approved for this purpose by the Committee to the
Vice President, Human Resources of the Company during the thirty
day period ending with the date of the Annual Meeting at which
the Eligible Director is elected to serve for the following
year. An Eligible Director must make a new election for each
year for which he or she will be elected to serve as a director
and wishes to receive RSUs. Each such election shall be
irrevocable and shall include an irrevocable election of a time
of payment applicable to the separate account established as a
result of the election. The times of payment from which the
Eligible Director may choose each year are on or about
(i) the January 15th of the calendar year
following the calendar year in which the Eligible Director
terminates service on the Board of Directors, or (ii) the
fifth, tenth, or fifteenth anniversary of the Annual Meeting
Date on the election form for that year.
|
|
|
|
|
(b)
|
Restricted Share Unit Separate Accounts.
The
Company shall maintain separate bookkeeping accounts to reflect
each Eligible Directors RSUs credited for each year and
the time of payment selected by the Eligible Director for that
separate account. As of the date the Company pays any dividend
(whether in cash or in kind) on shares of Stock, each Eligible
Directors accounts shall be credited with that number of
RSUs equal to the ratio of (1) the aggregate value of the
dividend that would have been payable on the vested RSUs held by
the account immediately prior to such payment date had the
shares of Stock represented by such RSUs been outstanding as of
such payment date to (2) the fair market value per share of
Stock on such date (as described in Section 6).
|
|
|
|
|
(c)
|
Eligible Director Rights Not Secured.
No
separate fund or trust shall be created or moneys set aside on
account of the separate accounts established under this Section.
To the extent that any person acquires a right to receive
deferred compensation from the Company under the Plan, such
right shall be no greater than the right of any unsecured
general creditor of the Company. The right of an Eligible
Director or beneficiary to the payment of benefits under the
Plan shall not be assignable or transferable other than by will
or the laws of descent and distribution and shall be exercisable
during the holders lifetime only by the holder or the
holders guardian or legal representative.
|
|
|
|
|
(d)
|
Payment of Separate
Account Balances.
Subject to subsection (f),
below, amounts credited to an Eligible Directors separate
accounts hereunder shall be distributed in whole shares of Stock
(with fractional shares paid in cash). The payment of each
separate account shall be made in a single lump sum at the time
specified in the election form establishing the separate account.
|
|
|
|
|
(e)
|
Designation of Beneficiary.
Each Eligible
Director shall have the right to designate a beneficiary who is
to succeed to his or her right to receive payment of any
remaining balance of all of the Eligible Directors
separate accounts hereunder in the event of the death of the
Eligible Director. A designated beneficiary shall receive
payment in a single lump sum. Notwithstanding the time of
payment elected by the Eligible Director with respect to any
separate account, all payments of separate account balances to a
beneficiary will be made on or about
January 15
th
of
the calendar year following the calendar year in which the date
of death occurs, or if later, the sixth month anniversary of the
date of death. In case of a failure of designation or the death
of a designated beneficiary without a designated successor, the
balance of the amounts contained in all of the Eligible
Directors separate accounts shall be paid in a single lump
sum payment to
|
4
|
|
|
|
|
the Eligible Directors or former Eligible Directors
estate in full on or about the
January 15
th
of
the calendar year following the calendar year in which the date
of death occurs, or if later, the sixth month anniversary of the
date of death. No designation of beneficiary or changes in
beneficiary shall be valid unless it is in writing signed by the
Eligible Director and filed with the Vice President Human
Resources.
|
|
|
|
|
(f)
|
Change in Control.
Notwithstanding the other
provisions of the Plan to the contrary, if a Change in Control
occurs prior to the complete distribution of an Eligible
Directors separate accounts, then any portion of such
accounts that has not already been distributed (including
previously unvested amounts) shall be distributed in a single
lump sum amount to the Eligible Director (or, as applicable, to
his or her beneficiary) immediately following the Change in
Control. Change in Control, for this purpose, means a change in
the ownership or control of the Company effected through
(1) the acquisition, other than from the Company, by any
individual, entity or group of beneficial ownership (within the
meaning of Rule
l3d-3
promulgated under the Securities Exchange Act of 1934, as
amended), including in connection with a merger, consolidation
or reorganization, of more than thirty-five percent (35%) of the
combined voting power of the Companys securities
outstanding immediately after the acquisition, or
(2) individuals who, as of May 10, 2007, constitute
the Board (the Incumbent Board) ceasing to
constitute at least a majority of the Board during any
12-month
period, provided that any individual becoming a director
subsequent to such date, whose election or nomination for
election by the Companys shareholders was approved by a
vote of at least a majority of the directors then comprising the
Incumbent Board, shall be considered as though such individual
were a member of the Incumbent Board.
|
|
|
|
|
11.
|
Merger, Consolidation or Liquidation
|
At least thirty days prior written notice of a merger,
consolidation or liquidation of the Company shall be given by
the Company to each option holder and each holder of restricted
shares of Stock and RSUs issued under this Plan, in which case
vesting shall accelerate and all outstanding options shall
become fully exercisable and all unvested restricted shares and
RSUs shall become fully vested. Upon the occurrence of a merger,
consolidation or liquidation of the Company, all options then
outstanding hereunder shall automatically terminate unless the
surviving or acquiring corporation shall assume the outstanding
options or substitute new options for them.
|
|
|
|
12.
|
Assignment and Transfer
|
Each option and all rights thereunder shall be non-assignable
and non-transferable other than by will or the laws of descent
and distribution and shall be exercisable during the
holders lifetime only by the holder or the holders
guardian or legal representative. Each unvested share of Stock
issued under this Plan shall be non-assignable and
non-transferable other than by will or the laws of descent and
distribution and may not be sold, pledged, hypothecated,
assigned or transferred until only after each such share of
Stock has vested pursuant to the terms of this Plan.
|
|
|
|
(a)
|
No Right to Continue as a Director.
Neither
this Plan, nor the granting of an option, nor the issuance of
any restricted shares or RSUs nor any other action taken
pursuant to this Plan, shall constitute or be evidence of any
agreement or understanding, express or implied, that the
director has a right to continue as a director for any period of
time, or at any particular rate of compensation.
|
|
|
|
|
(b)
|
No Stockholders Rights for Options or Unvested
Restricted Shares or RSUs.
An optionee shall have
no rights as a stockholder with respect to the shares covered by
options granted hereunder until the date of the issuance of a
stock certificate therefor, and no adjustment will be made for
dividends or other rights for which the record date is prior to
the date such certificate is issued. The holder of unvested
restricted shares or unvested RSUs shall have no rights as a
stockholder with respect to such unvested shares or RSUs granted
hereunder until the date such shares or RSUs become vested in
the holder, and no adjustment will be made for dividends or
other rights for which the record date is prior to the date of
the vesting of such restricted shares or RSUs.
|
5
|
|
|
|
14.
|
Effective Date and Duration of Plan
|
This Plan first became effective immediately following the 2003
Annual Meeting of Stockholders and shall continue to be
effective, as amended, for the duration of the Plan set forth
below. The period during which grants of options, restricted
shares of Stock, and RSUs shall be made under this Plan shall
terminate on the fourth business day following the 2013 Annual
Meeting of Stockholders (unless this Plan is extended or
terminated at an earlier date) but such termination shall not
affect the terms of any then outstanding options, restricted
shares, or RSUs.
|
|
|
|
15.
|
Amendment, Suspension or Termination of the Plan
|
The Board of Directors may suspend or terminate this Plan or
revise or amend it in any respect whatsoever; provided, however,
that without approval of the stockholders, no revision or
amendment shall change the selection or eligibility of directors
to receive restricted shares of Stock under this Plan or RSUs,
the number of shares of Stock subject to any grants of
restricted shares or RSUs, or the Plan itself, the vesting
period of any grant of restricted shares or RSUs, or materially
increase the benefits accruing to participants under this Plan;
and further provided that the Plan provisions relating to grants
of restricted shares or RSUs shall not be amended more than once
every six months, other than to comport with changes under the
Internal Revenue Code, the Employee Retirement Income Security
Act or the rules thereunder.
No fractional shares of Stock shall be issued pursuant to prior
grants of options or restricted shares of Stock hereunder, but
in lieu thereof, the cash value of such fraction shall be paid.
6
|
|
|
|
|
THE BOARD OF DIRECTORS RECOMMENDS VOTING FOR THE FOLLOWING PROPOSALS:
|
|
Please
Mark Here
|
o
|
|
|
for Address
Change or
Comments
SEE REVERSE SIDE
|
|
|
|
|
|
|
|
|
|
|
|
|
|
FOR
|
|
WITHHOLD
|
1.
|
|
To Elect Directors
|
all nominees
|
|
AUTHORITY
|
|
|
|
|
|
except as
|
|
to vote for
|
|
|
Nominees:
|
marked to
|
|
all nominees
|
|
|
|
the contrary
|
|
listed
|
|
|
01 Edmond E. Charrette, M.D.,
02 Thomas P. Cooper, M.D.,
03 Cynthia L. Feldmann,
04 Eric Green,
05 Isaac Kaufman,
06 Thomas F. Kirk,
07 Bennett Rosenthal,
08 Ivan R. Sabel, CPO, and
09 H.E. Thranhardt, CPO.
|
o
|
|
o
|
INSTRUCTION: TO WITHHOLD AUTHORITY FOR ANY INDIVIDUAL NOMINEE, WRITE THAT NOMINEES NAME ON THE SPACE PROVIDED BELOW.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
FOR
|
|
AGAINST
|
|
ABSTAIN
|
2.
|
|
Proposal to amend the terms of the 2002 Stock Incentive Plan to provide for annual variable compensation payments.
|
|
o
|
|
o
|
|
o
|
|
|
|
|
|
|
|
|
|
|
FOR
|
|
AGAINST
|
|
ABSTAIN
|
3.
|
|
Proposal to amend the terms of
the 2003 Non-Employee Directors Stock Incentive Plan to
provide for the deferral of income related to stock-based compensation for Company directors.
|
|
o
|
|
o
|
|
o
|
|
|
|
|
|
|
4.
|
|
In their discretion, the Proxies are authorized to vote upon such other business as
properly may come before the meeting.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Signature
|
|
|
|
Signature
|
|
|
|
|
Date
|
|
|
,
2007
|
Sign
exactly as your name appears hereon. When signing in a representative or fiduciary capacity,
indicate title. If shares are held jointly, each holder should sign.
|
|
WE
ENCOURAGE YOU TO TAKE ADVANTAGE OF INTERNET OR TELEPHONE VOTING,
BOTH ARE AVAILABLE 24 HOURS A DAY, 7 DAYS A WEEK.
Internet and telephone voting is available through 11:59 PM Eastern Time
the day prior to annual meeting day.
Your
Internet or telephone vote authorizes the named proxies to vote your shares in the same manner
as if you marked, signed and returned your proxy card.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
INTERNET
|
|
|
|
|
|
TELEPHONE
|
|
|
http://www.proxyvoting.com/hgr
|
|
|
|
|
|
1-866-540-5760
|
|
|
Use the internet to vote your proxy.
Have your proxy card in hand
when you access the web site.
|
|
|
OR
|
|
|
Use any touch-tone telephone to
vote your proxy. Have your proxy
card in hand when you call.
|
|
|
|
|
|
|
|
|
|
|
If you vote your proxy by Internet or by telephone, you do NOT need to mail back your proxy
card.
To vote by mail, mark, sign and date your proxy card and return it in the enclosed
postage-paid envelope.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Choose
MLink
SM
for fast, easy and secure 24/7 online access to your future proxy
materials,
investment plan statements, tax documents and more. Simply log on to
Investor ServiceDirect
®
at
www.melloninvestor.com/isd
where step-by-step instructions will prompt you
through enrollment.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PROXY
HANGER ORTHOPEDIC GROUP, INC.
TWO BETHESDA METRO CENTER, SUITE 1200
BETHESDA, MARYLAND 20814
|
|
|
|
This proxy is solicited by the Board of Directors
for the ANNUAL MEETING OF STOCKHOLDERS of Hanger Orthopedic Group, Inc. (the Company), a Delaware corporation, on May 10, 2007, 10:00 a.m., local time.
The undersigned appoints Ivan R. Sabel
and Thomas F. Kirk, and each of them, a proxy of the undersigned,
with full power of substitution, to vote all shares of Common Stock, par value $.01 per
share, of the Company, which the undersigned is entitled to vote at the Annual Meeting of Stockholders to be held on May 10, 2007,
or at any adjournment thereof, with all powers the undersigned would have if personally present.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Address
Change/Comments
(Mark the corresponding box on the
reverse side)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|